PHYSIOLOGICAL REVIEWS
Vol. 80, No. 4, October 2000
Printed in U.S.A.
Proximal Tubular Phosphate Reabsorption:
Molecular Mechanisms
HEINI MURER, NATI HERNANDO, IAN FORSTER, AND JÜRG BIBER
Institute of Physiology, University of Zürich, Zürich, Switzerland
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
I. Introduction: Overall Mechanism
A. Site of reabsorption
B. Cellular mechanism
II. Physiological Regulation
A. Major factors
B. Other factors
III. Pathophysiological Alterations
A. Genetic aspects
B. “Acquired” alterations
IV. Phosphate Transport Molecules in Proximal Tubular Cells
A. Type I Na-Pi cotransporter
B. Type II Na-Pi cotransporter
C. Type III Na-Pi cotransporter
V. Type IIa Sodium-Phosphate Cotransporter: The Key Player in Brush-Border Membrane
Phosphate Flux
A. Transport characteristics
B. Altered expression as the basis for altered Pi reabsorption
C. Cellular mechanisms in the control of type II Na-Pi cotransporter expression
VI. Summary and Outlook
1373
1374
1374
1375
1375
1375
1377
1378
1378
1378
1379
1380
1385
1385
1386
1389
1393
1397
Murer, Heini, Nati Hernando, Ian Forster, and Jürg Biber. Proximal Tubular Phosphate Reabsorption:
Molecular Mechanisms. Physiol Rev 80: 1373–1409, 2000.—Renal proximal tubular reabsorption of Pi is a key
element in overall Pi homeostasis, and it involves a secondary active Pi transport mechanism. Among the molecularly
identified sodium-phosphate (Na/Pi) cotransport systems a brush-border membrane type IIa Na-Pi cotransporter is
the key player in proximal tubular Pi reabsorption. Physiological and pathophysiological alterations in renal Pi
reabsorption are related to altered brush-border membrane expression/content of the type IIa Na-Pi cotransporter.
Complex membrane retrieval/insertion mechanisms are involved in modulating transporter content in the brushborder membrane. In a tissue culture model (OK cells) expressing intrinsically the type IIa Na-Pi cotransporter, the
cellular cascades involved in “physiological/pathophysiological” control of Pi reabsorption have been explored. As
this cell model offers a “proximal tubular” environment, it is useful for characterization (in heterologous expression
studies) of the cellular/molecular requirements for transport regulation. Finally, the oocyte expression system has
permitted a thorough characterization of the transport characteristics and of structure/function relationships. Thus
the cloning of the type IIa Na-Pi cotransporter (in 1993) provided the tools to study renal brush-border membrane
Na-Pi cotransport function/regulation at the cellular/molecular level as well as at the organ level and led to an
understanding of cellular mechanisms involved in control of proximal tubular Pi handling and, thus, of overall Pi
homeostasis.
I. INTRODUCTION: OVERALL MECHANISM
Renal handling of Pi determines its concentration in
the extracellular space, the “traffic” place between the
two major body compartments: skeleton and intracellular
space (37, 46, 101, 102, 216 –218, 374). In cells phosphate
http://physrev.physiology.org
participates in energy metabolism and is a constituent of
signaling molecules, lipids, and nucleic acids. Under “normal” (“steady-state”) physiological conditions, urinary Pi
excretion corresponds roughly to phosphate intake in the
alimentary tract, mainly via upper small intestine (37, 94,
101, 218). To fulfill the “homeostatic” function, i.e., keep-
0031-9333/00 $15.00 Copyright © 2000 the American Physiological Society
1373
1374
MURER, HERNANDO, FORSTER, AND BIBER
Volume 80
ing extracellular Pi concentration within a narrow range,
urinary Pi excretion must be (and is) under strong physiological control (37, 101, 102). In contrast to intestinal Pi
absorption, which adjusts rather “slowly” (for review, see
Refs. 94, 290), renal Pi excretion can “adjust” very fast to
altered physiological conditions.
A. Site of Reabsorption
Renal Pi excretion is the balance between free glomerular filtration and regulated tubular reabsorption. Under normal physiological conditions, ⬃80 –90% of filtered
load is reabsorbed; renal tubular reabsorption occurs primarily in proximal tubules, with higher rates at early
segments (S1/S2 vs. S3) and in deep nephrons (e.g., Refs.
24, 142, 146, 159, 203, 232, 318; for review, see Refs. 37,
218, 374). A small fraction of filtered Pi seems to be
reabsorbed in the distal tubule (13), but the apparent loss
of Pi observed after proximal tubular micropuncture sites
could be most likely explained by the higher reabsorption
in proximal tubules of deep nephrons (for review, see Ref.
37). Therefore, a study/analysis of mechanisms participating at the level of the kidney in control of Pi excretion can
be reduced to phenomena occurring in the proximal tubule.
B. Cellular Mechanism
The cellular mechanisms involved in proximal tubular Pi reabsorption have been studied by a variety of
techniques including in vivo and in vitro microperfusions
(e.g., Refs. 24, 49, 99, 100, 142, 144, 402), tissue-culture
techniques (e.g., Refs. 41, 43, 64, 66, 67, 116, 261, 264), and
studies with isolated brush-border and basolateral membrane vesicles (e.g., Refs. 18, 22, 23, 33–35, 44, 52, 53, 55,
76, 78, 80, 88, 95, 98, 118, 127, 143, 148, 149, 152, 153, 155,
179 –182, 204, 239 –241, 245, 246, 255, 256, 278, 291, 321,
324, 328, 352, 355, 356, 360, 370 –372, 375, 392, 400, 401,
410, 429 – 434). We and others have written previously
several comprehensive reviews on cellular mechanisms
participating in renal tubular handling of Pi and summarized the experiments with above-mentioned techniques
(e.g., Refs. 37, 46, 100, 101, 138, 149, 278, 282, 283, 291).
From these studies a secondary active transport scheme
emerged (see Fig. 1, left). Pi is taken up from the tubular
fluid by (a) brush-border membrane sodium/phosphate
(Na-Pi) cotransporter(s) and leaves the cell via basolateral transport pathways. The brush-border entry step is
the rate-limiting step and the target for almost all physiological (and pathophysiological) mechanisms altering Pi
reabsorption (see below). Basolateral exit is ill defined,
and several Pi transport pathways have been postulated
including Na-Pi cotransport, anion exchange, and even an
“unspecific” Pi leak (channel?). Basolateral Pi transport
has to serve at least two functions: 1) complete transcellular Pi reabsorption in a case where luminal Pi entry
exceeds the cellular Pi requirements and 2) guarantee
basolateral Pi influx if apical Pi entry is insufficient to
satisfy cellular requirements. The second can be considered as a “house-keeping” function and might not be
specific for (re)absorptive cells. In this review we sum-
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
FIG. 1. Scheme for proximal tubular Pi reabsorption. Left: concept of secondary active transport as evidenced by
microperfusion studies and studies on isolated membrane vesicles. Right: Na-Pi cotransporter molecules in the proximal
tubular epithelial cell. For further details and references, see text. [Adapted from Murer et al. (288).]
October 2000
PROXIMAL TUBULAR PHOSPHATE REABSORPTION
marize the present knowledge on the key transporter
molecules involved in proximal tubular transmembrane Pi
movement (apical and basolateral; see Fig. 1, right).
1375
brane Na-Pi cotransport activity (e.g., Refs. 41, 43, 64, 309,
339).
2. Parathyroid hormone
II. PHYSIOLOGICAL REGULATION
A. Major Factors
1. Dietary Pi intake
A low dietary Pi intake can lead to an almost 100%
reabsorption of filtered Pi, whereas a high dietary Pi intake leads to a decreased proximal tubular Pi reabsorption (for review, see Refs. 37, 218). These changes can
occur independent of changes in the plasma concentration of different phosphaturic hormones (for review, see
Refs. 37, 218; see also Refs. 7, 9, 316). Thus an “unknown”
humoral factor may be involved in the mediation of these
effects. However, as evidenced by studies on cultured
renal proximal tubular epithelial cells (e.g., OK cells), a
direct effect (“intrinsic”) of altered Pi concentration in the
extracellular fluid (plasma, glomerular filtrate, culture
media) also elicits changes in apical (brush-border) mem-
3. Vitamin D
Vitamin D is suggested to increase/stimulate proximal tubular Pi reabsorption. 1,25-Dihydroxycholecalciferol treatment of rats was found to stimulate brush-border membrane Na-Pi cotransport (226, 227). It is,
however, difficult to discriminate between direct versus
indirect effects, as in vivo the vitamin D status is closely
associated with alterations in plasma calcium and PTH
concentrations (for review, see Refs. 37, 46, 101, 107).
Thus, at present, it is not clear whether 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] directly regulates mammalian
brush-border membrane Na-Pi cotransport. This is in contrast to the upper small intestine where 1,25(OH)2D3 stimulates brush-border membrane Na-Pi cotransport (for review, see Refs. 94, 290). In chicken tubular preparations,
administration of 1,25(OH)2D3 increased Pi uptake, an
effect prevented by inhibition of protein synthesis (249,
250). However, in these studies in suspended cells, it is
not clear whether the stimulation is related to an increased uptake across the brush-border membrane. It has
been suggested that the effects of 1,25(OH)2D3 are related
to changes in the lipid characteritsics of the membrane
(114; for review, see Refs. 21, 37). A stimulatory effect of
1,25(OH)2D3 was also observed in a subclone of OK cells
and in studies on promoter activation (see sect. VC; Refs.
8, 380).
B. Other Factors
1. Hormonal factors
There are additional hormonal factors (e.g., insulin,
growth hormone/insulin-like growth factor I/other growth
factors, thyroid and other lipophilic hormones, calcitonin,
glucocorticoids, atrial natriuretic peptide, nerve transmit-
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
As already indicated, regulation of proximal tubular
Pi reabsorption and thus of brush-border membrane Na-Pi
cotransport codetermines overall Pi homeostasis. Again,
many reviews summarizing the regulation of proximal
tubular Pi reabsorption at the organ, tubule, cell, and
membrane levels have been written (37, 46, 138, 282–289,
292). This information is briefly presented here. In this
review we focus on the molecular mechanisms underlying
these regulations.
For a brief overview on regulatory events, we focus
on major factors and other factors, and the latter is subdivided into hormonal and nonhormonal factors controlling proximal tubular Pi reabsorption (see Ref. 37). For
each of these regulatory phenomena, a “memory” effect
exists, i.e., the changes are induced by adequate pretreatment, and after characterization (e.g., by clearance techniques) in vivo can then be further analyzed in vitro, e.g.,
in microperfusion studies or in studies with isolated membrane vesicles (for review, see Refs. 37, 46, 138, 282, 283,
287). This memory effect can at present easily be understood, as physiological regulation of Pi reabsorption involves, as far as they have been studied at the molecular
level, an altered expression of a brush-border Na-Pi cotransporter protein (type IIa Na-Pi cotransporter; for review, see Refs. 39, 242, 284 –289, 292; see below). Therefore, they are in all cases, with the possible exception of
“fasting” (204), related to changes in maximum velocity
(Vmax) of brush-border membrane Na-Pi cotransport activity in isolated brush-border membrane vesicles (for
review, see Refs. 37, 46, 107, 206, 283).
Parathyroid hormone (PTH) induces phosphaturia by
inhibiting brush-border membrane Na-Pi cotransport activity; removal of PTH (parathyroidectomy) leads to an
increase in Na-Pi cotransport activity (e.g., Refs. 108, 120,
153; for review, see Refs. 37, 46, 101, 138, 206, 218, 283,
292). These effects can also be analyzed in a tissue-culture
model to study cellular/molecular mechanisms involved
in proximal tubular Pi handling, in opossum kidney cells
(OK cells; Refs. 67, 85, 86, 261–264, 267, 268, 307, 308, 310,
311, 341–345). This in vitro model also provided evidence
for cAMP-dependent and cAMP-independent signaling
mechanisms in PTH action (see below; see also Refs. 85,
86, 235, 264, 308, 329 –333; for review, see Refs. 280, 283,
288, 289).
1376
MURER, HERNANDO, FORSTER, AND BIBER
intracellular calcium concentration (for review, see Ref.
37).
E) GLUCOCORTICOIDS. Glucocorticoids increase phosphate excretion by an inhibition of proximal tubular
brush-border membrane Na-Pi cotransport (47, 127; see
also Ref. 411); this effect can occur independent of an
increase in PTH (for review, see Ref. 37). The effects of
glucocorticoids are also apparent in vitro, in primary
chick proximal tubular cells (299), and in OK cells (192;
see also Refs. 156a, 319, 320). An increase in plasma
glucocorticoid levels may mediate the phosphaturic response in chronic metabolic acidosis (11, 47, 127; for
review, see Ref. 37).
F) ATRIAL NATRIURETIC PEPTIDE. Atrial natriuretic peptide
(ANP) also inhibits proximal tubular brush-border membrane Na-Pi cotransport (156, 429). Although a small effect of ANP, mediated by a rise in cGMP, was observed on
OK cell Na-Pi cotransport (294), a direct effect on proximal tubular cells is questionable, since receptors for ANP
were not identified in proximal tubular epithelial cells (for
review, see Ref. 37). An increase in renal dopamine production (see below) could mediate, in the intact organ,
the effect of ANP on brush-border membrane Na-Pi cotransport (for review, see Ref. 37; see also Ref. 419).
G) PTH-RELATED PEPTIDE. PTH-related peptide produced
by tumors causes phosphaturia. This “PTH analog” causes
phosphaturia by mechanisms identical to that involved in
PTH action (for review, see Refs. 37, 206; see also Refs.
315, 349).
H) PHOSPHATONIN. Studies in patients with tumor-induced osteomalacia, with associated hypophosphatemia
and renal Pi wasting, led to the hypothesis that there is an
additional humoral factor controlling serum Pi concentration and renal Pi handling (for review, see Refs. 37, 111,
224, 225). This as yet unidentified factor was named phosphatonin and is suggested to inhibit proximal tubular Pi
reabsorption (60). It was observed that conditioned culture media from tumor cells derived from patients inhibited OK cell Na-Pi cotransport. This factor (phosphatonin?) was suggested to have a proteinous nature and a
molecular weight between 8,000 and 25,000. The inhibition of Na-Pi cotransport occurred independently of
changes in cellular cAMP content. Also, a PTH-receptor
antagonist was found (but not identified; PTH related) in
these culture media; it interfered with PTH inhibition of
OK cell Na-Pi cotransport but not with the inhibitory
effect of phosphatonin (for review, see Refs. 37, 111, 224,
225).
I) GLUCAGON. Glucagon administration increases Pi excretion. It was suggested that the effect of pharmacological doses of glucagon is indirect and related to an increase in plasma concentration of liver-derived cAMP (3).
J) STANNIOCALCIN. Two different isoforms of stanniocalcin (STC) were identified and suggested to be involved in
calcium and phosphate homeostasis in fish and in mam-
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
ters, prostaglandins, parathyroid hormone-related peptide, phosphatonin, and stanniocalcin) with reported effects on proximal tubular Pi reabsorption, i.e., brushborder membrane Na-Pi cotransport (for review, see Refs.
37, 101, 107, 206, 283).
A) INSULIN. Insulin enhances proximal tubular Pi reabsorption by stimulation of brush-border membrane Na-Pi
cotransport and prevents the phosphaturic action of PTH
(e.g., Ref. 155; for review, see Refs. 37, 150, 206). Specific
binding sites for insulin have been identified in basolateral membranes of proximal tubular epithelial cells (154,
155; for review, see Ref. 150).
B) GROWTH HORMONE/INSULIN-LIKE GROWTH FACTOR I/OTHER
GROWTH FACTORS. Growth hormone, at least in part mediated by insulin-like growth factor I (IGF-I; locally produced in the kidney), stimulates proximal tubular Na-Pi
cotransport (e.g., Refs. 65, 153, 281, 335; for review, see
Refs. 37, 150, 206), an effect also observed in OK cells (63,
193). Receptors for growth hormone have been identified
on the basolateral membrane of proximal tubular cells
and appear to activate the phospholipase C pathway
(350). Receptors for IGF-I have also been identified in
proximal tubular cell membranes, and associated effects
may involve tyrosine kinase activity (151, 154; for review,
see Ref. 150).
Epidermal growth factor (EGF) stimulates Pi reabsorption in perfused proximal tubules (336, 337) but inhibits Pi transport in LLC-PK1 and OK cells (15, 140, 314).
These effects are independent of cAMP and may involve
tyrosine kinase activity and/or phospholipase C activation
(see below; for review, see Ref. 206).
Transforming growth factors [i.e., transforming
growth factor-␣ (TGF-␣)] decrease Na-Pi cotransport activity in OK cells (233, 314). These effects are independent
of cAMP, and the mechanisms might be similar to those in
EGF action, sharing the same receptor (TGF-␣ and EGF;
for review, see Refs. 150, 206).
C) THYROID HORMONE/LIPOPHILIC HORMONES. Thyroid hormone stimulates proximal tubular Pi reabsorption via a
specific increase in brush-border membrane Na-Pi cotransport (31, 118, 213, 433, 434; for review, see Refs. 37,
107). The effect of thyroid hormone can also be observed
in primary cultured chick renal cells and in OK cells and
is dependent on protein synthesis (298, 367).
There are additional lipophilic hormones with reported effects on “renal tubular” Pi transport. All-transretinoic acid (CatRA) specifically increases Na-Pi cotransport in OK cells (30; for review, see Ref. 107). On the other
hand, ␤-estradiol specifically decreases Na-Pi cotransport
in brush-border membranes from adequately pretreated
rats (32; for review, see Ref. 107).
D) CALCITONIN. Calcitonin reduces proximal tubular
brush-border membrane Na-Pi cotransport in a PTH- and
cAMP-independent manner (36, 430, 436; for review, see
Refs. 37, 206). This effect might be mediated by a rise in
Volume 80
October 2000
PROXIMAL TUBULAR PHOSPHATE REABSORPTION
2. Nonhormonal factors
In addition to above hormonal factors, there are several nonhormonal factors known to affect proximal tubular Na-Pi cotransport.
A) FASTING. Fasting may result in phosphaturia and
reverse the effects of a low-Pi diet (for review, see Ref. 37;
see also Ref. 28). This effect relates also to a change in
brush-border membrane Na-Pi cotransport (204). In contrast to dietary Pi-induced changes and other regulatory
conditions, the lowered Pi uptake under fasting conditions might be explained by an increase in the apparent
Michaelis constant (Km) value for Pi (204). The effect of
fasting may involve, but cannot be explained by, an increase in glucagon levels (for review, see Ref. 37).
B) PLASMA CALCIUM. Changes in plasma calcium lead to
changes in renal proximal tubular Pi reabsorption that are
primarily associated with the corresponding changes in
PTH concentration (12, 421; for review, see Ref. 37).
However, in vitro data also suggest a direct cellular effect
of extracellular calcium on proximal tubular brush-border
membrane Na-Pi cotransport (e.g., Ref. 301). In isolated
perfused convoluted rabbit proximal tubules, an increase
in bath and perfusate calcium concentration provoked an
increase in Pi reabsorption (351). In studies on OK cells,
opposite data were obtained: a decrease in medium calcium concentration stimulated Na-Pi cotransport (62).
These differences are not understood but might be related
to the time scale used in the experiments. The effects in
OK cells required prolonged exposure, were dependent
on protein synthesis, and may be related to changes in
intracellular Ca2⫹ concentration (see sect. VC4; see also
Ref. 353).
C) ACID BASE. The influence of changes in systemic
acid-base status on renal proximal tubular Na-Pi cotransport are rather complex and are summarized only briefly.
The effects on the kinetic properties of the carrier are
discussed in section VA4; in brief, an alkaline intratubular
pH leads to a stimulation of Na-Pi cotransport (14, 328,
334, 352; for review, see Refs. 37, 138, 216 –218, 283).
Acute metabolic acidosis does not significantly interfere
with Pi reabsorption. In contrast, chronic metabolic acidosis leads to a decrease in Na-Pi cotransport, most likely
related to the evaluated glucocorticoid levels (11, 47, 127).
These effects are also apparent in OK cells following
appropriate changes in media pH conditions (192, 194).
Respiratory acidosis leads to phosphaturia involving corresponding changes in Na-Pi cotransport. In contrast, respiratory alkalosis stimulates proximal tubular Pi reabsorption (for review, see Ref. 37).
D) VOLUME EXPANSION. Volume expansion of animal increases Pi excretion and decreases Na-Pi cotransport
rates in isolated brush-border membrane vesicles and in
isolated perfused proximal tubules (74, 313, 317, 323, 324;
for review, see Ref. 37). It is assumed that the effect of
volume expansion on proximal tubules is indirect (i.e., via
some humoral factors, in part ANP and/or dopamine).
III. PATHOPHYSIOLOGICAL ALTERATIONS
In addition to the above briefly discussed physiological regulatory mechanisms, that adjust brush-border
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
mals. STC-1 was originally identified in fish and later in rat
kidney, in more distally located nephron segments (420).
STC-2, ⬃34% amino acid similarity to STC-1 (189), was
identified from an osteosarcoma library, and related transcripts were found in different tissues including kidney
(72, 105, 189). STC-1 stimulates proximal tubular brushborder membrane Na-Pi cotransport (409); STC-2 has at
least in vitro (OK cells), the opposite effect, by a suppression of the type IIa Na-Pi cotransporter (189). Thus STC1/2 may serve paracrine modulators of Pi reabsorption.
K) PROSTAGLANDIN. Prostaglandins, produced intrarenally, also modulate renal Pi handling. PGE2 antagonizes
the phosphaturia observed under different physiological
conditions, e.g., increased PTH levels. This effect is in
part, but not fully, explained by effects on the cAMP
signaling cascade. The latter is illustrated by the observation that inhibition of renal prostaglandin synthesis (by
indomethacin) potentiates the cAMP-independent phosphaturic action of calcitonin (36; for review, see Ref. 37).
L) NERVE TRANSMITTERS. Nerve transmitters also appear
to control renal proximal tubular Na-Pi cotransport. Acute
renal denervation increases renal Pi excretion, independent of the PTH status (for review, see Ref. 37). These
effects can be related to the production of dopamine
and/or reduced ␣- or ␤-adenoreceptor activity. Dopamine
and its precursor L-dopa increase Pi excretion (104, 187,
188) and inhibit Na-dependent Pi transport in OK cells as
well as in isolated rabbit proximal tubules (19, 79, 104,
129, 137, 196). Dopamine can be generated from L-dopa
after brush-border membrane uptake of ␥-glutamyl-L-dopa
and leads in an autocrine/paracrine manner via a stimulation of adenylate cyclase to the inhibition of brushborder membrane Na-Pi cotransport (104). Stimulation of
␣-adenoreceptors might interfere with hormone-dependent stimulation of adenylate cyclase activity (e.g., by
PTH) and might therefore lead to an apparent increase in
Na-Pi cotransport activity, and explain a hypophosphaturic action of ␣-agonists (70, 403, 422, 423; see also Ref.
234). In addition, stimulation of ␣-adenoreceptors in OK
cells blunted the actions of PTH on cAMP production and
inhibition of Na-Pi cotransport (77; see also Ref. 103).
Serotonin is also synthesized in the proximal tubules and
is antiphosphaturic; it stimulates proximal tubular Pi reabsorption (103, 128, 129, 147).
Adenosine infusion in rats stimulates renal Pi reabsorption (312).
1377
1378
MURER, HERNANDO, FORSTER, AND BIBER
Na-Pi cotransport to the needs of body Pi homeostasis,
there are genetically determined alterations in renal Pi
handling and “acquired” alterations in renal Pi reabsorption.
A. Genetic Aspects
B. Acquired Alterations
Disturbances in proximal tubular Pi transport seem
to be an early indicator of “nonspecific” proximal tubular
alterations, occurring as a consequence of “unphysiological” extrarenal factors (for review, see Refs. 216, 217).
This may be explained by the specific kinetic properties of
the brush-border membrane Na-Pi cotransporter (see
sect. VH ). An example of this may be the observed phosphaturia when the filtered load of glucose is augmented
(in diabetes mellitus), where a “competition” for driving
force will reduce Na-Pi cotransport rate (22, 392). More
generally speaking, when driving forces across the brushborder membrane (Na⫹ gradient and/or membrane potential) are altered, the transport of phosphate will be reduced and thus phosphaturia will occur. Furthermore, as
part of its physiological regulation, the transporter protein mediating the rate-limiting Na-Pi cotransport has a
high turnover. Therefore, “damage” to the brush-border
membrane or the transporter protein itself will result in a
massive reduction in the brush-border membrane content
of Na-Pi cotransporters and thus reduce Pi transport leading to phosphaturia. This may explain, for example, the
sensitivity of renal Pi reabsorption to heavy metal intoxication (see Refs. 4, 141, 169).
Diuretics may inhibit proximal tubular Pi reabsorption when administered to animals or intact tubular preparations (for review, see Ref. 37). Because the greatest
effect is produced by acetazolamide, it is assumed that
inhibition is related to an inhibition of carbonic anhydrase; therefore, the effect is also dependent on the presence of bicarbonate. The effect of other diuretics on
proximal tubular Pi reabsorption correlates to some extent with their potency to inhibit carbonic anhydrase.
Inhibition of carbonic anhydrase leads to acute and/or
chronic changes in systemic and/or tubular pH, which in
turn causes the changes in Pi reabsorption.
IV. PHOSPHATE TRANSPORT MOLECULES
IN PROXIMAL TUBULAR CELLS
The cellular scheme for proximal tubular Pi reabsorption given above includes three Na-Pi cotransporters (Fig.
1). They have been molecularly identified and have been
named type I, type II, and type III Na-Pi cotransporters
(175; for review, see Refs. 284 –289, 377). However, there
may be additional pathways in the brush-border and basolateral membranes that have not yet been defined at the
molecular level. In heterologous expression systems (e.g.,
Xenopus laevis oocytes), the corresponding cRNA/proteins augment highly Na⫹-dependent Pi uptake. The three
families of Na-Pi cotransporters share no significant homology at the level of their primary amino acid sequence
(Fig. 2 and Table 1). We discuss the structural properties,
tissue expression, and functional characteristics of these
three families of Na-Pi cotransporters. Because the type
IIa Na-Pi cotransporter is the key player (see sect. V), the
kinetic properties and the regulatory behavior of the type
IIa transporter are then covered separately and in more
detail.
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
The genetic aspects of proximal tubular Na-Pi cotransport have been covered in many reviews (e.g., Refs.
338, 384, 390), and we only mention those disorders that
have been characterized at the molecular level. Several
genetic defects resulting in isolated renal phosphate wasting have been described, such as X-linked hypophosphatemic rickets (XLH; e.g., Refs. 295, 384, 385), autosomal dominant hypophosphatemic rickets not associated
with hypercolcinuria (ADHR, 110, 113), and hereditary
hypophosphatemic rickets with hypercalciuria (HHRH;
136, 394). The first is caused by mutations in the PHEX
gene, which has homology to neutral endopeptidase
genes and is hypothesized to process or degrade a circulating factor that regulates by an unknown mechanism
renal brush-border membrane Na-Pi cotransport (see below; for review, see Refs. 110, 112, 384, 390). A candidate
gene for ADHR and/or HHRH could be the brush-border
membrane Na-Pi cotransporter (see below). However, the
gene involved in ADHR was recently mapped to chromosome 12p13 (113), a gene locus different from the brushborder Na-Pi cotransporter (5q35; 222, 223; see below).
Although HHRH has the biochemical features of mice
with a gene deletion for the brush-border membrane Na-Pi
cotransporter (25; see below), recent studies on a bedouin
kindred with HHRH do not support the hypothesis of a
direct involvement of the transporter gene in HHRH (A. O.
Jones, I. Tzenova, T. M. Fujiwara, D. Frapier, M. Tieder, K.
Morgan, and H. S. Tenenhouse, unpublished data). An
interesting form of a genetically determined reduction in
renal Pi handling is in Dent’s disease, where mutations in
a chloride channel (CLC5) lead to an apparent Pi transport defect (252; for review, see Ref. 391). How the loss of
function of an endosomal chloride channel leads to a
decreased brush-border Na-Pi cotransport needs to be
determined. Other genetic defects in renal Pi handling are
secondary to changes in vitamin D, PTH, or acid/base
metabolism or are a consequence of more general metabolic disorders (for review, see Refs. 109, 216, 217, 338,
390).
Volume 80
1379
PROXIMAL TUBULAR PHOSPHATE REABSORPTION
October 2000
FIG. 2. Hydrophobicity predictions for the type I, type II, and type
III Na-Pi cotransporters. Shaded areas
indicate potential transmembrane
segments. Sequence similarities are
indicated by the vertical bars. For further discussion and references, see
text.
A cDNA related to the type I Na-Pi cotransporter was
initially identified by screening a rabbit kidney cortex
library for expression of Pi transport activity in X. laevis
oocytes (416). Homologous cDNA (and in part proteins)
were then found in human, mouse, and rat kidney cortex,
in cerebellar granular cells, and in Caenorhabditis elegans (81, 82, 247, 248, 276, 277, 296, 297; for review, see
Ref. 414).
The gene encoding the type I cotransporter (NPT 1)
maps in humans to chromosome 6 p21.3-p23 (82, 223), in
mouse to chromosome 13 close to the Tcrg locus (81,
TABLE
437), and in rabbits to chromosome 12p11 (223). The
promoter organization of NPT 1 has been characterized;
104 bp upstream of exon 1, a single transcription start site
was found and a TATA-like sequence at ⫺41 (378).
Type I transporter mRNA has been detected by in situ
hybridization in mouse kidney proximal tubules and to a
lesser extent also in distal tubules (81). In rabbits, RTPCR of microdissected tubular segments localized type I
mRNA to the proximal tubules (92). Immunohistochemical experiments and studies with isolated membranes
localized the type I transporter protein to the proximal
tubular brush-border membrane in rabbits and in mice
(40; M. Lötscher, J. Biber, and H. Murer, unpublished
1. The three families of Na-Pi cotransporters
Type II
Family Name
Molecule name
Chromosomal location
(human)
Amino acids
Predicted
transmembrane
segments
Function (in Xenopus
oocytes)
Substrate
Affinity for Pi
Affinity for Na⫹
Na⫹-Pi coupling
pH dependence
Tissue expression
(mRNA protein)
Regulated by PTH/Pi diet
Type I
Type IIa
NaPi-I, rabbit, rat, mouse, or
human (NaPi-1, NPT1,
Npt1)
6
NaPi-IIa, mouse, rat,
human, rabbit, or
opossum (NaPi-2/3/
4/6/7)
5
⬃465
6–8
⬃640
8
Na-Pi cotransport, Cl channel
activity, interaction with
organic anions
Pi, organic anions
⬃1.0 mM
50–60 mM
⬎1
Na-Pi cotransport,
electrogenic, pH
dependent
Pi
0.1–0.2 mM
50–70 mM
3
Stimulated at high pH
Kidney cortex/PT
Kidney cortex/PT, liver, brain
No
PT, parathyroid; PTH, parathyroid hormone.
PTH and Pi diet
Type IIb
NaPi-IIb, mouse,
human, flounder, or
Xenopus (NaPi-5)
4
⬃690
8
Type III
Glvr-1 (PiT-1)
Ram-1 (PiT-2)
human, mouse, rat
2 (PiT-1)
8 (PiT-2)
679, 656
10
Na-Pi cotransport,
electrogenic
Na-Pi cotransport,
electrogenic
Pi
0.05 mM
33 mM
3
“Decreased” at high pH
Small intestine, lung,
and other tissues
Pi diet
Pi
0.025 mM
40–50 mM
3
“Decreased” at high pH
Ubiquitous
(Pi diet)
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
A. Type I Na-Pi Cotransporter
1380
MURER, HERNANDO, FORSTER, AND BIBER
Volume 80
FIG. 3. Proximal tubular expression of the type IIa Na-Pi cotransporter protein (left) and mRNA
(right). The protein shows a luminal
and some distinct intracellular localization. The mRNA is also exclusively
located in the proximal tubules. P,
proximal tubules; G, glomeruli; D, distal tubules. For comparison, see also
Figures 11 and 12. For details, see
text and references given in the text.
protein may or may not be a Na-Pi cotransporter itself but
rather an anion channel protein with expression in renal
brush-border membrane. Its role in proximal tubular secretion of anions (e.g., organic anions, xenobiotics) needs
to be determined. Certainly, the above-described characteristics of type I transporter-induced Na⫹-dependent Pi
uptake does not resemble the characteristics of Na⫹dependent Pi uptake in brush-border membrane vesicles
(e.g., Ref. 14; for review, see Refs. 138, 283). Therefore,
the type I transporter is not a major player in mediating or
controlling brush-border membrane Na-Pi cotransport.
Yabuuchi et al. (426) have studied in more detail the
anion conductive properties of the type I Na-Pi cotransporter (human Npt 1). In oocytes, benzylpenicillin, ␤-lactam antibiotics, probenecid, foscarnet, and melavonic
acid were transport substrates. In the hepatocytes, Npt 1
was located on the sinusoidal membrane (426).
To establish the physiological role of NPT 1 in above
anion secretion (as well as in renal Pi handling), gene
deletion experiments are required (H. S. Tenenhouse and
I. Soummounou, personal communication).
B. Type II Na-Pi Cotransporter
The cDNA encoding the type II (type IIa) Na-Pi cotransporter was identified by expression cloning in X.
laevis oocytes, from rat and human kidney cortex libraries, respectively (260). Homology-based approaches then
led to the identification of type II-related transporters in
kidneys from different species including flounder and
zebrafish, in opossum kidney cells (OK cells), and in a
bovine epithelial cell line (NBL-1; Refs. 87, 88, 163, 168,
219, 294a, 366, 405, 417; see also Fig. 3). A type II-related
Na-Pi cotransporter was identified in apical membranes of
mammalian small intestine and type II pneumocytes (121,
175, 396) and has been designated type IIb Na-Pi cotransporter (Table 1). The regions with highest homology be-
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
observations). Studies on brush-border membranes provided evidence for a higher expression in “deep” juxtamedullary compared with superficial nephrons (97).
On the basis of hydropathy predictions, the type I
Na-Pi cotransporter protein may contain six to eight transmembrane regions (Fig. 2); it contains three N-glycosylation motifs of which some are used as indicated by immunoblotting studies with isolated brush-border
membrane vesicles and by in vitro translation experiments (416; for review, see Refs. 285, 284, 414).
The induction of increased Na-Pi cotransport activity
after injection into X. laevis oocytes was the basis for the
expression cloning of the cDNA encoding the type I Na-Pi
cotransporter cDNA (416). Stable transfection of type I
transporter cDNA into Madin-Darby canine kidney
(MDCK) and LLC-PK1 cells resulted also in an increased
cellular uptake of Pi (325). Na⫹-dependent Pi uptake,
induced after expression of the type I transporter in oocytes, has been extensively characterized (50, 56, 276, 297,
416). The apparent Km for Pi was ⬃0.3 mM for expression
of the human and ⬃1 mM for the rabbit type I Na-Pi
cotransporter. The apparent Km value for Na⫹ interaction
was ⬃50 mM,with a Hill coefficient exceeding unity. Furthermore, no pH dependence of type I transporter-mediated Na⫹-dependent Pi uptake could be observed in oocytes. In electrophysiological studies in oocytes, evidence
was obtained that the type I transporter protein might be
multifunctional, since evidence for anion channel function with permeability for chloride and different organic
anions was obtained (50, 57). In the oocyte experiments it
was observed that the induction of chloride conduction
by expression of the type I transporter cDNA was time
and dose dependent, in contrast to Na⫹-dependent Pi
uptake, which was maximally increased at low doses of
injected cRNA and after short time periods of expression
(50). This could suggest that the type I transporter protein
may modulate an intrinsic “oocyte” Na-Pi uptake activity,
present not only in oocytes, and that the type I transporter
October 2000
PROXIMAL TUBULAR PHOSPHATE REABSORPTION
1381
tween type IIa and type IIb transporters are in transmembrane domains, and regions with no or little homology are
at the cytoplasmic NH2 and COOH termini (Fig. 4; Ref.
175).
Werner et al. (414) compared the sequences of the
type II Na-Pi cotransporters (Fig. 5) and three “families”
were identified. Interestingly, the type IIa transporter is
preferentially expressed in kidney, with a proximal tubular apical location (see sect. VB1). The type IIb transporter
can have multiple locations; in mammals, it is expressed
in the small intestine, type II pneumocytes, and other
tissues, whereas in nonmammalian vertebrates it can be
either in the kidney and/or small intestine (175, 190, 219,
294a, 396). A type IIa Na-Pi cotransporter appears to be
expressed also in osteoclasts and may play a role in bone
resorption (145). A type II Na-Pi cotransporter seems also
to be expressed in brain, where the function is not yet
established (177). Finally, type II related proteins appeared very early in evolution, and related genes were
found in Vibrio cholerae and C. elegans (see Fig. 5; for
review, see Ref. 414).
1. Chromosomal location/genomic organization
The human type IIa cotransporter gene (NPT 2) maps
to chromosome 5q35 (Fig. 6; Refs. 222, 223, 269, 277) and
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
FIG. 4. Sequence comparisons between type IIa and type IIb Na-Pi cotransporters. Predicted transmembrane areas
are given by black bars above the sequences and show high sequence homologies. For further discussion, see text and
included references. [Adapted from Hilfiker et al. (175).]
1382
MURER, HERNANDO, FORSTER, AND BIBER
Volume 80
2. Tissue-specific expression
FIG. 5. Evolutionary tree of type II Na-Pi cotransporters identified in
different species. The database accession numbers are as follows:
mouse kidney, L33878 and U22465; rat kidney, L13257; human kidney,
L13258; sheep, AJ001385; rabbit kidney, U20793; opossum kidney cells,
L26308; mouse intestine, AF081499; human intestine, AF111856; bovine
kidney cells, X81699; chicken kidney (A. Werner, unpublished data);
carp kidney (Werner, unpublished data); zebrafish kidney (Werner, unpublished data), flounder kidney and intestine, U13963; Xenopus intestine, L78836; zebrafish intestine (Werner, unpublished data); Vibrio
cholerae, AJ010968; Caenorhabditis elegans, AF095787. A type II Na-Pi
cotransporter was also identified from sheep kidney (S. P. ShiraziBeechey, unpublished data; accession number AJ001385). [Dendrogram
is extended from that published by Werner et al. (414) and given to us
courtesy of Andreas Werner.]
the murine (Npt 2) gene to chromosome 13B (437). The
human type IIb Na-Pi cotransporter maps to chromosome
4p15–16 (418a).
The genomic structure of NPT 2 (human IIa) and Npt
2 (murine IIa) has been determined; they are ⬃16 kb in
length and consist of 13 exons and 12 introns (Fig. 6; Refs.
162, 379). In the promoter region of the human, murine
and OK cell NPT 2/Npt 2 gene, a TATA box is present 31
bp upstream from the transcription start sites. A GCAAT
element and several AP-1 sites may control promoter
activity (162, 379). The NPT 2/Npt 2 promoter is active
only in a proximal tubular environment, i.e., in OK cells
(162, 174, 176). 5⬘-Flanking sequences of the OK cell type
II Na-Pi cotransporter gene contain elements mediating
transcriptional control under different bicarbonate/carbon dioxide tensions (194). For the rat Npt 2 promoter, an
important role of repeating AP-2 consensus sites in regu-
In situ hybridization of renal sections (Fig. 3) and
nephron microdissection, followed by RT-PCR, documented that type IIa mRNA expression is restricted to the
kidney proximal tubule (87, 91, 348, 388). Therefore, in
mouse kidney, the type IIa is by far the most abundant of
known Na-Pi cotransporters (388). Type IIa Na-Pi cotransporter protein is found in the brush-border membrane of
proximal tubules (see Fig. 3; Refs. 91, 348). Inter- and
intranephron distribution type of IIa Na-Pi cotransporter
highly depends on the physiological requirements within
overall Pi homeostasis, (see Figs. 3 and 11; Refs. 91, 210,
243, 348; for review, see Refs. 242, 284 –287). The type IIa
Na-Pi cotransporter is also expressed in OK cells but not
in other renal cell lines (310, 311, 366, 386, 424; and J.
Forgo, G. Strange, J. Biber, and H. Murer, unpublished
observations). Recently, a type IIa transporter proteinrelated immunoreactivity was observed in membrane
fractions isolated from nontransformed immortalized
mice kidney cortex epithelial cells (71). There is no evidence that the type IIa Na-Pi cotransporter is expressed in
primary renal proximal tubular epithelial cell cultures
(Forgo et al., unpublished observations). Its expression in
OK cells is the basis for the use of this cell line as an in
vitro model for the study of cellular mechanisms involved
in regulation of type IIa Na-Pi cotransport activity (see
Refs. 192–194, 234 –236, 263, 307–311; for review, see Refs.
283–288).
The related type IIb Na-Pi cotransporter is found in
the apical membrane of upper small intestinal enterocytes
and type II pneumocytes (see Refs. 175, 396); type IIb
transcripts have been found in a variety of other tissues
(175).
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
lating cell-specific expression was documented (359). In
reporter gene studies, no physiological regulation (e.g., by
low-Pi medium, PTH, thyroid hormones, and growth factors) was observed using a short promoter (327 bp) fragment (174, 176). However, in COS-7 cells expressing the
human vitamin D receptor, a vitamin D response element
was observed at ⬃2 kb upstream from the transcription
initiation site of the NPT 2/Npt 2 gene (380). Furthermore,
regulatory sequences within the NPT 2 gene, ⬃1 kb upstream of the transcription start site, were identified as
binding sites to nuclear proteins upregulated in kidneys of
weaning mice fed a low-Pi diet (212a). The corresponding
DANN-binding protein could be identified; it corresponds
to a known transcription factor (TFE3) that activates
transcription through the ␮E3 site of the immunoglobin
heavy chain enhancer (212a). The mRNA encoding TFE3
was found to be significantly increased in kidney tissues
of weaning mice fed a low-Pi diet (212a).
October 2000
PROXIMAL TUBULAR PHOSPHATE REABSORPTION
1383
3. Structural aspects
Hydropathy analysis predicted eight transmembrane
segments for the type IIa cotransporter protein (Fig. 2;
Ref. 260; for review, see Refs. 284, 285). This membrane
topology was supported by several experimental findings:
1) insertion of FLAG epitopes and accessibility of the
epitope to antibodies (231); 2) lack of accessibility of
antibodies directed against COOH- and NH2-specific
amino acid sequences (231); 3) identification of two glycosylation sites in the second “suggested” extracellular
loop (166); and 4) accessibility to membrane-impermeant
sulfhydryl reagents after insertion of cysteine residues at
specific sites of the protein (228, 229). Two regions may
penetrate partially into the lipid bilayer (Fig. 7).
Type IIa Na-Pi cotransporters contain numerous potential phosphorylation sites for protein kinase C and casein II
kinases (165, 260). The role of these sites in physiological
control of transport activity is not clear (see sect. VC4).
On immunoblots of brush-border membrane proteins
performed under nonreducing conditions, the type IIa
Na-Pi cotransporter shows an apparent molecular mass of
80 –90 kDa; under reducing conditions two bands of
⬃45–50 kDa appear (39, 48, 91, 425). The latter suggests
that the transporter might be proteolytically cleaved between the two glycosylation sites at positions N298 and
N328 (39, 48, 228, 229, 305). It is not known whether this
proteolytic cleavage occurs in situ or whether it is experimentally induced. Site-directed mutagenesis studies doc-
umented an S-S bridge in the second extracellular loop
(Fig. 7; Refs. 228, 229). It is of interest that separate
oocyte injections of cRNA encoding NH2- and COOHterminal fragments of the flounder type IIb Na-Pi cotransporter resulted in induction of Pi uptake activity only if
both “parts” of the proteins were “present” (220).
The question of a multimeric structure of the type IIa
cotransporter has been addressed mainly in radiation inactivation studies (33, 98, 195). The size of the functional
unit of brush-border membrane Na-Pi cotransport (mostly
type IIa Na-Pi cotransporter mediated) was found to be
between 170 and 200 kDa, suggesting a multimeric structure. Recent experiments in oocytes expressing wild-type
and mutant (inactivatable, cysteine insertion) type IIa
Na-Pi cotransporters suggested that each individual wildtype cotransporter molecule within an assumed homomultimeric complex is functional (220a). The apparent
high functional molecular mass observed in brush-border
membranes could also be due to a heteromultimeric complex (see below). The experiments in different heterologous expression systems (e.g., in Sf9 cells, Refs. 134, 135;
in MDCK cells and LLC-PK1 cells, Refs. 325, 326; and in
oocytes, Ref. 260) suggest that an unknown additional
protein within the functional complex is not an obligatory
requirement for the type IIa Na-Pi cotransporter-mediated
Pi uptake activity or, rather unlikely, is present as an
intrinsic protein (to serve as a transporter subunit) in
different expression systems.
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
FIG. 6. Chromosomal location and genomic organization of human type IIa Na-Pi cotransporter. The gene is localized
on chromosome 5 (5q35) and has 12 introns and 13 exons. The position of the introns and their size is given with respect
to the transcription initiation site. For further discussion, see text and included references. [Adapted from Hartmann et
al. (162) and Kos et al. (222).]
1384
MURER, HERNANDO, FORSTER, AND BIBER
Volume 80
Tatsumi et al. (381) have identified type IIa Na-Pi
cotransporter-related cDNA (named NaPi-2␣, NaPi-2␤,
and NaPi-2␥). The NaPi-2␣-encoded protein (355 amino
acids) has a high homology to the NH2-terminal half of the
type IIa cotransporter, NaPi-2␤ encodes for 327 amino
acids identical to the NH2-terminal part of type IIa cotransporter with a completely different 146-amino acid
COOH-terminal end, and NaPi-2␥ encodes a 268-amino
acid protein from the COOH-terminal end of the molecule
(381). It seems that the related mRNA are formed by
alternative splicing of the type IIa cotransporter gene
(381). Isoform specific mRNA were found on Northern
blots of rat kidney cortex mRNA. With the use of a fulllength type IIa Na-Pi cotransporter cDNA probe, the major transcript detected was ⬃2.6 kb (260, 381). Additional
bands (9.5, 4.6, and 1.2 kb) were seen, although in our
experience, these bands are not abundant (260, 381). The
NaPi-2␣ probe hybridizes with transcripts of 9.5 and 4.6
kb, the NaPi-2␤ probe with a transcript of 1.2 kb, and the
NaPi-2␥ probe with transcripts of 9.5 and 2.6 kb (381). In
Western blots, with the use of NH2- or COOH-terminal
type IIa Na-Pi cotransporter specific antibodies, proteins
of 45, 40, and 37 kDa were observed, corresponding approximatively to the size of the in vitro translated proteins
(NaPi-2␣, NaPi-2␤, NaPi-2␥; Ref. 381). The full-length type
IIa Na-Pi cotransporter protein is recognized in Western
blots from brush-border membrane as a 80- to 90-kDa
protein in its glycosylated form (87). In our hands, the
lower molecular mass bands are not detected in the absence of reducing agents (see Refs. 39, 91). Because they
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
FIG. 7. Secondary structure (membrane topology) of type IIa Na-Pi cotransporter (rat, NaPi-2). The model is derived
from hydropathy predictions (Fig. 2; Ref. 260) and is experimentally supported by studies on N-glycosylation (166),
accessibilities of specific antibodies to either the NH2 or COOH terminus (231), FLAG-epitope insertion (231), and
cysteine insertions/deletions (228, 229). For further details, see text and included references.
October 2000
PROXIMAL TUBULAR PHOSPHATE REABSORPTION
C. Type III Na-Pi Cotransporter
Surprisingly, the receptor for gibbon ape leukemia
virus (Glvr-1) and the receptor for the mouse amphotropic retrovirus (Ram-1) have been shown to mediate
Na-Pi cotransport activity after their expression in X.
laevis oocytes (201, 202, 302). The transporter proteins
have been named PiT-1 and PiT-2 and are now classified
as type III Na-Pi cotransporters (Table 1).
Expression of type III Na-Pi cotransporters seems to
be ubiquitous, and related mRNA have been identified in
kidney, parathyroid glands, bone, liver, lung, striated muscle, heart, and brain (Table 1; Refs. 84, 201, 202, 302, 303,
362, 382). In mouse kidney, transcripts of type III cotransporters are found throughout the different structures
(362, 388). Immunofluorescence studies showed in the
proximal tubule a basolateral location (C. Silve, personal
communication). Based on mRNA levels, type III Na-Pi
cotransporters are two orders of magnitude less abundant
than type IIa transporters (388). Its role in the proximal
tubule seems not to be in transcellular Pi transport but
rather in cell Pi uptake if luminal Pi entry is insufficient for
cell metabolic functions. Type III transporter expression
seems not to be altered by PTH (386).
The type III transporters show some homology to a
Neurospora crassa gene (Pho-4⫹) involved in transmembrane Pi movements (302). Hydropathy analysis suggests
10 transmembrane regions (Fig. 2; Refs. 201, 202).
PiT-1- and PiT-2-mediated Na-Pi cotransport has been
studied by expression in X. laevis oocytes or in fibroblast
transfection (201, 202, 302). Transport is characterized by
a Km for Pi in the order of 20 –30 ␮M and a Km for Na of
40 –50 mM. pH dependence of type III Na-Pi cotransporter
is opposite to the type IIa cotransporter, i.e., decreased
activity by increasing pH. Similar to the type IIa, type
III-mediated transport of Pi is electrogenic with a net
influx of a positive charge during the transport cycle,
suggesting also a 3:1 stoichiometry .
V. TYPE IIA SODIUM-PHOSPHATE
COTRANSPORTER: THE KEY PLAYER
IN BRUSH-BORDER MEMBRANE
PHOSPHATE FLUX
The tissue expression, the relative renal abundance,
and overall transport characteristics of type I, II (IIa), and
III Na-Pi cotransporters suggest that the type IIa transporter plays a key role in brush-border membrane Pi flux.
As discussed in this section, changes in expression of the
type IIa Na-Pi cotransporter protein parallel alterations in
proximal tubular Pi handling, documenting its physiological importance (for review, see Refs. 242, 284 –289). In
addition, experiments on molecular (genetic) suppression
of the type IIa Na-Pi cotransporter support its role in
mediating brush-border membrane Na-Pi cotransport. 1)
Intravenous injection of specific antisense oligonucleotides led to reduced brush-border membrane Na-Pi cotransport activity that was associated with a decrease in
type IIa cotransporter protein (300). 2) Disruption of the
type IIa Na-Pi cotransporter gene (Npt 2) in mice led to an
⬃70% reduction in brush-border Na-Pi cotransport rate
and complete loss of the protein (25, 178; see also below).
The molecular basis for the remaining brush-border membrane Na-Pi cotransport after Npt 2 gene disruption is
unclear. Either the type I transporter protein or another
not yet identified Na-Pi cotransporter could account for
residual transport activity. 3) Injection of type IIa antisense oligonucleotides in oocytes completely inhibited
Na-Pi cotransport mediated by kidney cortex mRNA, confirming its major role in brush-border membrane Na-Pi
cotransport (275, 276, 389, 415).
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
are only visible under reducing conditions, type 2␣, 2␤,
and/or 2␥ related proteins might be linked to the full size
type IIa Na-Pi cotransporter via S-S bridges. Alternatively,
the possibility exists that the smaller proteins, apparent
after reduction of S-S bridges, are a product of proteolytic cleavage of the full size type IIa Na-Pi cotransporter protein (see above). Based on coexpression experiments in oocytes, Tatsumi et al. (381) postulated
that the smaller isoforms might regulate, in a dominant
negative manner, the function of the type IIa Na-Pi
cotransporter protein. However, this interpretation requires further studies to, for example, document the
coexistence, within a “heterologous” complex, of the
different proteins at the brush-border membrane. Furthermore, quantitative aspects are crucial, since in our
experience NaPi-2␣, -2␤, and -2␥ can only be present in
rather small amounts relative to the full size type IIa
cotransporter. Thus the role of the small type IIa Na-Pi
cotransporter-related proteins in brush-border membrane Na-Pi cotransport in vivo is not clear.
An antisense type IIb Na-Pi cotransporter transcript
was detected in different nonmammalian tissues. It was
postulated that it might be involved in the control of
cotransporter protein expression (physiological control;
tissue specificity; Ref. 184).
When expressed in X. laevis oocytes, the type IIa
Na-Pi cotransporter mediates Na-Pi cotransport activity
with functional characteristics identical to those observed in isolated brush-border vesicles (87, 163, 260, 366,
405). A 3:1 stoichiometry (Na⫹:Pi) is the basis for its
membrane potential sensitivity (electrogenicity; e.g., Refs.
59, 123). As discussed in section V, the transport characteristics and kinetic behavior of the type IIa transporter
have been studied in great detail. Similar transport characteristics were also observed in different other heterologous expression systems such as insect Sf9 cells, fibroblasts, and MDCK cells (134, 135, 326, 395).
1385
1386
MURER, HERNANDO, FORSTER, AND BIBER
A. Transport Characteristics
1. Steady-state electrophysiological characteristics
Under voltage-clamp conditions, superfusion of oocytes expressing the rat type IIa cotransporter with 1 mM
Pi in the presence of Na⫹ (100 mM) elicits an inward
current, the magnitude of which depends on the holding
potential (Fig. 8, A and B; Refs. 56, 58, 59, 122, 123, 125,
126, 407, 408). This observation indicates that a Pi-induced inward movement of positive charge(s) occurs during the transport cycle. At a given membrane potential,
dose-response relationships can then be obtained for both
Na⫹ and Pi. Furthermore, the interdependence of the
apparent affinity for either Na⫹ or Pi and/or the applied
membrane potential was studied (e.g., Ref. 122). For Pi, a
hyperbolic saturation curve is observed, whereas for Na⫹,
the saturation curve is sigmoidal (Fig. 8, C and D). At 100
mM Na⫹, the apparent Km for Pi interaction is ⬃0.1 mM
and shows little dependency on the holding potential (Fig.
8E). At 1 mM Pi, the apparent Km for Na⫹ interaction is
⬃50 mM (Fig. 8F). The concentration dependence of Piinduced current depends on the external Na⫹ concentration with a dual effect: increasing Na⫹ leads to a decrease
in the apparent Km for Pi and to an increase in the
apparent Vmax (Fig. 8C). On the other hand, increasing Pi
also leads to an increase in affinity for Na⫹ (Fig. 8D). At
the lower Na⫹ concentrations, the apparent Km for Pi
interaction shows a marked dependence on the holding
membrane potential (Fig. 8E); this is not observed for the
Km for Na⫹ interaction (Fig. 8F). Finally, these saturation
experiments provide some information with respect to
the stoichiometry (Pi :Na⫹). Hill coefficients calculated on
the basis of the Pi saturation curves were always close to
1, whereas those calculated for Na⫹ saturation were always close to 3 (e.g., Refs. 59, 122 123). A 3:1 stoichiometry explains the positive inward current (59, 122, 123).
The stoichiometry (Na⫹:Pi) has been determined more
directly by simultaneous measurements of substrate flux
and charge movement under voltage-clamp conditions in
the same oocytes (123). It was found that translocation of
a positive charge into the oocyte is associated with the
transfer of 1 Pi and 3 Na⫹. These experiments also provided evidence for the preferential transport of divalent Pi
anions (123).
The antiviral agent foscarnet (phosphonoformic acid,
PFA) is a known competitive inhibitor of brush-border
membrane Na-Pi cotransport (e.g., Refs. 10, 205, 256, 375,
404). In electrophysiological studies, PFA inhibited Piinduced inward currents but did not elicit PFA-induced
currents (59, 122). Thus PFA interferes with Pi binding but
is not a transported substrate. In addition, arsenate is a
competitive inhibitor of brush-border membrane and oocyte type IIa Na-Pi cotransporter-mediated Pi uptake
(179). In contrast to PFA, arsenate induces inward currents and is thus a transported substrate (e.g., Ref. 163).
Recently, a “slippage current” associated with the transfer
of the partially loaded type IIa cotransporter was identified (only with Na⫹, see below; Fig. 9; Ref. 122). This
current was blocked by PFA and showed a dose dependence suggesting interaction with only one Na⫹. The slippage current accounts for ⬃10% of maximally induced
current of the fully loaded carrier (122). Although this
slippage current is of little functional significance, it is
important in our understanding of the transporter cycle
(see sect. VA3).
2. Pre-steady-state electrophysiological characteristics
Pre-steady-state relaxation’s resulting from the application of voltage steps to the voltage-clamped cell have been
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
As already indicated, the transport characteristics of
the type IIa cotransporter heterologously expressed in
different cellular systems (mainly X. laevis oocytes) resembles closely those of Na-Pi cotransport activity observed in isolated brush-border membranes (e.g., Refs. 87,
88, 163, 168, 219, 260, 366, 405, 417). In particular, in all
expression systems studied thus far, type IIa-mediated
Na-Pi cotransport activity increased with increasing media pH values, a “signature” for proximal tubular brushborder membrane Na-Pi cotransport (e.g., Refs. 14, 260).
The simplest experimental technique to analyze the
transport characteristics of a Na-substrate cotransporter
is by studying Na⫹ gradient-driven tracer substrate influx
under different conditions. For the type IIa cotransporter,
this has been done already in 1976 in isolated rat brushborder membrane vesicles (179); obviously, it was then
not known that the brush-border Na-Pi cotransport activity is mostly associated with the type IIa cotransporter
protein (25, 260). The studies with isolated membrane
vesicles provided, however, significant insights into the
mechanism/kinetic of brush-border membrane Na-Pi cotransport (e.g., Refs. 14, 34, 35, 55, 80, 352). A detailed
kinetic characterization of type IIa-mediated Na-Pi cotransport activity was performed after its expression in X.
laevis oocytes (e.g., Ref. 260). The first characterization,
performed using tracer techniques, suggested a Na⫹:Pi
stoichiometry exceeding unity (see sect. VA1; Ref. 260).
These data and the evidence for electrogenicity of Na-Pi
cotransport across the brush-border membrane from microperfusion experiments in vivo (133) and from studies
with isolated vesicles (35, 55) were the rationale for an
electrophysiological characterization of the type IIa Na-Pi
cotransporter after its expression in oocytes. The electrophysiological studies, performed under steady-state conditions, complemented the tracer uptake study, whereas
pre-steady-state measurements provided new insights
into individual steps within the transport cycle (see below).
Volume 80
October 2000
PROXIMAL TUBULAR PHOSPHATE REABSORPTION
1387
first reported for the cloned Na⫹-glucose cotransporter
(SGLT-1; Refs. 45, 75, 167) expressed in oocytes and subsequently for many other Na⫹-solute cotransport systems (e.g.,
Ref. 117). They permit an identification of partial reactions
within the transport cycle. Such measurements were also
performed with the rat (types IIa and IIb) and flounder
isoforms (type IIb) of the type II Na-Pi cotransporters expressed in oocytes (122, 124, 125, 126). Figure 9 provides an
example from a study on the rat type IIa cotransporter (122).
Application of a voltage step in the presence of 96 mM Na⫹,
and in the presence or absence of saturating Pi, leads to
current transients that are primarily due to charging oocyte
membrane capacitance (Fig. 9A). Recording at a higher gain
results in a slower relaxation to the steady state in the
absence of Pi (Fig. 9B). Subtraction of the curves obtained in
the presence/absence of Pi shows transporter cycle-dependent relaxation currents (Fig. 9C), whose magnitude could
be directly related to the magnitude of Pi-induced steadystate currents in oocytes expressing different amounts of
cotransporters at their surface (122). Furthermore, the Piinduced effects on the pre-steady-state relaxation shows the
same saturation characteristics (apparent Km) as that ob-
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
FIG. 8. Electrogenic behavior of type IIa Na-Pi cotransporter (rat, NaPi-2). A: basic scheme for the two-electrode
voltage-clamp system as used in oocytes expressing the transporter. Vc, current potential; Im, membrane current. B: basic
experimental recording. When Pi is suppressed in the presence of Na⫹, an inward current is recorded; its amplitude
depends on the transmembrane holding potential (steady-state current recordings). Vh, holding potential. C: doseresponse data obtained at ⫺50 mV (holding potential) by altering Pi concentrations in the superfusate containing either
96 mM Na⫹ (■) or 50 mM Na⫹ (䊐), resulting in Michaelis constant (Km) values for Pi interaction (see E). Ip, pipette
current. D: dose-response data obtained at ⫺50 mV (holding potential) by altering Na⫹ concentration at either 1.0 mM Pi (■)
or 0.1 mM Pi (䊐), resulting in Km values for Na⫹ interaction (see F). E: dependence of Km values for Pi interaction on different
holding potentials (see C). F: dependence of Km values for Na⫹ interaction on different holding potentials (see D).
1388
MURER, HERNANDO, FORSTER, AND BIBER
Volume 80
served for Pi interaction in steady-state measurements (122).
These current transients are consistent with the translocation of charged entities within the transmembrane electric
field. The voltage dependence of the time constants of relaxation and equivalent charge associated with the relaxation can be obtained from measurements after voltage
jumps of different magnitudes from the same holding potential. With the Boltzmann equation, the transporter number,
turnover number, and the apparent valency for the charge
movement can be calculated, taking also into account Piinduced steady-state currents obtained in the same oocytes
as the pre-steady-state measurements. A value of 25 s⫺1 was
estimated for the turnover of the rat type IIa Na-Pi cotransporter at ⫺100 mV, in agreement with that measured for
other Na-solute transporters (e.g., Refs. 45, 75, 117, 167); the
apparent valency of the charge translocated within the relaxation cycle is ⫺1 (122).
3. Kinetic scheme
Above steady-state measurements (electrophysiological and tracer studies) as well as electrophysiological
pre-steady-state measurements led to the formulation of a
kinetic scheme as shown in Figure 10 (122). The empty
carrier has a valency of ⫺1 and can interact at the extracellular surface with one Na⫹. Translocation of the empty
carrier as well as interaction with one Na⫹ are voltagedependent partial reactions within the transporter cycle.
The carrier loaded with only 1 Na⫹ can translocate (“slippage”); this is an electroneutral process. The Na⫹ interaction then allows interaction with Pi (or with the inhibitor PFA) at the extracellular surface. Finally, the fully
loaded carrier is formed by interaction with two additional Na⫹. Translocation of the fully loaded carrier is
again an electroneutral process. We have no information
for distinct steps occurring at the cytoplasmic surface but
assume a transition from the fully loaded to the empty
state (mirror symmetry). A net inward movement of one
positive charge occurs per transport cycle, due to the
reorientation of the charged (⫺1) empty carrier. Although
the carrier might interact with mono- or divalent Pi, a
preferential transport of divalent Pi prevails under most
physiological and experimental conditions.
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
FIG. 9. Pre-steady-state charge movements related to type IIa Na-Pi cotransporter (rat NaPi-2). A: voltage step
between ⫺100 to 0 mV applied to oocyte and corresponding membrane currents superimposed for 96 mM Na⫹ with and
without 1 mM Pi. The small displacement in the baseline preceding the step represents the steady-state induced current
at ⫺100 mV. B: magnified view of current records in A showing a clear difference in the relaxations depending on the
presence or absence of substrate. Thin trace is for 1 mM Pi; bold trace is for 0 mM Pi. C: difference between records in
B, showing the relaxations superimposed on the Pi-induced steady-state currents. Note that the rate of relaxation for the
forward step (⫺100 to 0 mV) is faster than the return relaxation, indicating that the relaxation time constant depends
on the target potential that is a characteristic of voltage-dependent charge movements. The area under each relaxation,
determined by numerical integration, is a measure of the apparent charge translocated and should be equal for the
depolarizing and hyperpolarizing steps. For further discussion, see text and included references.
October 2000
PROXIMAL TUBULAR PHOSPHATE REABSORPTION
1389
4. pH dependence of transport
Proximal tubular brush-border membrane Na-Pi
cotransport is increased by increasing pH (e.g., Refs.
14, 52, 55, 80, 327, 328, 334, 352). Studies with brushborder membrane vesicles provided evidence that this
phenomenon is to a significant extent explained by a
competition of protons with sodium for an interaction
with the carrier (14). Preferential transport of divalent
Pi also contributes to the observed pH dependence
(352). Steady-state electrophysiological measurements
also suggested a competitive interaction of H⫹ with the
Na⫹-binding site(s) (59). Pre-steady-state measurements provided evidence for an additional direct effect
of H⫹ on the carrier, on the reorientation of the empty
transporter (124). As indicated in Figure 10, the pH
dependence of the carrier includes a kinetic effect on
the reorientation of the free carrier as well as competition for Na⫹ binding. Thus the pH dependence of type
IIa Na-Pi cotransport activity is in part but cannot be
fully explained by preferential transport of divalent Pi.
More recent studies indicated that this pH dependence
is determined by basic amino acid residues in the third
extracellular loop (96).
cotransport (see above and below), the tools were available for a more detailed analysis of cellular/molecular
mechanisms involved in physiological/pathophysiological
alterations of proximal tubular Na-Pi cotransport.
The Npt 2 knockout mice (25, 178) documented
clearly the importance of the type IIa Na-Pi cotransporter
in renal Pi handling and in the overall maintenance of Pi
homeostasis. In Npt 2 knockout mice, other Na-Pi cotransporters (e.g., Npt 1, Glvr-1, and Ram-1) are not
upregulated (178). Furthermore, renal handling of Pi is in
Npt 2 knockout mice unaffected by PTH and Pi diet (178;
N.-X. Zhao and H. S. Tenenhouse, personal communication). In addition to the renal defects, Npt 2 knockout
mice have intrinsic skeletal abnormalities most likely related to the lack of type IIa Na-Pi cotransporter in osteoclasts (145a).
Alterations in proximal tubular Na-Pi cotransport activity after induction of altered renal Pi handling in the
intact organism or in the OK cell tissue-culture model are
always associated with an altered apical membrane expression of the type II Na-Pi cotransporter protein (fasting
as an exception). In the following sections, we might first
describe situations of altered expression and discuss then
cellular mechanisms leading to altered brush-border expression.
B. Altered Expression as the Basis for Altered
Pi Reabsorption
1. Ontogeny/aging
With the cloning of the type IIa Na-Pi cotransporter
(Npt 2), the key player in brush-border membrane Na-Pi
Pi reabsorption in the kidney shows a strong ontogenetic/developmental as well as age-dependent behavior
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
FIG. 10. Kinetic models for type IIa Na-Pi cotransporter. A: model derived from studies on rat renal brush-border
membrane vesicles. [From Gmaj and Murer (138). This model was published in Physiological Reviews in 1986.] B: an
ordered kinetic model for type IIa Na-Pi cotransporter. This scheme shows the partial reactions that have been identified
by the steady-state and pre-steady-state analyses (see Figs. 8 and 9). The shaded reactions represent the two voltagedependent steps that contribute to the pre-steady-state charge movements. Substrate concentrations are assumed to
modify the binding rate constants only. Protons modulate the voltage-dependent rate constant associated with the empty
carrier as well as the final Na⫹-binding step, whereas phosphonoformic acid (PFA) most likely competes directly with
Pi binding. The binding/debinding steps on the cytosolic side have not yet been characterized. For further details, see text
and included references (see also Refs. 122, 229).
1390
MURER, HERNANDO, FORSTER, AND BIBER
2. Regulatory control
As already indicated, physiological (and pathophysiological) alterations in renal handling of Pi are related to
an altered brush-border content of the type IIa Na-Pi
cotransporter protein.
This was observed for altered brush-border membrane Na-Pi cotransport activity as observed in response
to altered dietary Pi intake (e.g., Refs. 48, 53, 61, 76, 78,
204, 243, 245, 246, 348, 370 –372, 387, 405, 415, 434; for
review, see Ref. 283). An increase in brush-border membrane Na-Pi cotransporter activity in response to a low-Pi
diet correlated with an increase in type IIa transporter
protein in Western blots and in immunohistochemistry
(e.g., Refs. 48, 243, 258). The histochemical analysis suggests a “recruitment” phenomenon (Fig. 11; Ref. 348). In
animals fed a high (or normal)-Pi diet, expression of
transporter is mostly in deep (juxtamedullary) nephrons,
and in animals fed a low-Pi diet, the transporter is also
highly expressed in superficial nephrons. The diet-induced changes are observed at the functional and protein
levels within the first 2 h, but feeding a low-Pi diet for
prolonged time periods also leads to a change in type IIa
Na-Pi cotransporter mRNA that is not observed after short
time periods. Refeeding high-Pi diets to animals adapted
chronically to low-Pi diet results in a reversal of this
phenomenon, first a decrease in brush-border expression
of the transporter protein without a decrease in specific
mRNA content (243; see also Refs. 27, 199, 376, 387, 415).
The type I Na-Pi cotransporter does not show such alterations (e.g., Refs. 48, 405). Similar findings could also be
obtained in OK cells, i.e., an increase in type IIa protein
content in response to a low-Pi media occurred within
hours, in parallel with an increase in Na-Pi cotransport
activity (e.g., Refs. 266, 309). The findings on the response
of OK cell-specific type IIa transporter mRNA to low-Pi
diet are controversial (266, 309, 353, 354). In our laboratory, the low-Pi diet-induced changes in specific mRNA
content were rather small, and transport adaptation was
not prevented by actinomycin D (41, 266, 309). Furthermore, the adaptive phenomena were also observed in OK
cells with the transfected rat type IIa cotransporter on the
protein but not mRNA level (309).
An altered PTH status in the animal is associated
with an altered brush-border expression of the type IIa
Na-Pi cotransporter as analyzed by Western blots of isolated brush-border membrane vesicles or by immunohistochemical staining on kidney sections (210). Injection of
PTH in rats or mice leads within minutes to a reduction in
brush-border membrane transporter content without a
concomitant loss of other brush-border proteins, e.g., the
Na-sulfate cotransporter protein (Fig. 12; Refs. 210, 257,
259; see also Ref. 265). A prolonged increase in PTH can
also lead to a decrease in type II Na-Pi cotransporter
mRNA content (210). Also in OK cells, PTH leads to a
decrease in the apical expression of the intrinsic and
transfected rat type IIa Na-Pi cotransporters (235, 308 –
311).
A role for insulin has been postulated for the adaptive
response of the proximal tubule to changes in dietary Pi
intake (247). In vitro and in vivo experiments provided
evidence that insulin stimulates brush-border membrane
Na-Pi cotransport. Streptozotocin-induced diabetes is associated with a reduced proximal tubular Pi reabsorption,
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
(e.g., Refs. 20, 66, 160, 161, 383). Age dependence was also
observed at the level of the type IIa Na-Pi cotransporter
protein expression (365). In kidneys of newborn rats,
expression of the type IIa Na-Pi cotransporter was observed in differentiated juxtamedullary and intermediate
nephrons only and was absent in nephron “Anlagen” in
the outer cortex (S-shaped bodies; Ref. 397). After completion of nephron formation, during suckling, expression
of the transporter was similarly high in the brush-border
membrane of all nephron generations. In weaning, the
expression pattern resembled that in adults (238, 397),
i.e., type IIa abundance decreased in the brush-border
membrane of superficial and midcortical nephrons. The
immunohistochemical data suggest that, as soon as
nephrogenesis is completed, the type IIa transporter in
the kidney is functional. As indicated above, in weaning
mice, a specific transcription factor (TFE3) might contribute to the expression of the Npt 2 gene, especially in low
Pi conditions (212a).
A specific type IIa-related Na-Pi cotransporter protein
was postulated to account for high Pi transport rates in
weaning rats (363, 364). Evidence for this postulate was
obtained by antisense experiments and transport expression in X. laevis oocytes. When mRNA isolated from
kidney cortex of rapidly growing rats was treated with
type IIa transporter antisense oligonucleotides, or depleted of type IIa specific mRNA by a subtractive hybridization procedure, Na⫹-dependent Pi uptake was still detected in injected oocytes. The type IIa transporterdepleted mRNA contained a mRNA species that has some
sequence homology to the type IIa transporter encoding
message. This interesting observation was not followed
up, and at present, the identity of this growth-related
transporter is not clear and/or remains hypothetical.
Tubular Pi reabsorption decreases during aging as
has been indicated by metabolic balance studies, clearance studies, and studies with isolated vesicles (66, 160,
161, 214). This decrease is due to a reduction in the Vmax
without a change in the apparent Km for Pi of brushborder membrane Na-Pi cotransport. The type IIa Na-Pi
cotransporter brush-border membrane protein mRNA
abundance decreased approximatively twofold when
3-mo-old rats are compared with 12- to 16-mo-old rats, in
parallel to the decrease in brush-border membrane Na-Pi
cotransport activity (365).
Volume 80
October 2000
PROXIMAL TUBULAR PHOSPHATE REABSORPTION
1391
a decreased type I Na-Pi cotransporter content, and no
change in either type IIa or III Na-Pi cotransporter content
(247). It is, however, questionable whether phosphaturia
in diabetes can be explained by a reduced type I Na-Pi
cotransporter expression. Phosphaturia could rather be
explained by an inhibition of type IIa Na-Pi cotransport
activity related to a competition for driving forces (increase in glucose reabsorption; see Refs. 22, 392). In
streptozotocin-induced diabetes, the adaptive response
(dietary intake) of the type IIa Na-Pi cotransporter was
prevented (1, 7, 358).
Thyroid hormone (3,3⬘,5-triiodothyronine; T3) increases proximal tubular brush-border membrane and
OK cell apical Na-Pi cotransport (e.g., Refs. 31, 107, 118,
213, 433); a parallel increase in PFA binding sites sug-
gested an increased brush-border membrane content of
transporters (433, 434). Euzet et al. (119) have shown
an important role for T3 in the maturation of the type
IIa Na-Pi cotransporter (119). It was shown that physiological doses of T3 lead in rats to an increase in
brush-border membrane Na-Pi cotransport activity,
type IIa transporter protein content, and specific mRNA
content (6). The stimulatory effect of T3 is less evident
in aging animals (6). Nuclear run-on experiments provided evidence that these effects are due to an increased transcription of the transporter gene (6). In OK
cells, the stimulatory effect of T3 was completely prevented by the transcriptional inhibitor actinomycin D
(367).
IGF-I directly stimulated OK cell Na-Pi cotransport
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
FIG. 11. Effect of dietary Pi intake on type IIa Na-Pi cotransporter (rat, NaPi-2) mRNA (A–C) and protein (D–I). Left:
animals fed chronically a high-Pi diet (1.2% Pi) and switched for different time periods to low-Pi diets (0.1% Pi). Right:
animals fed chronically a low-Pi diet (0.1% Pi) and switched for different time periods to high-Pi diets. Magnifications:
A–F, ⫻45; G–I, ⫻1,200. Bars: A–F, 200 ␮m; G–I, 5 ␮m. For further details, see text and included references. [Adapted
from Ritthaler et al. (348).]
1392
MURER, HERNANDO, FORSTER, AND BIBER
Volume 80
associated with an increase in specific type IIa Na-Pi
cotransporter content, an effect most likely involving activation of tyrosine kinase activity (193).
EGF caused a time- and dose-dependent decrease in
OK cell Na-Pi cotransport rate, an effect associated with a
decrease in type IIa Na-Pi cotransporter mRNA abundance (15). This observation is in agreement with findings
on weaned and suckling rats but in disagreement with
observations on isolated perfused rabbit proximal tubules
where EGF stimulates Na-Pi cotransport (17, 336).
Glucocorticoid administration to rats and neonatal
rabbits decreased rat brush-border membrane Na-Pi cotransport activity and kidney cortex type IIa transporter
content (16, 244, 254, 320). Also in OK cells glucocorticoids led to a reduction in Na-Pi cotransport activity and
associated transporter protein content (192; see also Ref.
156a).
Fasting-induced phosphaturia leads to decreased expression of type I Na-Pi cotransporter mRNA but to no
change in type IIa mRNA content (247). However, it is
unlikely that a decreased type I Na-Pi cotransporter content accounts for the phosphaturia observed in fasting
conditions (28). As indicated above, the type IIa Na-Pi
cotransporter determines overall renal Pi handling.
Acid-base changes also induce alterations in the expression of the type IIa Na-Pi cotransporter. Chronic metabolic acidosis in rats significantly decreased brush-border membrane Na-Pi cotransport activity, associated with
a decrease in type IIa cotransporter protein and mRNA
content (11). At the onset of acute (6 h) metabolic acidosis, changes in transport activity and brush-border transporter protein content were not paralleled by a change in
cortical tissue type IIa Na-Pi cotransporter mRNA or protein (11). This may indicate that in acute situations
changes in membrane trafficking of the type IIa Na-Pi
cotransporter (see below) contribute to the acid-induced
changes. Interestingly, in OK cells, we have found an
opposite effect of exposure to an acid medium (192, 194).
Transport activity, transporter protein, and mRNA content were all increased; the increase was, however, pre-
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
FIG. 12. Parathyroid hormone
(PTH)-dependent retrieval of type IIa
Na-Pi cotransporters from the brushborder membrane. Rats with removed
parathyroid glands (PTX) were injected with PTH, and kidney slices
were then stained for the type IIa
Na-Pi cotransporter (NaPi-2) or for
the Na-SO4 cotransporter (NaSi-1;
Ref. 265). It was seen that the type IIa
Na-Pi cotransporter is removed from
the brush-border membrane in response to PTH administration. At
early time periods (35 min), a subapical appearance of the transporter is
visible. The Na-SO4 cotransporter is
not removed from the brush-border
membrane in response to PTH administration. For further reading, see text
and included references.
October 2000
PROXIMAL TUBULAR PHOSPHATE REABSORPTION
vented or reversed by adding glucocorticoids (192). This
indicates that the above observations in rat might be the
result of acid base-induced changes in glucocorticoid levels rather than of direct cellular effects (see also Refs. 47,
127).
3. Acquired alterations
4. Genetic abnormalities
Among the different genetically determined alterations in renal Pi handling, only X-linked defects have
been characterized at the level of brush-border membrane
Pi transporters. Studies on the murine Hyp and Gy homologs of the human disease X-linked hypophosphatemia
have identified a specific reduction in brush-border membrane Na-Pi cotransport activity that was associated with
a reduction in type IIa Na-Pi cotransporter protein and
specific mRNA content, thereby accounting for the Pi leak
in affected mice (27, 384, 385, 387, 389, 393; see also Refs.
87– 89). Because the Npt 2 gene does not map to the
X-chromosome (see above and Refs. 222, 223, 437), a
defect in a gene on the X-chromosome must influence the
renal brush-border expression of the type IIa Na-Pi cotransporter (for review, see Ref. 384). This mutant gene
has been identified in affected humans (106, 110, 112, 185)
by linkage/positional cloning and subsequently in Hyp
and Gy mice (26, 373); it was designated PHEX/Phex
(formerly PEX/Pex) to signify phosphate regulating gene
with homology to endopeptidases on the X-chromosome.
The PHEX/Phex protein is not expressed in the kidney but
rather in bones (26). On the basis of its homology to a
membrane-bound endopeptidases, it is postulated that
PHEX/Phex is involved in the processing of humoral factor(s) (e.g., phosphatonin and stanniocalcin 1/2; see also
Refs. 72, 105, 111, 189, 224, 225, 272) which regulate renal
Pi handling by altering the type IIa Na-Pi cotransporter
expression, and Pi metabolism in general (for review, see
Refs. 110, 112, 295, 384). In Hyp mice, a decreased transcription rate of the type IIa Na-Pi cotransporter gene was
observed (89). In Hyp and Gy mice, different gene deletions were identified: a 3⬘-deletion in Hyp and a 5⬘-deletion in Gy (26, 273).
C. Cellular Mechanisms in the Control of Type II
Na-Pi Cotransporter Expression
As discussed in section VB, changes in renal Pi handling are attributable, for the most part, to altered brushborder membrane expression of the type IIa Na-Pi cotransporter. It is apparent that alterations in the type IIa
Na-Pi cotransporter expression occur independently of
transcriptionally regulated changes in mRNA, perhaps
with the exception of T3 (6, 367), 1,25(OH)2D3-mediated
effects (8, 380), or prolonged feeding of low-Pi diets in
weaning mice (212a). If changes in type IIa Na-Pi cotransporter mRNA are observed, they are either rather small or
they occur only after prolonged stimulation (e.g., Refs.
210, 243), i.e., after changes in the specific transporter
protein content, suggesting that changes in mRNA represent a phenomenon secondary to the primary event, i.e.,
downregulation or upregulation of brush-border expression of type IIa Na-Pi cotransporter protein. In agreement
with this apparent lack of transcriptional control mechanisms are the negative observations with promoter/reporter gene studies in OK cells (e.g., Refs. 174, 176),
where with the above-mentioned exceptions of alterations in 1,25(OH)2D3 (380), of the low-Pi diet-dependent
increase in TFE3 in weaning mice (212a), or in ambient
bicarbonate/carbon dioxide tension (194) of the media, no
activation of the NPT 2/Npt 2 promoter could be detected.
Therefore, it is appropriate to restrict the discussion primarily to mechanisms leading to altered membrane expression, i.e., mainly to membrane retrieval and membrane insertion of the type IIa Na-Pi cotransporter (for
review, see Refs. 286, 288). The crucial role of “membrane
trafficking” in the control of brush-border membrane expression of the type IIa Na-Pi cotransporter offers the
potential for physiological/pathophysiological control of
Na-Pi cotransport involving alterations in the participating
complex machinery. In this way, for example, an endosomal chloride channel defect in Dent’s disease may affect
membrane insertion and thus lead to phosphaturia (252,
253, 391).
1. Membrane retrieval
The phenomenon of membrane retrieval of the transporter can be best studied in PTH-induced or high-Pi
diet-induced downregulation of brush-border membrane
Na-Pi cotransport activity and type IIa Na-Pi cotransporter
protein abundance (see Figs. 11 and 12 and Refs. 208, 210,
257, 259; see also Refs. 180, 209, 211, 306). The data from
immunohistochemical (immunogold) studies on PTH-induced internalization are summarized in Figure 13 (398).
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
Proximal tubular brush-border membrane Na-Pi cotransport is sensitive to intoxication by heavy metals (5,
141, 255, 321). A direct acute inhibitory effect of Hg2⫹,
Pb2⫹, and Cd2⫹ has been shown in X. laevis oocytes
expressing the type IIa Na-Pi cotransporter (408). Hg2⫹
and Cd2⫹ effects were mostly on Vmax effects, but Pb2⫹
also increased the apparent Km for Pi (408). It will be of
interest to determine whether the described inhibitory
effect can be assigned to specific sulfhydryl groups, which
would then also explain the observations in brush-border
membranes (Refs. 255, 321; e.g., also in studies with cisplatin, Ref. 90). In vivo intoxication of rats with cadmium
reduced brush-border membrane Na-Pi cotransport rate
accompanied by a loss of the type IIa Na-Pi cotransporter
protein (169).
1393
1394
MURER, HERNANDO, FORSTER, AND BIBER
Volume 80
In rats, infusion of PTH or feeding high-Pi diets leads to a
transient accumulation of type IIa Na-Pi cotransporters in
the so-called subapical vacuolar apparatus (83, 164). Internalization can occur at intermicrovillar clefts via clathrin and adapter protein (AP-2) containing membrane cargos (398). The same endocytic structures can be filled by
horseradish peroxidase injected into the animals before
PTH treatment (398). Thus type IIa Na-Pi cotransporters
are internalized via the same pathway as soluble proteins.
Evidence from experiments with cholchicine-pretreated
rats indicates that there might be an additional “unknown” internalization step, separate from the intermicrovillar clefts (259; Fig. 13). Morphological and biochemical data suggest that internalized type IIa Na-Pi
cotransporters are directed to the lysosomes for degradation (212, 311, 398). Although recycling of transporters
back to the membrane cannot be entirely excluded, under
the experimental conditions applied, no evidence for such
a reutilization of internalized transporters could be obtained in studies on OK cells (262, 311). Surface biotinylation experiments performed in OK cells provided direct
evidence that the increase in intracellularly located transporters after PTH treatment is related to a decrease of
transporters at the cell surface (191). An alternate mechanism that would lead to reduced transporter expression
at the surface would have been degradation at the membrane site and/or a reduced insertion rate (see sect. VC2)
to account for intracellular accumulation. Obviously, this
phenomena of downregulation requires a complex machinery that provides specificity for the transporter molecule and specific signaling events. These issues are discussed in the following sections.
2. Membrane insertion
This phenomenon can be best analyzed in rats
adapted to high-Pi diet and fed “acutely” a low-Pi diet (e.g.,
Fig. 11; e.g., Refs. 243, 258). The increase in brush-border
type IIa Na-Pi cotransporter content is observed within
1–2 h and can also be observed in OK cells after exposure
to media with adjusted Pi contents (309). This rapid increase occurs independently of any change in specific
type IIa Na-Pi cotransporter mRNA content (243, 309). In
OK cells, this adaptive response could be prevented by
blocking protein synthesis at the translational level (e.g.,
Ref. 41). In contrast, in animal models, pretreatment with
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
FIG. 13. “Mechanisms” of type IIa Na-Pi cotransporter internalization. A and B: double labeling of Na/Pi-2 (rat
transporter) and horseradish peroxidase (HRP; fluid-phase marker) by the immunogold labeling technique on ultrathin
cryosection of rat kidneys after HRP and parathyroid hormone (PTH) injection. Gold particles (12 nm) bound to NaPi-2
are located at the microvillar membrane (MV) and at intermicrovillar clefts (arrows). NaPi-2 and HRP (gold particles 6
nm) are colocalized in the clefts (arrows) and in subapical vesicles of the vacuolar apparatus (A and B). Magnifications:
A, ⫻⬃23,000; B, ⫻⬃33,000. Bars: ⬃1 ␮m. C: proposed pathway of trafficking of NaPi-2 cotransporter in proximal tubule
cells. Newly synthezised NaPi-2 seems to travel to the brush-border membrane via the subacpical compartment (SAC;
corresponding to the vacuolar apparatus). During downregulation of the protein in the brush-border membrane,
internalized NaPi-2 seems to follow the same general endocytotic pathway like HRP via small endocytotic vesicles (SEV),
subapical compartment (SAC), and large endosomal vesicles (LEV); finally, the proteins will be degraded in lysosomes
(Ly). This pathway includes also the participation of clathrin and adaptor protein 2 (AP-2). For further details, see text
and included references. The Na/Pi cotransporter may also be internalized via a non-clathrin-mediated pathway (dashed
line; see text). [Adapted from Traebert et al. (398).]
October 2000
PROXIMAL TUBULAR PHOSPHATE REABSORPTION
3. Involvement of microtubules
In contrast to the known dependence of the endocytosis of soluble proteins on an intact microtubular network (115), the internalization of type IIa Na-Pi cotransporters in response to either PTH or acute high-Pi diet
feeding was not impaired (258, 259) by agents disturbing
microtubules. Similar observations were made in OK cells
(158). In contrast, the intracellular routing of the transporter to the lysosomes depends on an intact microtubular network (258, 259). Membrane insertion of the transporter, observed after acute administration of a low-Pi
diet, requires an intact microtubular network (258), in
agreement with the important role of microtubules for
apical routing of post-Golgi vesicles and for the maintenance of the dense tubular subapical network (115, 270).
It is of interest that PTH and altered medium Pi content
were found to have profound effects on the cytoskeleton
of cultured proximal tubular cells (139, 258, 259, 304).
4. Signaling pathways
A) CAMP AND DIACYLGLYCEROL/INOSITOL TRISPHOSPHATE
(CALcAMP- and diacylglycerol (DAG)/inositol trisphosphate (IP3)-related signaling pathways in the regulation of
brush-border membrane type II Na-Pi cotransporter activity and expression have been studied in relation to PTHdependent regulation of proximal tubular Pi reabsorption.
PTH and PTH-related peptide receptors, respectively, are
located in both apical and basolateral membranes of proximal tubular epithelial cells and of OK cells (e.g., Refs.
68 –70, 73, 85, 86, 186, 200, 215, 261–264, 331–333, 341, 342,
346; for review, see Refs. 280, 283). The PTH receptor can
signal through activation of both adenylate cyclase and
phospholipase C, generating the second messengers
cAMP, IP3, a rise in intracellular Ca2⫹, and DAG (e.g.,
Refs. 2, 183, 271). The PTH-(1O34) analog activates both
signaling pathways, whereas the PTH-(3O34) analog only
activates the cAMP-independent signaling pathway (e.g.,
Refs. 85, 86, 235, 308). Although pharmacological activation of either pathway separately leads to an inhibition of
CIUM).
apical Na-Pi cotransport activity associated with a decrease in brush-border membrane type IIa Na-Pi cotransporter protein content (e.g., Refs. 235, 264, 308), there
seems to be an interdependence of the two regulatory
pathways. In OK cells, abolition of the cAMP/protein kinase A pathway prevents PTH inhibition (267, 268, 357);
similarly, inhibition of the DAG/protein kinase C pathway
also reduces PTH inhibition of the Na-Pi cotransporter
(330, 333). Furthermore, in OK cells, the maximal inhibition induced by PTH-(3O34) is only ⬃50% of the maximal
PTH-(1O34)-induced inhibition (85, 86, 235, 308).
Although most observations on PTH-dependent signaling mechanisms were derived from studies with OK
cells, similar mechanisms may be operative in the proximal tubule; PTH-(3O34) similar to PTH-(1O34) leads to a
reduction in apical type IIa Na-Pi cotransporter content in
intact rats and in vitro perfused mice proximal tubules
(399). Furthermore, the experiments with the isolated
perfused tubules showed that PTH-(1O34) leads to a
reduction in brush-border transporter content after perfusion either through the lumen or basolateral side,
whereas PTH-(3O34) only induces this reduction after
apical perfusion only (399). It is of interest that earlier
studies on OK cells have also provided evidence for asymmetrical signaling mechanisms in PTH control of apical
Na-Pi cotransport (341, 342). The experiments with isolated perfused tubules also documented the involvement
of protein kinases A and C in internalization of the apical
Na-Pi cotransporter (399).
The events after second messenger generation leading to inhibition and/or retrieval of the type IIa Na-Pi
cotransporter are not clear. Obviously, phosphorylation
events do play a role, but there is no direct evidence that
altered phosphorylation of the type IIa Na-Pi cotransporter protein is essential in the regulation (42, 152, 182).
Recently, in studies in OK cells, it has been shown that the
type IIa transporter is a phosphoprotein. However, PTHinduced alterations in the type IIa Na-Pi cotransporter
phosphorylation are difficult to document (M. Jankowski,
H. Hiefiker, J. Biber, and H. Murer, unpublished observations). Because there are several potential phosphorylation sites within the protein sequence, changes at individual sites need to be analyzed. It is of interest that in X.
laevis oocytes, activation of protein kinase C leads to an
internalization of the transporter and to an associated
inhibition of transport (125). This inhibition/internalization is not prevented after mutagenesis of known kinase
consensus sites, indicating that at least in this experimental model, the phosphorylation consensus sites are not
involved in this regulation (165). Finally, it is reasonable
to assume that PTH-induced regulatory phosphorylation
events are not at the level of the transporter but rather at
interacting proteins required for its regulation (see sect.
VC4D). In this respect it is of interest that regulation by
PTH and/or pharmacological activation of protein kinases
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
cycloheximide did not prevent upregulation of brush-border membrane type IIa Na-Pi cotransport activity and
protein (242, 245, 246, 258). However, it has not been
shown whether protein synthesis is indeed blocked in
proximal tubular cells after intraperitoneal injection of
cycloheximide. Upregulation of Na-Pi cotransporter activity and type IIa transporter protein content is obviously
also observed after recovery from PTH inhibition. In OK
cells it was found that the recovery of Na-Pi cotransport
activity and type II Na-Pi transporter protein is entirely
dependent on protein synthesis (262, 311). In chronic
parathyroidectomized rats, a specific upregulation of type
IIa Na-Pi cotransporter protein was also observed in the
absence of changes in specific mRNA content (210).
1395
1396
MURER, HERNANDO, FORSTER, AND BIBER
the apical surface. Because the Ca2⫹ sensor (Ca2⫹ receptor CaR) is expressed at the apical cell surface of proximal tubular cells, it may “indirectly” be involved in tubular
Pi sensing, because changes in Pi and Ca2⫹ concentrations are interdependent (51, 347). Another possibility is
that the rate of Pi entry at the apical cell surface contributes to Pi sensing. It was observed that inhibition of OK
cell Na-Pi cotransport after prolonged exposure to PFA
results after PFA removal in an “adapted” state of Nadependent Pi uptake (J. Forgo and H. Murer, unpublished
observations). Similarly, reduced Pi entry in response to
PTH inhibition could provide a signal for the preferred
resynthesis of the type IIa cotransporter resulting in recovery of Na-Pi cotransport rates after removal of PTH. In
this case, the higher transport rates after recovery would
then serve as feedback to again slow down the rate of
transporter resynthesis. Finally, the adaptive response of
Na-Pi cotransport rate to low Pi intake (or low-Pi media)
may also involve a more general signaling that is related
to changes in intracellular Pi metabolism after lowering of
apical (and/or basolateral) Pi (20, 102; see also Ref. 38). In
addition, alterations in cytosolic Ca2⫹ concentrations
were postulated to be part of the Pi-sensing mechanisms
(353).
C) UBIQUITINYLATION. Membrane retrieval is involved in
regulation of the type IIa Na-Pi cotransporter. Membrane
retrieval of a variety of membrane proteins, including
membrane receptors and perhaps also transporter proteins, e.g., the epithelial Na⫹ channel, can depend on
ubiquitinylation, which can be a signal for endocytosis
followed by lysosomal and/or proteosomal degradation
(368, 369; see also Ref. 173). In OK cells, lysosomal degradation, but not proteosomal degradation of the type II
Na-Pi cotransporter protein, is involved in its PTH-dependent downregulation (311). Proteosomal (and lysosomal)
degradation seems also to be involved in the basic turnover of the OK cell type IIa cotransporter (311). Ubiquitinylation of the transporter itself or of interacting proteins
can be involved in membrane retrieval and/or targeting
the type IIa transporter to the degradation machinery.
D) INTRACRINE REGULATION. An intracrine regulation
pathway was postulated to control apical expression of
type IIa Na-Pi cotransporter (107; see also Refs. 29, 30,
207, 427). Different metabolic and/or hormonal stimuli
may lead to the synthesis of cyclic ADP-ribose, which in
turn may initiate an intracellular regulatory cascade, with
the release of Ca2⫹, activation of a Ca2⫹/calmodulin-dependent protein kinase, and changes in the turnover of
the transporter at the apical membrane (107).
E) PHOSPHATIDYLINOSITIDE 3-KINASE. Phosphatidylinositide 3-kinase (PI 3-kinase) seems to be involved in various
membrane trafficking processes. In OK cells, inhibition of
PI 3-kinase leads to a reduction of endocytosis of albumin
(54). However, endocytosis of type IIa Na-Pi cotransporter in OK cells and its degradation by PTH are not
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
A/C requires the correct cellular context; transfection
experiments showed that only the OK cells provide the
correct cellular environment for this regulation of the
type IIa Na-Pi cotransporter (Z. Karim-Jiminez, N. Hernando, H. Murer, and J. Biber, unpublished data). Such
dependence on an interacting protein has also been
shown for brush-border membrane Na/H exchange
(NHE-3) and its kinase A-induced inhibition (412, 413,
428; see also Ref. 293).
Extracellular cAMP (intratubular) is known to inhibit
proximal tubular and OK cell apical Na-Pi cotransport.
This effect can be related to specific receptor interactions
and intracellular signaling or more likely to luminal hydrolysis of cAMP followed by uptake of adenosine, which
might after incorporation into ATP be the source for
additional intracellular cAMP (130, 131, 132; see also Refs.
274, 361). A role of intratubular cAMP, generated in the
liver after stimulation by glucagon, has been suggested for
in vivo control of Pi reabsorption (3). It is unclear at this
moment how these observations and interpretations can
be reconciled with the stimulatory effect of adenosine on
tubular Pi reabsorption in rats (312).
Alterations in cytoplasmic calcium concentrations
per se are not sufficient/important in PTH-induced signaling of OK cell apical Na-Pi cotransport; this has been
documented using Ca2⫹-clamping protocols (332). Saxena
and Allon (353) have postulated that an increase in
steady-state cytosolic calcium plays a role in “chronic”
adaptation of OK cell Na-Pi cotransport to low-Pi media.
B) PI ADAPTATION (PI SENSING). As discussed above,
brush-border membrane type IIa Na-Pi cotransporter protein content, and thus proximal tubular Pi reabsorption,
responds within hours to alterations in dietary Pi intake
(242, 243, 258). This phenomenon is also observed in OK
cells, induced by alteration in media Pi content (41, 309).
In the animal models the adaptive phenomena might be in
part related to alterations in different humoral factors and
local auto/paracrine factors, although PTH can be excluded as a major factor (see above; for review, see Ref.
37). In this regard, it is interesting that intravenous injections of Pi are sufficient to induce alterations in brushborder membrane Na-Pi cotransport rate in thyroparathyroidectomized rats (76; for review, see Refs. 37, 46, 283).
Because alterations in dietary Pi intake are paralleled by
rapid changes in plasma Pi concentration and thus of
filtered Pi load (61, 316), the question of direct Pi sensing
by the cells has to be considered, as indicated by the
experiments on OK cells. Experiments with OK cells provided an interesting clue on the potential mechanisms in
Pi sensing by the proximal tubular cell. In cells grown on
permeant filters, depletion of Pi at the apical site was
sufficient to provoke an adaptive increase of apical Na-Pi
cotransport rate, whereas removal of Pi only from the
basolateral cell surface was without effect (339, 340).
Thus there is the possibility of a Pi sensing mechanism at
Volume 80
October 2000
PROXIMAL TUBULAR PHOSPHATE REABSORPTION
5. Endocytic motifs
Tyrosine based and dileucine signals within the type
IIa Na-Pi cotransporter sequence might be important motifs for the endocytic removal and/or membrane targeting,
in a manner similar to some “model” proteins in polarized
epithelial cells (270). In mutagenesis experiments on the
type IIa Na-Pi cotransporter, various tyrosine-based motifs and dileucine motifs located at predicted intracellular
sites were found not to be essential for internalization in
oocytes and transfected OK cells (170 –172). Because the
type IIb transporter (intestinal isoform) transfected in OK
cells is also apically targeted but not internalized by PTH
(171, 197, 198), endocytic motifs/domains can be identified on studies of type IIa/IIb chimeras; these studies
suggested a critical role of a dibasic motif located in the
last intracellular loop (198; see Fig. 7).
tive response (245, 246). In rat studies, evidence was
provided that the dexamethasone-induced inhibition of
brush-border membrane Na-Pi cotransport is associated
with a decrease in transporter protein content and an
increase in glucosylceramide (244). Taken together, it
seems unlikely that transport alterations are directly related to changes in membrane fluidity, but alterations in
lipid composition, e.g., in microdomains such as glycolipid-cholesterol rafts, may facilitate internalization of the
type IIa Na-Pi cotransporter.
Recently, it was shown that different inhibitors of
P-glycoprotein functions stimulate proximal tubular Pi
reabsorption related to an increased expression of type
IIa Na-Pi cotransporter protein. It is speculated that this
effect is associated with drug-induced changes in the
sphyngomyeline-ceramide pathway and associated
changes in the membrane traffic of the transporter protein
(D. Prié, S. Couette, I. Fernandes, C. Sieve, and G. Friedlander, personal communication).
7. Reduction of S-S bridge
In Western blots of isolated brush-border membranes, a significant proportion of the type IIa cotransporter appears to be cleaved under reducing conditions,
suggesting that the transporter is stabilized by a S-S
bridge (e.g., Refs. 39, 48, 91, 229, 305, 425). The degree of
transport inhibition under reducing conditions correlated
with the appearance of cleaved moieties (425). Internalization and cleavage of the transporter can also be induced in X. laevis oocytes by a treatment with reducing
agents (230). On the basis of these findings, we suggest
that a reduction of S-S bridge within the type IIa Na-Pi
cotransporter may contribute to its basal turnover and
perhaps regulation. Reduction of the S-S bridge within the
second extracellular loop (Fig. 7) may destabilize the
secondary structure of the type IIa transporter protein
followed by a degradation at the cell surface or after
internalization. Reducing agents might enter the proximal
tubular lumen by the secretory mechanism for organic
anions.
8. Interacting proteins
6. Lipids
Alterations in brush-border membrane lipid composition have been associated with altered brush-border
membrane Na-Pi cotransport (e.g., Refs. 240, 241, 246, 279,
406). Changes in membrane fluidity and a role of a sphingomyelin-ceramide regulatory pathways were postulated
(157, 221, 237, 251, 435). Chronic adaptation to low-Pi diet
was reported to alter cholesterol and glycosphingolipid
content and thus membrane fluidity (240, 241). However,
alterations in Na-Pi cotransport induced by acute changes
in low-Pi diets occur before the changes in brush-border
lipid composition and thus are not essential for the adap-
Type IIa Na-Pi cotransporters are located among
many other membrane proteins along the microvilli. However, in physiological regulation they are specifically internalized at intermicrovillar clefts (210, 257, 259, 398).
Conceptionally there should be “anchoring” mechanisms
keeping proteins within the microvilli “en place.” In regulation, the interaction between specific anchor (interacting) proteins and specific membrane proteins (e.g., the
type IIa Na-Pi cotransporter) could be controlled, permitting via lateral mobility the protein to enter into clefts
where it is removed. Alternatively, unrestricted lateral
mobility could allow the transporter protein to enter al-
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
prevented by inhibition of PI 3-kinase (307). On the other
hand, inhibition of PI 3-kinase retards the recovery from
PTH inhibition and reduces transport activity and transporter protein content in control cells (307). Thus PTHinduced endocytosis of the type IIa Na-Pi cotransport
occurs via a different pathway than albumin endocytosis.
PI 3-kinase activity may be involved in the resynthesis/
reinsertion of apically located transporters.
F) TYROSINE KINASE ACTIVITY. In OK cells, vanadate, a
potent inhibitor of protein tyrosine phosphatases, mimicks the stimulatory effect of IGF-I on Na-Pi cotransport
activity (63, 65). Similarly, IGF-I and vanadate increase
the membrane abundance of type IIa Na-Pi cotransporter
protein content (193). The effects on transporter protein
content could not be prevented by actinomycin D and
cycloheximide (193). The latter observation led to the
conclusion that tyrosine kinase-dependent mechanisms
may control the membrane stability (i.e., reduce the retrieval rate) of the type IIa Na-Pi cotransporter (193).
Tyrosine kinase activity may also be involved in TGF-␣
and EGF effects on apical Na-Pi cotransport activity (15,
314). However, the participation of phospholipase C/protein kinase C has also been proposed for the TGF-␣and/or EGF-mediated effects (335–337).
1397
1398
MURER, HERNANDO, FORSTER, AND BIBER
trieval of the transporter and the specific steps within the
transport cycle were dicussed. Finally, for an understanding of renal Pi handling at a molecular level, the in vitro
molecular studies (e.g., in oocytes) have to be reintegrated into the function of the entire cell, nephron, organ,
and animal. Tissue-culture experiments, studies on isolated perfused tubules, and experiments on animals (rats
and/or mice; normal and/or genetically modified) are essential to develop a more detailed understanding of renal
Pi handling.
This review is devoted to many co-workers and collaborators contributing to this work over the last 10 years. The excellent secretarial help of Denise Neukom-Rossi and the excellent
art work done by Christian Gasser are gratefully ackowledged.
We also specifically acknowledge the excellent collaborations
with the laboratories of Dr. M. Levi (Dallas), Dr. H. S. Tenenhouse (Montreal), Dr. S. Kempson (Indianapolis), and Dr. B.
Kaissling (Zürich). A special thank goes to H. S. Tenenhouse and
M. Levi for critical reading and correction of the manuscript.
This review is in memory of our dear colleague, Thomas P.
Dousa (10/01/99), a leading investigator in the field of renal
phosphate handling.
Major financial support by the Swiss National Science
Foundation is gratefully acknowledged.
Address for reprint requests and other correspondence: H.
Murer, Institute of Physiology, Univ. of Zürich, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland (E-mail:
[email protected]).
VI. SUMMARY AND OUTLOOK
REFERENCES
The type IIa Na-Pi cotransporter located in the renal
proximal tubular brush-border membrane is the key
player in renal Pi reabsorption and thus also in overall Pi
homeostasis. Physiological regulation of the type IIa Na-Pi
cotransporter is responsible for altered renal Pi handling
and is mostly directly related to its altered brush-border
expression. The latter involves complex membrane retrieval and reinsertion mechanisms. Its expression can
also be abnormally regulated in different disease states
(e.g., in X-linked hypophosphatemia). Transport activity
mediated by the type IIa transporters in the brush-border
membrane can also be controlled by changes in intratubular/intracellular pH, in transmembrane potential difference, and posttranslational modification (e.g., protein
phosphorylation, reduction of S-S bridge). Finally, the
type IIa Na-Pi cotransporter gene might also be directly
affected in autosomal disorders in renal Pi handling.
With the cloning of the type IIa cotransporter, tools
and information (gene location and structure) become
available to dissect physiological regulation and pathophysiological alterations at the molecular level. In the
future, studies on the structure/function relationship will
provide new insights into the mechanisms of cotransporter regulation/function. Several novel approaches to
understand the mechanisms determining the specific re-
1. ABRAHAM MI, WOODS RE, BREEDLOVE DK, AND KEMPSON SA. Renal
adaptation to low phosphate diet in diabetic rats. Am J Physiol
Renal Fluid Electrolyte Physiol 262: F731–F736, 1992.
2. ABU-SAMRA AB, JUEPPNER H, FORCE T, FREEMAN MW, KONG X-F,
SCHIPANI E, URENA P, RICHARDS J, BONVENTRE JV, POTTS JT JR, KRONENBERG HM, AND SEGRE GV. Expression cloning of common receptor for parathyroid hormone and parathyroid hormone related
peptide from rat osteoblast-like cells: a single receptor stimulates
intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium. Proc Natl Acad Sci
USA 89: 2732–2736, 1992.
3. AHLOULAY M, DÉCHAUX M, HASSLER CH, BOUBY N, AND BANKIR L.
Cyclic AMP is a hepatorenal link influencing natriuresis and contributing to glucagon-induced hyperfiltration in rats. J Clin Invest
98: 2251–2258, 1996.
4. AHN DW, KIM YM, KIM KR, AND PARK YS. Cadmium binding and
sodium-dependent solute transport in renal brush-border membrane vesicles. Toxicol Appl Pharmacol 154: 212–218, 1999.
5. AHN DW AND PARK YS. Transport of inorganic phosphate in renal
cortical brush-border membrane vesicles of cadmium intoxicated
rats. Toxicol Appl Pharmacol 133: 239 –243, 1995.
6. ALCALDE AI, SARASA M, RALDUA D, ARAMAYONA J, MORALES R, BIBER J,
MURER H, LEVI M, AND SORRIBAS V. Role of thyroid hormone in
regulation of renal phosphate transport in young and aged rats.
Endocrinology 140: 1544 –1551, 1999.
7. ALLON M AND HRUSKA KA. Renal adaptation to dietary phosphate
restriction in rats. Interactions with insulin and calcitrol. Diabetes
40: 1134 –1140, 1991.
8. ALLON M AND PARRIS M. Calcitriol stimulates Na⫹/Pi cotransport in
a subclone of opossum kidney cells (OK-7A) by genomic mechanism. Am J Physiol Renal Fluid Electrolyte Physiol 264: F404 –
F410, 1993.
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
ways into the cleft region and transporters to be removed
would then be posttranscriptionally modified (e.g., phosphorylation, ubiquitinylation; see above) providing a signal for membrane retrieval of the transporters to be
downregulated. Also, this latter mechanism would require
specific proteins to recognize (“interact” with) the transporter protein. PDZ-domain containing proteins have
been described to interact with the brush-border membrane Na/H exchange NHE-3 and to be required for its
kinase-mediated regulation (293, 412, 413, 428); such regulation also involves the internalization of the NHE-3
exchanger. Interestingly, we recently identified a PDZdomain containing protein (diphor-1) that colocalized
with the type IIa Na-Pi cotransporter in brush borders and
interacting with the COOH-terminal cytosolic portion of
the molecule (93, 418, 418a). When coexpressed in oocytes with the type IIa Na-Pi cotransporter protein, a
diphor-1-induced specific increase in Na-Pi cotransport
activity was observed without a stimulatory effect on
Na-SO4 cotransport after coexpression with a cloned NaSO4 cotransporter (93). Interacting proteins might be required for brush-border expression of type II Na-Pi cotransporter and/or for its regulation. However, the precise
role of above-mentioned PDZ-domain containing proteins
(e.g., diphor-1) in controlling the apical expression of the
transporter is not yet established.
Volume 80
October 2000
PROXIMAL TUBULAR PHOSPHATE REABSORPTION
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
ADP-ribose in opossum kidney renal epithelial cells. Am J Physiol
Cell Physiol 268: C741–C746, 1995.
BEERS KW AND DOUSA TP. Thyroid hormone stimulates the Na⫹-PO4
symporter in the renal brush border. Am J Physiol Renal Fluid
Electrolyte Physiol 265: F323–F326, 1993.
BEERS KW, THOMSON MA, CHINI EN, AND DOUSA TP. ␤-Estradiol
inhibits Na⫹/Pi cotransport across renal brush-border membranes
from ovarectomized rats. Biochem Biophys Res Commun 221:
442– 445, 1996.
BELIVEAU R, DEMEULE M, IBNOUL-KHATIB H, BERGERON M, BEAUREGARD
G, AND POTIER M. Radiation-inactivation studies on brush-bordermembrane vesicles. General considerations, and application to the
glucose and phosphate carriers. Biochem J 252: 807– 813, 1988.
BELIVEAU R AND STREVEY J. Kinetic model for phosphate transport in
renal brush-border membranes. Am J Physiol Renal Fluid Electrolyte Physiol 249: F329 –F336, 1988.
BELIVEAU R AND STREVEY J. Phosphate transport in kidneys: effect of
transmembrane electrical potential. Am J Physiol Renal Fluid
Electrolyte Physiol 261: F663–F669, 1991.
BERNDT TJ AND KNOX FG. Proximal tubule site of inhibition of
phosphate reabsorption by calcitonin. Am J Physiol Renal Fluid
Electrolyte Physiol 246: F927–F930, 1984.
BERNDT TJ AND KNOX FG. Renal regulation of phosphate excretion.
In: The Kidney, Physiology and Pathophysiology, edited by Seldin
DW and Giebisch G. New York: Raven, 1992, p. 2511–2532.
BEVINGTON A, KEMP GJ, GRAHAM R, AND RUSSELL RGG. Phosphate
sensitive enzymes: a possible molecular basis for cellular disorders
of phosphate metabolism. Clin Chem Enzyme Commun 4: 235–
257, 1992.
BIBER J, CUSTER M, MAGAGNIN S, HAYES G, WERNER A, LÖTSCHER M,
KAISSLING B, AND MURER H. Renal Na/Pi cotransporters. Kidney Int
49: 981–985, 1995.
BIBER J, CUSTER M, WERNER A, KAISLLING B, AND MURER H. Localization of NaPi-1, a putative Na/Pi cotransporter, in rabbit kidney
proximal tubules. Part II. Localization by immunohistochemistry.
Pflügers Arch 424: 210 –215, 1993.
BIBER J, FORGO J, AND MURER H. Modulation of Na/Pi cotransport in
opossum cells by extracellular phosphate. Am J Physiol Cell
Physiol 255: C155–C161, 1988.
BIBER J, MALMSTRÖM K, SCALERA V, AND MURER H. Phosphorylation of
rat kidney proximal tubular brush-border membranes. Role of
cAMP dependent protein phosphorylation in the regulation of
phosphate transport. Pflügers Arch 398: 221–226, 1983.
BIBER J, AND MURER H. Na/Pi cotransport in LLC-PK1 cells: fast
adaptive response to Pi deprivation. Am J Physiol Cell Physiol 249:
C430 –C434, 1985.
BINDELS RJM, GEERTSEN JAM, AND VAN OS CH. Increased transport
of inorganic phosphate in renal brush borders of spontaneously
hypertensive rats. Am J Physiol Renal Fluid Electrolyte Physiol
250: F470 –F475, 1986.
BIRNIR B, LOO DDF, AND WRIGHT EM. Voltage clamp studies of the
Na/glucose cotransporter cloned from rabbit small intestine.
Pflügers Arch 418: 78 –95, 1990.
BONJOUR JP AND CAVERZASIO J. Phosphate transport in the kidney.
Rev Physiol Biochem Pharmacol 100: 161–214, 1984.
BOROSS M, KINSELLA J, CHENG L, AND SACKTOR B. Glucocorticoids and
metabolic acidosis-induced renal transports of inorganic phosphate, calcium and NH4. Am J Physiol Renal Fluid Electrolyte
Physiol 250: F827–F833, 1986.
BOYER CJC, XIAO Y, DUGRE A, VINCENT E, DELISLE MC, AND BELIVEAU
R. Phosphate deprivation induces overexpression of two proteins
related to the rat renal phosphate cotransporter NaPi-2. Biochim
Biophys Acta 1281: 117–123, 1996.
BRAZY PC, GULLANS SR, MANDEL LJ, AND DENNIS VW. Metabolic
requirement for inorganic phosphate by the rabbit proximal tubule:
evidence for a crabtree effect. J Clin Invest 70: 53– 62, 1982.
BRÖER ST, SCHUSTER A, WAGNER C, BRÖER A, FORSTER I, BIBER J,
MURER H, LANG F, AND BUSCH AE. Chloride conductance and Pitransport are separate functions induced by the expression of
NaPi-1 in Xenopus oocytes. J Membr Biol 164: 71–77, 1998.
BROWN E, POLLACK MM, AND HEBERT SC. The extracellular calciumsensing receptor: its role in health and disease. Annu Rev Med 49:
15–29, 1998.
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
9. ALLON M, RODRIGUEZ M, AND LLACH F. Insulin in the acute renal
adaptation to dietary phosphate restriction in the rat. Kidney Int
37: 14 –20, 1990.
10. AL-MAHROUQ HA AND KEMPSON SA. Photoaffinity labeling of brushborder membrane proteins which bind phosphonoformic acid.
J Biol Chem 266: 1422–1427, 1991.
11. AMBUHL PM, ZAJICEK HK, WANG H, PUTTAPARTHI K, AND LEVI M.
Regulation of renal phosphate transport by acute and chronic
metabolic acidosis in the rat. Kidney Int 53: 1288 –1298, 1998.
12. AMIEL C, KUNTZIGER H, COUETTE S, COUREAU C, AND BERGOUNIOUX N.
Evidence for a parathyroid hormone-independent calcium modulation of phosphate transport along the nephron. J Clin Invest 57:
256 –263, 1976.
13. AMIEL C, KUNTZIGER H, AND RICHET G. Micropuncture study of handling of phosphate by proximal and distal nephron in normal and
parathyroidectomized rats. Evidence for a distal reabsorption.
Pflügers Arch 317: 93–109, 1970.
14. AMSTUTZ M, MOHRMANN M, GMAJ P, AND MURER H. Effect of pH on
phosphate transport in rat renal brush-border membrane vesicles.
Am J Physiol Renal Fluid Electrolyte Physiol 248: F705–F710,
1985.
15. ARAR M, BAUM M, BIBER J, MURER H, AND LEVI M. Epidermal growth
factor inhibits Na-Pi cotransport and mRNA in OK cells. Am J
Physiol Renal Fluid Electrolyte Physiol 268: F309 –F314, 1995.
16. ARAR M, LEVI M, AND BAUM M. Maturational effects of glucocorticoids on neonatal brush-border membrane phosphate transport.
Pediatr Res 35: 474 – 478, 1994.
17. ARAR M, ZAJICEK HK, ELSHIHABI I, AND LEVI M. Epidermal growth
factor inhibits Na-Pi cotransport in weaned and suckling rats. Am J
Physiol Renal Physiol 276: F72–F78, 1999.
18. AZZAROLO AM, RITCHIE G, AND QUAMME GA. Some characteristics of
sodium independent phosphate transport across renal basolateral
membranes. Biochim Biophys Acta 1064: 229 –234, 1991.
19. BAINES AD AND DRANGOVA R. Does dopamine use several signal
pathways to inhibit Na-Pi-transport in OK cells. J Am Soc Nephrol
9: 1604 –1612, 1998.
20. BARAC-NIETO M, TOWD TL, AND SPITZER A. Effect of Pi restriction on
the relationship between the intracellular Pi and renal Na-Pi cotransport capacity in growing guinea pig (Abstract). Kidney Int 37:
453, 1990.
21. BARAN DT. Nongenomic actions of the steroid hormone 1␣,25dihydroxyvitamin D3. J Cell Biochem 56: 303–306, 1994.
22. BARRETT PQ AND ARONSON PS. Glucose and alanine inhibition of
phosphate transport in renal microvillus membrane vesicles. Am J
Physiol Renal Fluid Electrolyte Physiol 242: F126 –F131, 1982.
23. BARRETT PQ, GERTNER JM, AND RASMUSSEN H. Effect of dietary
phosphate on transport properties of pig renal microvillus vesicles.
Am J Physiol Renal Fluid Electrolyte Physiol 239: F352–F359,
1980.
24. BAUMANN K, DE ROUFFIGNAC C, ROINEL N, RUMRICH G, AND ULLRICH KJ.
Renal phosphate transport: inhomogeneity of local proximal transport rates and sodium dependence. Pflügers Arch 356: 287–297,
1975.
25. BECK L, KARAPLIS AC, AMIZUKA N, HEWSON AS, OZAWA H, AND TENENHOUSE HS. Targeted inactivation of Npt 2 in mice leads to severe
renal phosphate wasting, hypercalciuria and skeletal annormalities. Proc Natl Acad Sci USA 95: 5372–5377, 1998.
26. BECK L, SOUMOUNOU Y, MARTEL J, KRISHNAMURTHY G, GAUTHIER C,
GOODYER CG, AND TENENHOUSE HS. Pex/PEX tissue distribution and
evidence for a deletion in the 3⬘ region of the Pex gene in X-linked
hypophosphatemic mice. J Clin Invest 99: 1200 –1209, 1997.
27. BECK L, TENENHOUSE HS, MEYER RA, MEYER MH, BIBER J, AND MURER
H. Renal expression of Na-phosphate cotransporter mRNA and
protein: effect of the Gy mutation and low phosphate diet. Pflügers
Arch 431: 936 –941, 1996.
28. BECK N, WEBSTER SK, AND REINECK HJ. Effect of fasting on tubular
phosphorous reabsorption. Am J Physiol Renal Fluid Electrolyte
Physiol 237: F241–F246, 1979.
29. BEERS KW, CHINI EN, AND DOUSA TP. All-trans-retinoic acid stimulates synthesis of cyclic ADP-ribose in renal epithelial cells. J Clin
Invest 95: 2385–2390, 1995.
30. BEERS KW, CHINI EN, LEE HC, AND DOUSA TP. Metabolism of cyclic
1399
1400
MURER, HERNANDO, FORSTER, AND BIBER
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
85.
86.
87.
88.
89.
90.
SV40 transgenic mice retain intrinsic properties of polarized proximal tubule cells. Kidney Int 56: 559 –570, 1999.
CHANG AC AND REDDEL RR. Identification of a second stanniocalcin
cDNA in mouse and human: stanniocalcin 2. Mol Cell Endocrinol
141: 95–99, 1998.
CHASE LR AND AURBACH GD. Parathyroid function and the renal
excretion of 3⬘,5⬘-adenylic acid. Proc Natl Acad Sci USA 58: 518 –
525, 1967.
CHEN TC, HUMPIERRES J, HANNA D, PERREGAUX SB, AND PUSCHETT JB.
Volume expansion-induced changes in renal tubular membrane
protein phosphorylation. Biochem Biophys Res Commun 143: 74 –
80, 1987.
CHEN XZ, COADY MJ, AND LAPOINTE J-Y. Fast voltage clamp discloses
a new component of presteady-state currents from the Na⫹-glucose
cotransporter. Biophys J 71: 2544 –2552, 1996.
CHENG L, DERSCH C, KRAUS E, SPECTOR D, AND SACKTOR B. Renal
adaptation to phosphate load in the acutely thyroparathyroidectomized rat: rapid alteration in brush-border membrane phosphate
transport. Am J Physiol Renal Fluid Electrolyte Physiol 246: F488 –
F494, 1984.
CHENG L, LIANG CT, PRECHT P, AND SACKTOR B. Alpha-2 adrenergic
modulation of the parathyroid hormone dependent inhibition of
phosphate uptake in cultured renal (OK) cells. Biochem Biophys
Res Commun 155: 74 – 82, 1988.
CHENG L, LIANG CT, AND SACKTOR B. Phosphate uptake by renal
membrane vesicles of rabbits adapted to high and low phosphorus
diets. Am J Physiol Renal Fluid Electrolyte Physiol 245: F175–
F180, 1983.
CHENG L, PRECHT P, FRANK D, AND LIANG CT. Dopamine stimulation
of cAMP production in cultured opossum kidney cells. Am J
Physiol Renal Fluid Electrolyte Physiol 258: F877–F882, 1990.
CHENG L AND SACKTOR B. Sodium gradient dependent phosphate
transport in renal brush-border membrane vesicles. J Biol Chem
256: 1556 –1564, 1981.
CHONG SS, KOZAK CA, LIU L, KRISTJANSSON K, DUNN ST, BOURDEAU JE,
AND HUGHES MR. Cloning, genetic mapping and expression analysis
of a mouse renal sodium-dependent phosphate cotransporter. Am J
Physiol Renal Fluid Electrolyte Physiol 268: F1038 –F1045, 1995.
CHONG SS, KRISTJANSSON K, ZOGHBI HY, AND HUGHES MR. Molecular
cloning of the cDNA encoding a human renal sodium phosphate
transport protein and its assignment to chromosome 6p21.3-p23.
Genomics 18: 355–359, 1993.
CHRISTENSEN EI AND NIELSEN S. Structural and functional features of
protein handling in the kidney proximal tubule. Semin Nephrol 11:
414 – 439, 1991.
CIEN ML, O’NEILL E, AND GARCIA JV. Phosphate depletion enhances
the stability of the amphotropic murine leukemia virus receptor
mRNA. Virology 240: 109 –117, 1998.
COLE JA, EBER SL, POELLING RE, THORNE PK, AND FORTE LR. A dual
mechanism for regulation of kidney phosphate transport by parathyroid hormone. Am J Physiol Endocrinol Metab 253: E221–E227,
1987.
COLE JA, FORTE LR, EBER S, THORNE PK, AND POELLING RE. Regulation of sodium-dependent phosphate transport by parathyroid hormone in opossum kidney cells: adenosine 3⬘,5⬘-monophosphatedependent and -independent mechanisms. Endocrinology 122:
2981–2989, 1988.
COLLINS JF AND GISHAN FK. Molecular cloning, functional expression, tissue distribution and in situ hybridization of the renal sodium phosphate (Na/Pi) transporter in the control and hypophosphatemic mouse. FASEB J 8: 862– 868, 1994.
COLLINS JF AND GHISHAN FK. The molecular defect in the renal
sodium-phosphate transporter expression pathway of Gyro (Gy)
mice is distinct from that of hypophosphatemic (Hyp) mice.
FASEB J 10: 751–759, 1996.
COLLINS JF, SCHEVING LA, AND GHISHAN FK. Decreased transcription
of the sodium-phosphate transporter gene in the hypophosphatemic mouse. Am J Physiol Renal Fluid Electrolyte Physiol
269: F439 –F448, 1995.
COURJAULT-GAUTIER F, LE GRIMELLEC C, GIOCONDI MC, AND TOUTAIN
HJ. Modulation of sodium-coupled uptake and membrane fluidity
by cisplatin in renal proximal tubular cells in primary culture and
brush-border membrane vesicles. Kidney Int 47: 1048 –1056, 1995.
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
52. BRUNETTE MG, BELIVEAU R, AND CHAN M. Effect of temperature and
pH on phosphate transport through brush-border membrane vesicles in rats. Can J Physiol Pharmacol 62: 229 –234, 1984.
53. BRUNETTE MG, CHAN M, MAAG U, AND BELIVEAU R. Phosphate uptake
by superficial and deep nephron brush-border membranes. Effect
of dietary phosphate and parathyroid hormone. Pflügers Arch 400:
356 –362, 1984.
54. BRUNSKILL NJ, STUART J, TOBIN AB, WALLS J, AND NAHORSKI S. Receptor-mediated endocytosis of albumin by kidney proximal tubule
cells is regulated by phosphatidylinositide 3-kinase. J Clin Invest
101: 2140 –2150, 1998.
55. BURCKHARDT G, STERN H, AND MURER H. The influence of pH on
phosphate transport into renal brush-border membrane vesicles.
Pflügers Arch 390: 191–197, 1981.
56. BUSCH AE, BIBER J, MURER H, AND LANG F. Electrophysiological
insights of type I and II Na/Pi transporters. Kidney Int 49: 986 –987,
1996.
57. BUSCH AE, SCHUSTER A, WALDEGGER S, WAGNER CA, ZEMPEL G, BROER
S, BIBER J, MURER H, AND LANG F. Expression of a renal type
sodium/phosphate transporter (NaPi-1) induces a conductance in
Xenopus oocytes permeable for organic and inorganic anions. Proc
Natl Acad Sci USA 93: 5347–5351, 1996.
58. BUSCH AE, WAGNER CA, SCHUSTER A, WALDEGGER S, BIBER J, MURER
H, AND LANG F. Properties of electrogenic Pi transport by human
renal brush border Na⫹/Pi transporter. J Am Soc Nephrol 6: 1547–
1551, 1995.
59. BUSCH AE, WALDEGGER S, HERZER T, BIBER J, MARKOVICH D, HAYES G,
MURER H, AND LANG F. Electrophysiological analysis of Na⫹/Pi
cotransport mediated by a transporter cloned from rat kidney and
expressed in Xenopus oocytes. Proc Natl Acad Sci USA 91: 8205–
8208, 1994.
60. CAI Q, HODGSON SF, KAO PC, LENNON VA, KLEE GG, ZINSMIESTER AR,
AND KUMAR R. Inhibition of renal phosphate transport by a tumor
product in a patient with oncogenic osteomalacia. N Engl J Med
330: 1645–1649, 1994.
61. CAVERZASIO J AND BONJOUR JP. Mechanism of rapid phosphate (Pi)
transport adaptation to a single meal in rat renal brush-border
membranes. Pflügers Arch 404: 227–331, 1985.
62. CAVERZASIO J AND BONJOUR JP. Influence of calcium on phosphate
transport in cultured kidney epithelium. Am J Physiol Renal Fluid
Electrolyte Physiol 254: F217–F222, 1988.
63. CAVERZASIO J AND BONJOUR JP. Insulin-like growth factor 1 stimulates Na-dependent Pi transport in cultured kidney cells. Am J
Physiol Renal Fluid Electrolyte Physiol 257: F712–F717, 1989.
64. CAVERZASIO J, BROWN CDA, BIBER J, BONJOUR J-P, AND MURER H.
Adaptation of phosphate transport in phosphate-deprived LLC-PK1
cells. Am J Physiol Renal Fluid Electrolyte Physiol 248: F122–
F127, 1985.
65. CAVERZASIO J, MONTESSUIT C, AND BONJOUR J-P. Stimulatory effect of
insulin-like growth factor-1 on renal Pi transport and plasma 1,25dihydroxi-vitamin D3. Endocrinology 127: 453– 459, 1990.
66. CAVERZASIO J, MURER H, FLEISCH H, AND BONJOUR J-P. Phosphate
transport in brush-border membrane vesicles isolated from renal
cortex of young growing and adult rats: comparison with whole
kidney data. Pflügers Arch 394: 217–221, 1982.
67. CAVERZASIO J, RIZZOLI R, AND BONJOUR JP. Sodium dependent phosphate transport inhibited by parathyroid hormone and cyclic AMP
stimulation in an opossum kidney cell line. J Biol Chem 261:
3233–3237, 1986.
68. CHABARDÈS D, GAGNAN-BRUNETTE M, IMBERT-TEBOUL M, GONTCHAREVSKAIA O, MONTEGUT M, CLIQUE A, AND MOREL F. Adenylate cyclase
responsiveness to hormones in various portions of the human
nephron. J Clin Invest 65: 439 – 448, 1980.
69. CHABARDÈS D, IMBERT M, CLIQUE A, MONTEGUT M, AND MOREL F.
PTH-sensitive adenylate cyclase activity in different segments of
the rabbit nephron. Pflügers Arch 354: 229 –236, 1975.
70. CHABARDÈS D, IMBERT-TEBOUL M, MONTEGUT M, CLIQUE A, AND MOREL
F. Catecholamine sensitive adenylate cyclase activity in different
segments of the rabbit nephron. Pflügers Arch 36: 9 –15, 1975.
71. CHALUMEAU C, LAMBLIN D, BOURGEOIS S, BORENSZTEIN P, CHAMBREY R,
BRUNEVAL P, VAN HUYEN JPD, FROISSART M, BIBER J, PAILLARD M,
KELLERMANN O, AND POGGIOLI J. Kidney cortex cells derived from
Volume 80
October 2000
PROXIMAL TUBULAR PHOSPHATE REABSORPTION
113. ECONS MJ, MCENERY PT, LENNON F, AND SPEER MC. Autosomal
dominant hypophosphatemic rickets is linked to chromosome
12p13. J Clin Invest 100: 2656 –2657, 1997.
114. ELGAVISH A, RIFKIND J, AND SACKTOR B. In vitro effects of vitamin D3
on the phospholipids of isolated renal brush-border membranes. J
Membr Biol 72: 85–91, 1983.
115. ELKJAER ML, BIRN H, AGRE P, CHRISTENSEN S, AND NIELSEN S. Effects
of microtubule disruption on endocytosis, membrane recycling and
polarized disruption of aquaporin-1 and gp330 in proximal tubule
cells. Eur J Cell Biol 67: 57–52, 1995.
116. ESCOUBET B, DJABALI K, AND AMIEL C. Adaptation to Pi deprivation of
cell Na-dependent Pi uptake: a widespread process. Am J Physiol
Cell Physiol 256: C322–C328, 1989.
117. ESKANDARI S, LOO DD, DAI G, LEVY O, WRIGHT EM, AND CARRASCO N.
Thyroid Na⫹/I⫺ symporter. Mechanism, stoichiometry and specificty. J Biol Chem 272: 27230 –27238, 1997.
118. ESPINOSA RE, KELLER MJ, YUSUFI ANK, AND DOUSA P. Effect of
thyroxine administration on phosphate transport across renal cortical brush-border membrane. Am J Physiol Renal Fluid Electrolyte Physiol 246: F133–F139, 1984.
119. EUZET S, LELIEVRE-PEGORIER M, AND MERLET-BENICHOU C. Maturation
of rat renal phosphate transport: effect of triiodothyronine.
J Physiol (Lond) 488: 449 – 457, 1995.
120. EVERS C, MURER H, AND KINNE R. Effect of parathyrin on the transport properties of isolated renal brush border vesicles. Biochem J
172: 49 –56, 1978.
121. FEILD JA, ZHANG L, BRUN KA, BROOKS DP, AND EDWARDS RM. Cloning
and functional characterization of a sodium-dependent phosphate
transporter expressed in human lung and small intestine. Biochem
Biophys Res Commun 258: 578 –582, 1999.
122. FORSTER I, HERNANDO N, BIBER J, AND MURER H. The voltage dependence of a cloned mammalian renal type II Na⫹/Pi cotransporter
(NaPi-2). J Gen Physiol 112: 1–18, 1998.
123. FORSTER I, LOO DDF, AND ESKANDARI S. Stoichiometry and Na⫹binding cooperativity of rat and flounder renal type II Na⫹-Pi
cotransporters. Am J Physiol Renal Physiol 276: F644 –F649, 1999.
124. FORSTER I, STANGE G, BIBER J, AND MURER H. Kinetic characterization
of the pH-dependence of the type II Na/Pi cotransporters. Biophys
J. In press.
125. FORSTER I, TRAEBERT M, JANKOWSKI M, STANGE G, BIBER J, AND MURER
H. Protein kinase C acivators induce membrane retrieval of type II
Na⫹-phosphate cotransporters expressed in Xenopus oocytes.
J Physiol (Lond) 517: 327–340, 1999.
126. FORSTER I, WAGNER CA, BUSCH AE, LANG F, BIBER J, HERNANDO N,
MURER H, AND WERNER A. Electrophysiological characterization of
the flounder type II Na/Pi cotransporter (NaPi-5) expressed in
Xenopus laevis oocytes. J Membr Biol 160: 9 –25, 1997.
127. FREIBERG JM, KINSELLA J, AND SACKTOR B. Glucocorticoids increase
the Na⫹-H⫹ exchange and decrease the Na⫹ gradient-dependent
phosphate-uptake systems in renal brush-border membrane vesicles. Proc Natl Acad Sci USA 79: 4932– 4936, 1982.
128. FRIEDLANDER G. Regulation of renal phosphate handling: recent
findings. Curr Opin Nephrol Hypertens 5: 316 –320, 1996.
129. FRIEDLANDER G AND AMIEL C. Autocrine/paracrine control of renal
phosphate transport. Kidney Int 57: S148 –S153, 1996.
130. FRIEDLANDER G AND AMIEL C. Extracellular nucleotides as modulators of renal tubular transport. Kidney Int 47: 1500 –1506, 1995.
131. FRIEDLANDER G, COUETTE S, COUREAU C, AND AMIEL C. Mechanisms
whereby extracellular adenosine 3⬘,5⬘-monophosphate inhibits
phosphate transport in cultured opossum kidney cells and in rat
kidney. Physiological implications. J Clin Invest 90: 848 – 858, 1992.
132. FRIEDLANDER G, PRIÉ D, SIEGFRIED G, AND AMIEL C. Role of renal
handling of extracellular nucleotides in modulation of phosphate
transport. Kidney Int 49: 1019 –1022, 1996.
133. FRÖMTER E. Viewing the kidney through microelectrodes. Am J
Physiol Renal Fluid Electrolyte Physiol 247: F695–F705, 1984.
134. FUCENTESE M, WINTERHALTER K, MURER H, AND BIBER J. Functional
expression of rat renal Na⫹/Pi cotransport (NaPi-2) in Sf9 cells by
the Baculovirus system. J Membr Biol 144: 43– 48, 1995.
135. FUCENTESE M, WINTERHALTER K, MURER H, AND BIBER J. Functional
expression and purification of histidine-tagged rat renal Na/phosphate (NaPi-2) and Na/sulfate (NaSi-1) cotransporters. J Membr
Biol 160: 111–117, 1997.
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
91. CUSTER M, LÖTSCHER M, BIBER J, MURER H, AND KAISSLING B. Expression of Na/Pi cotransport in rat kidney: localization by RT-PCR and
immunohistochemistry. Am J Physiol Renal Fluid Electrolyte
Physiol 266: F767–F774, 1994.
92. CUSTER M, MEIER F, SCHLATTER E, GREGER R, GARCIA-PEREZ A, BIBER
J, AND MURER H. Localization of NaPi-1, a putative Na/Pi cotransporter, in rabbit kidney proximal tubules. Part I: mRNA localization
by RT-PCR. Pflügers Arch 424: 203–209, 1993.
93. CUSTER M, SPINDLER B, VERREY F, MURER H, AND BIBER J. Identification of a new gene product (Diphor-1) regulated by dietary phosphate. Am J Physiol Renal Physiol 273: F801–F806, 1997.
94. DANISI G AND MURER H. Inorganic phosphate absorption in small
intestine. In: Handbook of Physiology. The Gastrointestinal System. Intestinal Absorption and Secretion. Bethesda, MD: Am.
Physiol. Soc., 1991, sect. 6, vol. IV, chapt. 12, p. 323–336.
95. DEBIEC H AND LORENC R. Identification of Na⫹, Pi-binding protein in
kidney and intestinal brush-border membranes. Biochem J 255:
185–191, 1988.
96. DE LA HORRA C, HERNANDO N, STANGE G, FORGO J, FORSTER I, KARIM
JIMINEZ Z, BIBER J, AND MURER H. Molecular characterization of the
pH-dependence of the type IIa Na/Pi cotransporter. J Biol Chem.
275: 6284 – 6287, 2000.
97. DELISLE MC, BOYER C, VACHON V, GIROUX S, AND BELIVEAU R. Immunodetection and characterization of proteins implicated in renal
sodium/phosphate cotransport. Biochim Biophys Acta 1190: 289 –
296, 1994.
98. DELISLE MC, VACHON V, GIROUX S, POTIER M, LAPRADE R, AND
BÉLIVEAU R. Molecular size of the renal sodium/phosphate symporter in native and reconstituted systems. Biochim Biophys Acta
1104: 132–136, 1992.
99. DENNIS VW AND BRAZY PC. Sodium phosphate, glucose, bicarbonate
and alanine interactions in the isolated proximal convoluted tubule
of the rabbit kidney. J Clin Invest 62: 387–397, 1978.
100. DENNIS VW AND BRAZY PC. Divalent anion transport in isolated renal
tubules. Kidney Int 22: 498 –506, 1982.
101. DENNIS VW. Phosphate homeostasis. In: Handbook of Physiology.
Renal Physiology. Bethesda, MD: Am. Physiol. Soc., 1992 sect. 8,
vol. II, chapt. 37, p. 1785–1815.
102. DENNIS VW. Phosphate metabolism: contribution of different cellular compartments. Kidney Int 49: 938 –942, 1996.
103. DE TOLEDO FGS, BEERS KW, BERNDT TJ, THOMPSON MA, TYCE GM,
KNOX FG, AND DOUSA TP. Opposite paracrine effects of 5-HT and
dopamine on Na⫹-Pi cotransport in opossum kidney cells. Kidney
Int 52: 152–156, 1997.
104. DE TOLEDO FGS, THOMSON FGS, BOLLIGER C, TYCE GM, AND DOUSA
TP. Administration of ␥-L-glutamyl-L-DOPA inhibits Na⫹-phosphate
cotransport across renal brush-border membranes and increases
renal excretion of phosphate. Kidney Int 55: 1832–1842, 1999.
105. DI MATTIA GE, VARGESE R, AND WAGNER GF. Molecular cloning and
characterization of stanniocalcin related protein. Mol Cell Endocrinol 146: 137–140, 1998.
106. DIXON PH, CHRISTIE PT, WOODING C, TRUMP D, GRIEFF M, HOLM I,
GERTNER JM, SCHMIDKE J, SHAH N, SMITH C, TAU C, SCHLESSINGER D,
WHYTE MP, AND THAKKER RV. Mutational analysis of the PHEX gene
in X-linked hypophosphataemia. J Clin Endocrinol Metab 83: 3615–
3623, 1998.
107. DOUSA TP. Modulation of renal Na⫹/Pi cotransport by hormones
acting via genomic mechanism and by metabolic factors. Kidney
Int 49: 997–1004, 1996.
108. DOUSA TP, DUARTE CG, AND KNOX FG. Effect of colchicine on urinary
phosphate and regulation by parathyroid hormone. Am J Physiol
231: 61– 65, 1976.
109. DREZNER MK AND BURCH WM JR. Altered activity of the nucleotide
regulatory site in the parathyroid hormone-sensitive adenylate cyclase from the renal cortex of a patient with pseudohypoparathyroidism. J Clin Invest 62: 1222–1227, 1978.
110. ECONS MJ. Positional cloning of the HYP gene: a review. Kidney Int
49: 1033–1037, 1996.
111. ECONS MJ AND DREZNER MK. Tumor-induced osteomalacia: unveiling
a new hormone. N Engl J Med 330: 1679 –1681, 1994.
112. ECONS MJ AND FRANCIS F. Positional cloning of the PEX gene: new
insights into the pathophysiology of X-linked hypophosphatemic
rickets. Am J Physiol Renal Physiol 273: F489 –F498, 1997.
1401
1402
MURER, HERNANDO, FORSTER, AND BIBER
157.
158.
159.
160.
161.
162.
163.
164.
165.
166.
167.
168.
169.
170.
171.
172.
173.
174.
175.
176.
177.
involvement of cAMP and PKC. Kidney Blood Pressure Res 23: 1–9,
2000.
HANNUN Y. The sphingomyelin cycle and the second messenger
function of ceramide. J Biol Chem 269: 3125–3128, 1994.
HANSCH E, FORGO J, MURER H, AND BIBER J. Role of microtubules in
the adaptive response to low phosphate of Na/Pi cotransport in
opossum kidney cells. Pflügers Arch 422: 516 –522, 1993.
HARAMATI A. Tubular capacitiy for phosphate reabsorption in superficial and deep nephrons. Am J Physiol Renal Fluid Electrolyte
Physiol 248: F729 –F733, 1985.
HARAMATI A, MULRONEY SE, AND LUMPKIN MD. Regulation of renal
phosphate reabsorption during development: implications from a
new model of growth hormone deficiency. Pediatr Nephrol 4:
387–391, 1990.
HARAMATI A, MULRONEY SE, AND WEBSTER SK. Developmental
changes in the tubular capacity for phosphate reabsorption in the
rat. Am J Physiol Renal Fluid Electrolyte Physiol 255: F287–F291,
1988.
HARTMANN CM, HEWSON AS, KOS CH, HILFIKER H, SOUMOUNOU Y,
MURER H, AND TENENHOUSE HS. Structure of murine and human
renal type II Na-phosphate cotransporter genes (npt2 and NPT2).
Proc Natl Acad Sci USA 93: 7409 –7414, 1996.
HARTMANN CM, WAGNER CA, BUSCH AE, MARKOVICH D, BIBER J, LANG
F, AND MURER H. Transport characteristics of a murine renal Na/Pi
cotransport. Pflügers Arch 430: 830 – 836, 1995.
HATAE T, ICHIMURA T, ISHIDA T, AND SAKURAI T. Apical tubular network in the rat kidney proximal tubule cells studied by thicksection and scanning electron microscopy. Cell Tissue Res 288:
317–325, 1997.
HAYES G, BUSCH A, LANG F, BIBER J, AND MURER H. Protein kinase C
consensus sites and the regulation of renal Na/Pi cotransport
(NaPi-2) expressed in Xenopus laevis oocytes. Pflügers Arch 430:
819 – 824, 1995.
HAYES G, BUSCH A, LÖTSCHER M, WALDEGGER S, LANG F, VERREY F,
BIBER J, AND MURER H. Role of N-linked glycosylation in rat renal
Na/Pi cotransport. J Biol Chem 269: 24143–24149, 1994.
HAZAMA A, LOO DD, AND WRIGHT EM. Presteady-state currents of the
Na⫹/glucose cotransporter (SGLT1). J Membr Biol 155: 175–186,
1997.
HELPS C, MURER H, AND MCGIVAN J. Cloning, sequence analysis and
expression of the cDNA encoding a sodium-dependent phosphate
transporter from the bovine renal epithelial cell line NBL-1. Eur
J Biochem 228: 927–930, 1995.
HERAK-KRAMBERGER CM, SPINDLER B, BIBER J, MURER H, AND SABOLIC
I. Renal type II Na/Pi cotransporter is strongly impaired whereas
the Na/sulfate cotransporter and aquaporin 1 are unchanged in
cadmium treated rats. Pflügers Arch 432: 336 –344, 1996.
HERNANDO N, KARIM-JIMENEZ Z, FORGO J, BIBER J, AND MURER H.
Tyrosine and dileucine motifs in internalization and membrane
targeting of the type IIa Na/Pi cotransporter. J Am Soc Nephrol. In
press.
HERNANDO N, SHEIKH S, KARIM-JIMENEZ Z, GALLIKER H, FORGO J, BIBER
J, AND MURER H. Asymmetrical targeting of type II Na/Pi cotransporters in renal and intestinal epithelial cell lines. Am J Physiol
Renal Physiol 280: F361–F368, 2000.
HERNANDO N, TRAEBERT M, FORSTER I, BIBER J, AND MURER H. Effect
of two tyrosine mutations on the activity and regulation of the renal
type II Na⫹/Pi cotransporter expressed in oocytes. J Membr Biol
168: 275–282, 1999.
HICKE L. Getting down with ubiquitin: turning off cell-surface receptors, transporters and channels. Trends Cell Biol 9: 107–112,
1999.
HILFIKER H, HARTMANN C, STANGE G, AND MURER H. Characterization
of the 5⬘-flanking region of the OK-cell type II Na/Pi cotransport
gene. Am J Physiol Renal Physiol 274: F197–F204, 1998.
HILFIKER H, HATTENHAUER O, TRAEBERT M, FORSTER I, MURER H, AND
BIBER J. Characterization of a new murine type II sodium-phosphate cotransporter expressed in mammalian small intestine. Proc
Natl Acad Sci USA 95: 14564 –14569, 1998.
HILFIKER H, KVIETIKOVA I, HARTMANN CM, STANGE G, AND MURER H.
Characterization of the human type II Na/Pi cotransporter promoter. Pflügers Arch 436: 591–598, 1998.
HISANO S, HAGA H, LI Z, TATSUMI S, MIYAMOTO KI, TAKEDA E, AND FUKUI
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
136. GAZIT D, TIEDER M, LIBERMAN UA, PASSI-EVEN L, AND BAB A. Osteomalacia in hereditary hypophosphatemic rickets with hypercalciuria: a correlative clinical-histomorphometric study. J Clin Endocrinol Metab 72: 229 –235, 1991.
137. GLAHN RP, ONSGARD MJ, TYCE GM, CHINNOW SL, KNOX FG, AND DOUSA
TP. Autocrine/paracrine regulation of renal Na⫹-phosphate cotransport by dopamine. Am J Physiol Renal Fluid Electrolyte
Physiol 264: F618 –F622, 1993.
138. GMAJ P AND MURER H. Cellular mechanisms of inorganic phosphate
transport in the kidney. Physiol Rev 66: 36 –70, 1986.
139. GOLIGORSKY M, MENTON DN, AND HRUSKA KA. Parathyroid hormoneinduced changes of the brush border topography and cytoskeleton
in cultured renal proximal tubular cells. J Membr Biol 92: 151–162,
1986.
140. GOODYER PR, KACHRA Z, BELL C, AND ROZEN R. Renal tubular cells are
potential targets for epidermal growth factor. Am J Physiol Renal
Fluid Electrolyte Physiol 255: F1191–F1196, 1988.
141. GREENBERG A, PARKINSON DK, FETTEROLF DE, PUSCHETT JB, ELLIS KJ,
WIELOPOLSKI L, VASWANI AN, COHN SH, AND LANDRIGAN PJ. Effects of
elevated lead and cadmium burdens on renal function and calcium
metabolism. Arch Environ Health 41: 69 –76, 1986.
142. GREGER R, LANG F, MARCHAND G, AND KNOX FG. Site of renal phosphate reabsorption. Micropuncture and microinfusion study.
Pflügers Arch 369: 11–118, 1977.
143. GRINSTEIN S, TURNER RJ, SILVERMAN M, AND ROTHSTEIN A. Inorganic
anion transport in kidney and intestinal brush border and basolateral membranes. Am J Physiol Renal Fluid Electrolyte Physiol 238:
F452–F460, 1980.
144. GULLANS SR, BRAZY PC, MANDEL LJ, AND DENNIS V. Stimulation of
phosphate transport in the proximal tubule by metabolic substrates. Am J Physiol Renal Fluid Electrolyte Physiol 247: F582–
F587, 1984.
145. GUPTA A, GUO XL, ALVAREZ UM, AND HRUSKA KA. Regulation of
sodium-dependent phosphate transport in osteoclasts. J Clin Invest 100: 538 –548, 1997.
146. HAAS JA, BERNT T, AND KNOX FG. Nephron heterogeneity of phosphate reabsorption. Am J Physiol Renal Fluid Electrolyte Physiol
234: F287–F290, 1978.
147. HAFDI Z, COUETTE S, COMOY E, PRIE D, AMIEL C, AND FRIEDLANDER G.
Locally formed 5-hydroxytryptamine stimulates phosphate transport in cultured opossum kidney cells and in rat kidney. Biochem
J 320: 615– 621, 1996.
148. HAGENBUCH B AND MURER H. Phosphate transport across the basolateral membrane from rat kidney cortex: sodium-dependence?
Pflügers Arch 407: S149 –S155, 1986.
149. HAMMERMAN MR. Phosphate transport across renal proximal tubular cell membranes. Am J Physiol Renal Fluid Electrolyte Physiol
251: F385–F398, 1986.
150. HAMMERMAN MR. The growth hormone-insulin-like growth factor
axis in the kidney. Am J Physiol Renal Fluid Electrolyte Physiol
257: F503–F514, 1989.
151. HAMMERMAN MR AND GAVIN JR. Binding of IGF-I and IGF-I-stimulated phosphorylation in canine renal basolateral plasma membranes. Am J Physiol Endocrinol Metab 251: E32–E41, 1986.
152. HAMMERMAN MR AND HRUSKA KA. Cyclic AMP-dependent protein
phosphorylation in canine renal brush-border membrane vesicles is
associated with decreased phosphate transport. J Biol Chem 257:
992–999, 1982.
153. HAMMERMAN MR, KARL IE, AND HRUSKA KA. Regulation of canine
renal vesicle Pi transport by growth hormone and parathyroid
hormone. Biochim Biophys Acta 603: 322–335, 1980.
154. HAMMERMAN MR AND ROGERS SA. Distribution of IGF receptors in
the plasma membrane of proximal tubular cells. Am J Physiol
Renal Fluid Electrolyte Physiol 253: F841–F847, 1987.
155. HAMMERMAN MR, ROGERS S, HANSEN VA, AND GAVIN JR. Insulin stimulated Pi transport in brush border vesicles from proximal tubular
segments. Am J Physiol Endocrinol Metab 247: E616 –E624, 1984.
156. HAMMOND TG, YUSUFI ANK, KNOX FG, AND DOUSA TP. Administration
of atrial natriuretic factor inhibits sodium-coupled transport in
proximal tubules. J Clin Invest 75: 1983–1989, 1985.
156a.HAN HJ, KIM DH, AND PARK SH. Regulatory mechanisms of Na/Pi
cotransporter by glucocorticoid in renal proximal tubule cells:
Volume 80
October 2000
178.
179.
180.
181.
183.
184.
185.
186.
187.
188.
189.
190.
191.
192.
193.
194.
195.
196.
197.
Y. Immunohistochemical and RT-PCR detection of Na⫹-dependent
inorganic phosphate cotransporter (NaPi-2) in rat brain. Brain Res
772: 149 –155, 1997.
HOAG HH, GAUTHIER C, MARTEL I, AND TENENHOUSE HS. Effects of
Npt2 gene ablation and low Pi-diet on renal Na⫹-phosphate cotransport and cotransporter gene expression. J Clin Invest 104:
679 – 686, 1999.
HOFFMAN N, THEES M, AND KINNE R. Phosphate transport by isolated
renal brush border vesicles. Pflügers Arch 362: 147–156, 1976.
HOPPE A, LIN JT, ONSGARD M, KNOX FG, AND DOUSA TP. Quantitation
of the Na/Pi cotransporter in renal cortical brush-border membranes. 14C-phosphonoformic acid as a useful probe to determine
the intensity and its change in response to parathyroid hormone.
J Biol Chem 266: 11528 –11536, 1991.
HRUSKA KA, KLAHR S, AND HAMMERMAN MR. Decreased luminal membrane transport of phosphate in chronic renal failure. Am J Physiol
Renal Fluid Electrolyte Physiol 242: F17–F22, 1982.
HRUSKA KA, MILLS SC, KHALIFA S, AND HAMMERMAN MR. Phosphorylation of renal brush-border membrane vesicles. J Biol Chem 258:
2501–2507, 1983.
HRUSKA KA, MOSKOWITZ D, ESBRIT P, CIVITELLI R, WESTBROOK S, AND
HUSKEY M. Stimulation of inositol trisphosphate and diacylglycerol
production in renal tubular cells by parathyroid hormone. J Clin
Invest 79: 230 –239, 1987.
HUELSEWEH B, KOHL B, HENTSCHEL H, KINNE RK, AND WERNER A.
Translated anti-sense product of the Na/phosphate co-transporter
(NaPi-II). Biochem J 332: 483– 489, 1998.
HYP CONSORTIUM. A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nature Genet 11: 130 –136, 1995.
IMBERT M, CHABARDES D, MONTEGUT M, CLIQUE A, AND MOREL F.
Adenylate cyclase activity along the rabbit nephron as measured in
single isolated segments. Pflügers Arch 354: 213–228, 1975.
ISAAC J, BERNDT TJ, CHINNOW SL, TYCE GM, DOUSA TP, AND KNOX FG.
Dopamine enhances the phosphaturic response to parathyroid hormone in phosphate-deprived rats. J Am Soc Nephrol 2: 1423–1429,
1992.
ISAAC J, GLAHN RP, APPEL MA, ONSGARD M, DOUSA TP, AND KNOX FG.
Mechanisms of dopamine inhibition of renal phosphate transport.
J Am Soc Nephrol 2: 1601–1607, 1992.
ISHIBASHI K, MIYAMOTO K, TAKETANI Y, MORITA K, SASAKI S, AND IMAI M.
Molecular cloning of a second human stanniocalcin homologue
(STC-2). Biochem Biophys Res Commun 250: 252–258, 1998.
ISHIZUYA-OKA A, STOLOW MA, UEDA S, AND SHI Y. Temporal and
spatial expression of an intestinal Na/Pi cotransporter correlates
with epithelial transformation during thyroid hormone-dependent
frog metamorphosis. Dev Genet 20: 53– 66, 1997.
JANKOWSKI M, BIBER J, AND MURER H. PTH-induced internalization of
a type IIa Na/Pi cotransporter in OK cells. Pflügers Arch. 438:
689 – 693, 1999.
JEHLE AW, FORGO J, BIBER J, LEDERER E, KRAPF R, AND MURER H. Acid
induced stimulation of Na/Pi cotransport in OK cells: molecular
characterization and effect of dexamethasone. Am J Physiol Renal
Physiol 273: F396 –F403, 1997.
JEHLE AW, FORGO J, BIBER J, LEDERER E, KRAPF R, AND MURER H.
IGF-I and vanadate stimulate Na/Pi cotransport in OK cells by
increasing type II Na/Pi cotransporter protein stability. Pflügers
Arch 437: 149 –159, 1998.
JEHLE AW, HILFIKER H, PFISTER M, BIBER J, LEDERER E, KRAPF R, AND
MURER H. Type II Na⫹/Pi cotransport is regulated at the transcriptional level by ambient bicarbonate/carbon dioxide tension in
Opossum kidney cells. Am J Physiol Renal Physiol 276: F46 –F53,
1999.
JETTE M, VACHON V, POTIER M, AND BELIVEAU R. The renal sodium/
phosphate symporters— evidence for different functional oligomeric states. Biochemistry 35: 15209 –15214, 1996.
JUPPNER H, ABOU-SAMRA A-B, FREEMAN M, KONG XF, SCHIPANI E,
RICHARDS J, KANEDA Y, AND BELLO-REUSS E. Effect of dopamine on
phosphate reabsorption in isolated perfused rabbit proximal tubules. Miner Electrolyte Metab 9: 147–150, 1983.
KARIM-JIMENEZ Z, HERNANDO N, BIBER J, AND MURER H. Requirement
of a leucine residue for (apical) membrane expression of type IIB
Na/Pi-cotransporters. Proc Natl Acad Sci USA. 97: 2916 –2921, 2000.
1403
198. KARIM-JIMENEZ Z, HERNANDO N, BIBER J, AND MURER H. Molecular
signals in PTH-dependent endocytosis of type IIa Na/Pi cotransporters. Proc Natl Acad. Sci USA. In press.
199. KATAI K, SEGAWA H, HAGA H, MORITA K, ARAI H, TATSUMI S, TAKETANI
Y, MIYAMOTO K, HISANO S, FUKUI Y, AND TAKEDA E. Acute regulation
by dietary phosphate of the sodium-dependent phosphate transporter (NaPi-2) in rat kidney. J Biochem 121: 50 –55, 1997.
200. KAUFMANN M, MUFF R, STIEGER B, BIBER J, MURER H, AND FISCHER JA.
Apical and basolateral parathyroid hormone receptors in rat renal
cortical membranes. Endocrinology 134: 1173–1178, 1994.
201. KAVANAUGH MP AND KABAT D. Identification and characterization of
a widely expressed phosphate transporter/retrovirus receptor family. Kidney Int 49: 959 –963, 1996.
202. KAVANAUGH MP, MILLER DG, ZHANG W, LAW W, KOZAK SL, KABAT D,
AND MILLER AD. Cell-surface receptors for gibbon ape leukemia
virus and amphotropic murine retrovirus are inducible sodiumdependent phosphate symporters. Proc Natl Acad Sci USA 91:
7071–7075, 1994.
203. KAYNE LH, D’ARGENIO DZ, MEYER JH, HU MS, JAMGOTCHIAN N, AND LEE
DBN. Analysis of segmental phosphate absorption in intact rats. A
compartmental analysis approach. J Clin Invest 91: 915–922, 1993.
204. KEMPSON SA. Effects of fasting compared to low phosphorus diet on
the kinetics of phosphate transport by renal brush-border membranes. Biochim Biophys Acta 815: 85–90, 1985.
205. KEMPSON SA. Novel specific inhibitors of epithelial phosphate transport. News Physiol Sci 3: 154 –157, 1988.
206. KEMPSON SA. Peptide hormone action on renal phosphate handling.
Kidney Int 49: 1005–1009, 1996.
207. KEMPSON SA, COLON-OTERO G, OU SY, TURNER ST, AND DOUSA TP.
Possible role of nicotinamide adenine dinucleotide as an intracellular regulator of renal transport of phosphate in the rat. J Clin
Invest 67: 1347–1360, 1981.
208. KEMPSON SA, HELMLE-KOLB C, ABRAHAM MI, AND MURER H. Parathyroid hormone action on phosphate transport is inhibited by high
osmolality. Am J Physiol Renal Fluid Electrolyte Physiol 258:
F1336 –F1344, 1990.
209. KEMPSON SA, HELMLE-KOLB C, AND MURER H. Endocytosis and phosphate transport in OK epithelial cells. Renal Physiol Biochem 12:
359 –364, 1989.
210. KEMPSON SA, LÖTSCHER M, KAISSLING B, BIBER J, MURER H, AND LEVI M.
Parathyroid hormone action on phosphate transporter mRNA and
protein in rat renal proximal tubules. Am J Physiol Renal Fluid
Electrolyte Physiol 268: F784 –F791, 1995.
211. KEMPSON SA, YING AL, MCATEER JA, AND MURER H. Endocytosis and
Na⫹/solute cotransport in renal epithelial cells. J Biol Chem 264:
18451–18456, 1989.
212. KEUSCH I, TRAEBERT M, LÖTSCHER M, KAISSLING B, MURER H, AND BIBER
J. Parathyroid hormone and dietary phosphate provoke lysosomal
routing of the proximal tubular Na/Pi cotransporter type II. Kidney
Int 54: 1224 –1232, 1998.
212a.KIDO S, MIYAMOTO K, MIZOBUCHI H, TAKETANI Y, OHKIDO I, OGAWA N,
KANEKO Y, HARASHIMA S, AND TAKEDA E. Identification of regulatory
sequences and binding proteins in the type II sodium/phosphate
cotransporter NPT 2 gene responsive to dietary phosphate. J Biol
Chem 274: 28256 –28263, 1999.
213. KIEBZAK GM AND DOUSA TP. Thyroid hormones increase renal brushborder membrane transport of phosphate in X-linked hypophosphatemic (Hyp) mice. Endocrinology 117: 613– 619, 1985.
214. KIEBZAK GM AND SACKTOR B. Effect of age on renal conservation of
phosphate in the rat. Am J Physiol Renal Fluid Electrolyte Physiol
251: F399 –F407, 1986.
215. KIEBZAK GM, YUSUFI AN, KUSANO EBRAUN-WERNESS J, AND DOUSA TP.
ATP and cAMP system in the in vitro response of microdissected
cortical tubules to PTH. Am J Physiol Renal Fluid Electrolyte
Physiol 248: F152–F159, 1985.
216. KNOCHEL JP. The clinical and physiological implications of phosphorus deficiency. In: The Kidney, Physiology and Pathophysiology, edited by Seldin D and Giebisch W. New York: Raven, 1992, p.
2533–2562, 1992.
217. KNOCHEL JP AND ARGARWAL R. Hypophosphatemia and hyperphosphatemia. In: Rector’s The Kidney (5th ed.), edited by Brenner BM.
Philadelphia, PA: Saunders, 1996, p. 1086 –1133.
218. KNOX FG AND HARAMATI A. Renal regulation of phosphate excretion.
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
182.
PROXIMAL TUBULAR PHOSPHATE REABSORPTION
1404
MURER, HERNANDO, FORSTER, AND BIBER
241.
242.
243.
244.
245.
246.
247.
248.
249.
250.
251.
252.
253.
254.
255.
256.
257.
258.
259.
260.
brush-border membrane phosphate transport. J Clin Invest 85:
231–237, 1980.
LEVI M, JAMESON DM, AND VAN DER MEER BW. Role of BBM lipid
composition and fluidity in impaired renal Pi transport in aged rats.
Am J Physiol Renal Fluid Electrolyte Physiol 256: F85–F94, 1989.
LEVI M, KEMPSON SA, LÖTSCHER M, BIBER J, AND MURER H. Molecular
regulation of renal phosphate transport. J Membr Biol 154: 1–9,
1996.
LEVI M, LÖTSCHER M, SORRIBAS V, CUSTER M, ARAR M, KAISSLING B,
MURER H, AND BIBER J. Cellular mechanisms of acute and chronic
adaptation of rat renal Pi transporter to alterations in dietary Pi.
Am J Physiol Renal Fluid Electrolyte Physiol 267: F900 –F908,
1994.
LEVI M, SHAYMAN JA, ABE A, GROSS SK, MCCLUER RH, BIBER J, MURER
H, LÖTSCHER M, AND CRONIN RE. Dexamethasone modulates rat
renal brush-border membrane phosphate transporter mRNA and
protein abundance and glycosphingolipid composition. J Clin Invest 96: 207–216, 1995.
LEVINE BS, HO K, HODSMAN A, KUOROKAWA K, AND COBURN JW. Early
renal brush-border membranes adaptation to dietary phosphorous.
Miner Electrolyte Metab 10: 22–227, 1984.
LEVINE BS, KNIBLOE KA, GOLCHINI K, HASHIMOTO S, AND KURTZ I. Renal
adaptation to dietary phosphate deprivation: role of proximal tubule brush-border membrane fluidity. Am J Physiol Renal Fluid
Electrolyte Physiol 260: F613–F618, 1991.
LI H, ONWOCHEI M, RUCH RJ, AND XIE Z. Regulation of rat Na/Pi
cotransporter-1 gene expression: the roles of glucose and insulin.
Am J Physiol Endocrinol Metab 271: E1021–E1028, 1996.
LI H AND XIE Z. Molecular cloning of two rat Na/Pi cotransporters:
evidence for differential tissue expression of transcripts. Cell Mol
Biol Res 41: 451– 460, 1995.
LIANG CT, BARNES J, BALAKIR R, CHENG L, AND SACKTOR B. In vitro
stimulation of phosphate uptake in isolated chick renal cells by
1,25-dihydroxycholecalciferol. Proc Natl Acad Sci USA 79: 3532–
3536, 1982.
LIANG CT, BARNES J, CHENG L, BALAKIR R, AND SACKTOR B. Effects of
1,25-(OH)2D3 administered in vivo on phosphate uptake by isolated
chick renal cells. Am J Physiol Cell Physiol 242: C312–C318, 1982.
LICOVITCH M AND CANTLEY L. Lipid second messengers. Cell 77:
329 –334, 1994.
LLOYD SE, GUNTHER W, PEARCE SH, THOMSON A, BIANCHI ML, BOSIO M,
CRAIG IW, FISHER SE, SCHEINMAN SJ, WRONG O, JENTSCH TJ, AND
THAKKER RV. Characterization of renal chloride channel, CLC 5,
mutations in hypercaliuric nephrolithiasis (kidney stones) disorders. Hum Mol Genet 6: 1233–1239, 1997.
LLOYD SE, PEARCE SH, GUNTHER W, KAWAGUCHI H, IGARASHI T,
JENTSCH TJ, AND THAKKER RV. Idiopathic low molecular weight
proteinuria associated with hypercalciuric nephrocalcinosis in Japanese children is due to mutations of the renal chloride channel
(CLCN5). J Clin Invest 99: 967–974, 1997.
LOFFING J, LÖTSCHER M, KAISSLING B, BIBER J, MURER H, SEIKALY M,
ALPERN RJ, LEVI M, BAUM M, AND MOE OW. Renal Na/H exchanger
NHE-3 and Na-PO4 cotransporter NaPi-2 protein expression in glucocorticoid excess and deficient states. J Am Soc Nephrol 9: 1560 –
1567, 1998.
LOGHMAN-ADHAM M. Characterization of essential sulfhydryl groups
of rat renal Na-Pi cotransporter. Am J Physiol Renal Fluid Electrolyte Physiol 260: F874 –F882, 1991.
LOGHMAN-ADHAM M, SZCZEPANSKA-KONKEL M, AND DOUSA TP. Phosphate transport in brush-border membranes from uremic rats. Response to phosphonoformic acid. J Soc Nephrol 3: 1253–1259, 1992.
LÖTSCHER M, KAISSLING B, BIBER J, MURER H, KEMPSON SA, AND LEVI M.
Regulation of rat renal Na/Pi cotransporter by parathyroid hormone: immunohistochemistry. Kidney Int 49: 1005–1009, 1996.
LÖTSCHER M, KAISSLING B, BIBER J, MURER H, AND LEVI M. Role of
microtubules in the rapid regulation of renal phosphate transporter
content. J Clin Invest 99: 1302–1312, 1997.
LÖTSCHER M, SCARPETTA Y, LEVI M, WANG H, ZAJICEK HK, BIBER J,
MURER H, AND KAISSLING B. Rapid downregulation of rat renal Na/Pi
cotransporter in response to parathyroid hormone: role of microtubule rearrangement. J Clin Invest 104: 483– 494, 1999.
MAGAGNIN S, WERNER A, MARKOVICH D, SORRIBAS V, STANGE G, BIBER
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
In: The Kidney: Physiology and Pathphysiology, edited by Seldin
GW and Giebisch G. New York: Raven, 1985, p. 1351–1396.
219. KOHL B, HUELSEWEH B, ELGER M, HENTSCHEL H, AND KINNE RK. Na-Pi
cotransport in flounder: same system in kidney and intestine. Am J
Physiol Renal Fluid Electrolyte Physiol 270: F937–F944, 1996.
220. KOHL B, WAGNER CA, HUELSEWEH B, BUSCH AE, AND WERNER A. The
Na/Pi cotransport system (NaPi-II) with a cleaved backbone: implications on function and membrane insertion. J Physiol (Lond) 508:
341–350, 1998.
220a.KÖHLER K, FORSTER JC, LAMBERT G, BIBER J, AND MURER H. The
functional unit of the renal type IIa Na⫹/Pi-cotransporter is a
monomer. J Biol Chem. In press.
221. KOLESNICK J. Ceramide: a novel second messenger. Trends Cell Biol
2: 232–236, 1992.
222. KOS CH, TIHY F, ECONS MJ, MURER H, LEMIEUX N, AND TENENHOUSE
HS. Localization of a renal sodium phosphate cotransporter gene to
human chromosome 5q35. Genomics 19: 176 –177, 1994.
223. KOS CH, TIHY F, MURER H, LEMIEUX N, AND TENENHOUSE HS. Comparative mapping of Na⫹-phosphate cotransporte genes, NPT1 and
NPT2, in human and rabbit. Cytogenet Cell Genet 75: 22–24, 1996.
224. KUMAR R. New concepts concerning the regulation of renal phosphate excretion. News Physiol Sci 12: 211–214, 1997.
225. KUMAR R. Phosphatonin—a new phosphaturetic hormone? (Lessons from tumour-induced osteomalacia and X-linked hypophosphataemia). Nephrol Dial Transplant 12: 11–13, 1997.
226. KURNIK BRC AND HRUSKA KA. Effects of 1–25 dihydroxycholecalciferol on phosphate transport in vitamin D-deprived rats. Am J
Physiol Renal Fluid Electrolyte Physiol 247: F177–F184, 1984.
227. KURNIK BRC AND HRUSKA KA. Mechanism of stimulation of renal
phosphate transport by 1,25-dihydroxycholecalciferol. Biochim
Biophys Acta 817: 42–50, 1985.
228. LAMBERT G, BIBER J, AND MURER H. Cysteine residues and the structure of the rat renal type IIa sodium/phosphate cotransporter. J
Membr Biol. In press.
229. LAMBERT G, FORSTER IC, STANGE G, BIBER J, AND MURER H. Properties
of the mutant Ser-460-Cys implicate this site in a functionally
important region of the type IIa Na/Pi cotransporter protein. J Gen
Physiol 114: 637– 651, 1999.
230. LAMBERT G, TRAEBERT M, BIBER J, AND MURER H. Cleavage of disulfide bonds leads to inactivation and degradation of the sodium
phosphate cotransporter type IIa, but not type IIb expressed in
Xenopus laevis oocytes. J Membr Biol. In press.
231. LAMBERT G, TRAEBERT M, HERNANDO N, BIBER J, AND MURER H.
Studies on the topology of the renal type II NaPi cotransporter.
Pflügers Arch 437: 972–978, 1999.
232. LANG F, GREGER R, MARCHAND GR, AND KNOX FG. Stationary microperfusion study of phosphate reabsorption in proximal and
distal nephron segments. Pflügers Arch 368: 45– 48, 1977.
233. LAW F, RIZZOLI R, AND BONJOUR JP. Transforming growth factor-␤
inhibits phosphate transport in renal epithelial cells. Am J Physiol
Renal Fluid Electrolyte Physiol 264: F623–F628, 1993.
234. LEDERER ED AND MCLEISH KR. P2 purinoceptor stimulation attenuates PTH inhibition of phosphate uptake by a G protein-dependent
mechanism. Am J Physiol Renal Fluid Electrolyte Physiol 269:
F309 –F316, 1995.
235. LEDERER ED, SOHI SS, MATHIESEN JM, AND KLEIN JB. Regulation of
expression of type II sodium-phosphate cotransporters by protein
kinase A and protein kinase C. Am J Physiol Renal Physiol 275:
F270 –F277, 1998.
236. LEDERER ED, SOHI SS, AND MCLEISH KR. PTH stimulates extracellular
signal-regulated kinase activity through two independent signal
transduction pathways. Role of ERK in sodium-phosphate cotransport. J Am Soc Nephrol 9: 975–987, 1998.
237. LE GRIMELLEC C, FRIEDLANDER G, YANDOUZI EHE, ZLATKINE P, AND
GIOCONDI MC. Membrane fluidity and transport properties in epithelia. Kidney Int 42: 825– 836, 1992.
238. LELIEVRE-PEGORIER M AND MERLET-BENICHOU C. Effects of weaning
on phosphate transport maturation in the rat kidney. Clearance and
brush-border membrane studies. Pediatr Nephrol 7: 807– 814, 1993.
239. LEVI M. Heterogeneity of Pi transport by BBM from superficial and
juxtamedullary cortex of rat. Am J Physiol Renal Fluid Electrolyte
Physiol 258: F1616 –F1624, 1990.
240. LEVI M, BAIRD BM, AND WILSON PV. Cholesterol modulates rat renal
Volume 80
October 2000
261.
262.
263.
264.
265.
267.
268.
269.
270.
271.
272.
273.
274.
275.
276.
277.
278.
279.
280.
281.
J, AND MURER H. Expression cloning of human and rat renal cortex
Na/Pi cotransport. Proc Natl Acad Sci USA 90: 5979 –5983, 1993.
MALMSTRÖM K AND MURER H. Parathyroid hormone inhibits phosphate transport in OK cells but not in LLC-PK1 and JTC-12.P3 cells.
Am J Physiol Cell Physiol 251: C23–C31, 1986.
MALMSTRÖM K AND MURER H. Parathyroid hormone regulates phosphate transport in OK cells via an irreversible inactivation of a
membrane protein. FEBS Lett 216: 257–260, 1987.
MALMSTRÖM K, STANGE G, AND MURER H. Identification of proximal
tubular transport functions in the established kidney cell line, OK.
Biochim Biophys Acta 902: 269 –277, 1987.
MALMSTRÖM K, STANGE G, AND MURER H. Intracellular cascades in the
parathyroid-hormone-dependent regulation of Na⫹/phosphate cotransport in OK cells. Biochem J 251: 207–213, 1988.
MARKOVICH D, FORGO J, STANGE G, BIBER J, AND MURER H. Expression
cloning of rat renal Na/SO4 cotransport. Proc Natl Acad Sci USA 90:
8073– 8077, 1993.
MARKOVICH D, VERRI T, SORRIBAS V, FORGO J, BIBER J, AND MURER H.
Regulation of opossum kidney (OK) cell Na/Pi cotransport by Pi
deprivation involves mRNA stability. Pflügers Arch 430: 459 – 463,
1995.
MARTIN KJ, MCCONKEY CL, GARCIA JC, MONTANI D, AND BETTS CR.
Protein kinase A and the effects of parathyroid hormone on phosphate uptake in opossum kidney cells. Endocrinology 125: 295–301,
1989.
MARTIN KJ, MCCONKEY CL, JACOB AK, GONZALEZ EA, KHAN M, AND
BALDASSARE JJ. Effect of U-73122, an inhibitor of phospholipase C,
on actions of parathyroid hormone in opossum kidney cells. Am J
Physiol Renal Fluid Electrolyte Physiol 266: F254 –F258, 1994.
MCPHERSON JD, KRANE MC, WAGNER-MCPHERSON CB, KOS CH, AND
TENENHOUSE HS. High resolution mapping of the renal sodiumphosphate cotransporter gene (NPT2) confirms its localization to
human chromosome 5Q35. Pediatr Res 41: 632– 634, 1997.
MELLMAN I. Endocytosis and molecular sorting. Annu Rev Cell Dev
Biol 12: 575– 625, 1996.
MELTZER V, WEINREB S, BELLORIN-FONT E, AND HRUSKA KA. Parathyroid hormone stimulation of renal phosphoinositide metabolism is
a cyclic nucleotide-independent effect. Biochim Biophys Acta 712:
258 –267, 1982.
MEYER RA, MEYER MH, AND GRAY RW. Parabiosis suggests a humoral
factor is involved in X-linked hypophosphatemia in mice. J Bone
Miner Res 4: 493–500, 1989.
MEYER RA JR, HENLEY CM, MEYER MH, MORGAN PL, MCDONALD AG,
MILLS C, AND PRICE DK. Partial deletion of both the spermine
synthase gene and the Pex gene in the X-linked hypophosphatemic,
Gyro (Gy) mouse. Genomics 48: 289 –295, 1998.
MICHAUT P, PRIÉ D, AMIEL C, AND FRIEDLANDER G. New role for an old
drug: dipyridamole for renal phosphate leak. N Engl J Med 331:
58 –59, 1994.
MIYAMOTO K, SEGAWA H, MORITA K, NII T, TATSUMI S, TAKETANI Y, AND
TAKEDA E. Relative contributions of Na-dependent phosphate cotransporters to phosphate transport in mouse kidney: RNase H
mediated hybrid depletion analysis. Biochem J 327: 735–739, 1997.
MIYAMOTO K, TATSUMI S, SONODA T, YAMAMOTO H, MINAMI H, TAKETANI
Y, AND TAKEDA E. Cloning and functional expression of a Nadependent phosphate cotransporter from human kidney: cDNA
cloning and functional expression. Biochem J 305: 81– 85, 1995.
MIYAMOTO K, TATSUMI S, YAMAMOTO H, KATAI K, TAKETANI Y, MORITA K,
AND TAKEDA E. Chromosome assignments of genes for human
Na(⫹)-dependent phosphate cotransporters NaPi-3 and NPT-1. Tokushima J Exp Med 42: 5–9, 1995.
MIZGALA CL AND QUAMME GA. Renal handling of phosphate. Physiol
Rev 65: 431– 466, 1985.
MOLITORIS BA, ALFREY AC, HARRIS RA, AND SIMON FR. Renal apical
membrane cholesterol and fluidity in regulation of phosphate transport. Am J Physiol Renal Fluid Electrolyte Physiol 249: F12–F19,
1985.
MUFF R, FISCHER JA, BIBER J, AND MURER H. Parathyroid hormone
receptors in control of proximal tubule function. Annu Rev Physiol
54: 67–79, 1992.
MULRONEY SE, LUMPKIN MD, AND HARAMATI A. Antagonist to GHreleasing factor inhibits growth and renal Pi reabsorption in imma-
1405
ture rats. Am J Physiol Renal Fluid Electrolyte Physiol 257: F29 –
F34, 1989.
282. MURER H. Cellular mechanisms in proximal tubular Pi reabsorption:
some answers and more questions. J Am Soc Nephrol 2: 1649 –1665,
1992.
283. MURER H AND BIBER J. Renal tubular phosphate transport: cellular
mechanisms. In: The Kidney, Physiology and Pathophysiology,
edited by Seldin DW and Giebisch G. New York: Raven, 1992, p.
2481–2509.
284. MURER H AND BIBER J. Renal sodium-phosphate cotransport. Curr
Opin Nephrol Hypertens 3: 504 –510, 1994.
285. MURER H AND BIBER J. Molecular mechanisms of renal apical Na/
phosphate cotransport. Annu Rev Physiol 58: 607– 618, 1996.
286. MURER H AND BIBER J. Editorial overview: epithelial transport proteins: physiology and pathophysiology. Curr Opin Cell Biol 10:
429 – 434, 1998.
287. MURER H AND BIBER J. A molecular view of proximal tubular inorganic phosphate (Pi) reabsorption and of its regulation. Pflügers
Arch 433: 379 –389, 1997.
288. MURER H, FORSTER I, HERNANDO N, LAMBERT G, TRAEBERT M, AND
BIBER J. Post-transcriptional regulation of the proximal tubule Naphosphate transporter type II in response to PTH and dietary
phosphate. Am J Physiol Renal Physiol 277: F676 –F684, 1999.
289. MURER H, FORSTER I, HILFIKER H, PFISTER M, KAISSLING B, LÖTSCHER M,
AND BIBER J. Cellular/molecular control of renal Na/Pi cotransport.
Kidney Int 65: S2–S10, 1998.
290. MURER H AND HILDMANN B. Transcellular transport of calcium and
inorganic phosphate in the small intestinal epithelium. Am J
Physiol Gastrointest Liver Physiol 240: G409 –G416, 1981.
291. MURER H AND KINNE R. The use of isolated membrane vesicles to
study epithelial transport processes. J Membr Biol 55: 81–95, 1980.
292. MURER H, LÖTSCHER M, KAISSLING B, LEVI M, KEMPSON SA, AND BIBER
J. Renal brush-border membrane Na/Pi cotransport: molecular aspects in PTH-dependent and dietary regulation. Kidney Int 49:
1769 –1773, 1996.
293. MURPHY A, GONZALEZ A. GOSTI C, CORDERO E, PINNEY D, CABDIA C,
SOLOMON F, GUSELLA A, AND RAMESH V. NHE-RF, a regulatory cofactor for Na-H exchange, is a common interactor for merlin and ERM
(MERM) proteins. Proc Natl Acad Sci USA 273: 1273–1276, 1998.
294. NAKAI M, FUKASE M, KINOSHITA Y, AND FUJITA T. Atrial natriuretic
factor inhibits phosphate uptake in opossum kidney cells: as a
model of renal proximal tubules. Biochem Biophys Res Commun
152: 1416 –1420, 1988.
294a.NALBANT P, BOEHMER C, DEHMELT L, WEHNER F, AND WERNER A.
Functional characterization of a Na⫹-phosphate cotransporter
(NaP1-II) from zebrafish and identification of related transcripts.
J Physiol (Lond) 520: 79 – 89, 1999.
295. NESBITT T, COFFMAN TM, GRIFFITHS R, AND DREZNER MK. Crosstransplantation of kidneys in normal and Hyp mice: evidence that
the Hyp phenotype is unrelated to an intrinsic renal defect. J Clin
Invest 89: 1453–1459, 1992.
296. NI B, DU Y, WU X, DEHOFF BS, ROSTECK PR, AND PAUL SM. Molecular
cloning, expression, and chromosomal localization of a human
brain-specific Na-dependent inorganic phosphate cotransporter.
J Neurochem 66: 2227–2238, 1996.
297. NI B, ROSTECK PR, NADI NS, AND PAUL SM. Cloning and expression
of a cDNA encoding a brain-specific Na-dependent inorganic phosphate cotransporter. Proc Natl Acad Sci USA 91: 5607–5611, 1994.
298. NORONHA-BLOB L, LOWE V, AND SACKTOR B. Stimulation by thyroid
hormone of phosphate transport in primary cultured renal cells.
J Cell Physiol 137: 95–101, 1988.
299. NORONHA-BLOB L AND SACKTOR B. Inhibition by glucocorticoids of
phosphate transport in primary cultured renal cells. J Biol Chem
265: 2164 –2169, 1986.
300. OBERBAUER R, SCHREINER GF, BIBER J, MURER H, AND MEYER TW. In
vivo suppression of the renal Na/Pi cotransporter by antisense
oligonucleotides. Proc Natl Acad Sci USA 93: 4903– 4906, 1996.
301. OBERLEITHNER H, LANG F, GREGER R, AND SPORER H. Influence of
calcium and ionophore 23187 on tubular phosphate reabsorption.
Pflügers Arch 379: 37– 41, 1979.
302. OLAH Z, LEHEL C, ANDERSON WB, EIDEN MV, AND WILSON CA. The
cellular receptor for gibbon ape leukemia virus is a novel high
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
266.
PROXIMAL TUBULAR PHOSPHATE REABSORPTION
1406
303.
304.
305.
306.
308.
309.
310.
311.
312.
313.
314.
315.
316.
317.
318.
319.
320.
321.
affinity sodium-dependent phosphate transporter. J Biol Chem 269:
25426 –25431, 1994.
PALMER G, BONJOUL J-P, AND CAVERZASIO J. Expression of a newly
identified phosphate transporter/retrovirus receptor in human
SaOS-2 osteoblast-like cells and its regulation by insulin-like
growth factor I. Endocrinology 138: 5202–5209, 1997.
PAPAKONSTANTI EA, EMMANOUEL DS, GRAVANIS A, AND STOURNARAS C.
Na/Pi cotransport alters rapidly cytoskeletal protein polymerization
dynamics in oppossum kidney cells. Biochem J 315: 241–247, 1996.
PAQUIN J, VINCENT E, DUGRE A, XIAO YS, BOYER CJC, AND BELIVEAU R.
Membrane topography of the renal phosphate carrier NaPi-2: limited proteolysis studies. Biochim Biophys Acta 1431: 315–328,
1999.
PARAISO MS, MCATEER JA, AND KEMPSON SA. Parathyroid hormone
inhibits plasma membrane Pi transport without changing endocytic
activity in opossum kidney cells. Biochim Biophys Acta 1266:
143–147, 1995.
PFISTER MF, BRUNSKILL NJ, FORGO J, STANGE G, BIBER J, AND MURER
H. Inhibition of phosphatidylinositide 3-kinase reduces in OK cells
Na/Pi cotransport but does not interfere with its regulation by PTH.
Pflügers Arch 438: 392–396, 1999.
PFISTER MF, FORGO J, ZIEGLER U, BIBER J, AND MURER H. cAMPdependent and -independent downregulation of type II Na⫹/Pi cotransporters by PTH. Am J Physiol Renal Physiol 276: F720 –F725,
1999.
PFISTER MF, HILFIKER H, FORGO J, LEDERER E, BIBER J, AND MURER H.
Cellular mechanisms involved in the acute adaptation of Na/Pi
cotransport to high or low-Pi medium in OK cells. Pflügers Arch
435: 713–719, 1998.
PFISTER MF, LEDERER E, FORGO J, ZIEGLER U, LÖTSCHER M, QUABIUS
ES, BIBER J, AND MURER H. Parathyroid hormone-dependent degradation of type II Na/Pi cotransporters. J Biol Chem 272: 20125–
20130, 1997.
PFISTER MF, RUF I, STANGE G, ZIEGLER U, LEDERER E, BIBER J, AND
MURER H. Lysosomal degradation of renal type II Na/Pi cotransporter, a novel principle in the regulation of membrane transport.
Proc Natl Acad Sci USA 45: 1909 –1914, 1998.
PFLÜGER AC, BERNDT TJ, AND KNOX FG. Effect of renal interstitial
adenosine infusion on phosphate excretion in diabtes mellitus rats.
Am J Physiol Regulatory Integrative Comp Physiol 274: R1228 –
R1235, 1998.
PITTS TO, MCGOWAN JA, CHEN TC, SILVERMAN M, ROSE ME, AND
PUSCHETT JB. Inhibitory effects of volume expansion performed in
vivo on transport of the isolated rabbit proximal tubule perfused in
vitro. J Clin Invest 81: 997–1003, 1988.
PIZURKI L, RIZZOLI R, CAVERZASIO J, AND BONJOUR JP. Effect of transforming growth factor-␣ and parathyroid hormone-related protein
on phosphate transport in renal cells. Am J Physiol Renal Fluid
Electrolyte Physiol 259: F929 –F935, 1990.
PIZURKI L, RIZZOLI R, MOSELEY J, MARTIN TJ, CAVERZASIO J, AND BONJOUR J-P. Effect of synthetic tumoral PTH-related peptide on cAMP
production and Na-dependent Pi transport. Am J Physiol Renal
Fluid Electrolyte Physiol 255: 5957–F961, 1988.
PORTALE AA, HALLORAN BP, AND MORRIS RC JR. Dietary intake of
phosphorus modulates the circadian rhythm in serum concentration of phosphorus. J Clin Invest 80: 1147–1154, 1987.
POUJEOL P, CHABARDES D, ROINEL M, AND DE ROUFFIGNAC C. Influence
of extracellular fluid volume expansion on magnesium calcium and
phosphate handling along the rat nephron. Pflügers Arch 365: 203–
211, 1976.
POUJEOL P, CORMAN B, TOUVAY C, AND DE ROUFFIGNAC C. Phosphate
reabsorption in rat nephron terminal segments: intrarenal heterogeneity and strain differences. Pflügers Arch 371: 39 – 44, 1977.
POUJEOL P AND VANDEWALLE A. Phosphate uptake by proximal cells
isolated from rabbit kidney: role of dexamethasone. Am J Physiol
Renal Fluid Electrolyte Physiol 249: F74 –F83, 1985.
PRABHU S, LEVI M, DWARAKANATH V, ARAR M, BIBER J, MURER H, AND
BAUM M. Effect of glucocorticoids on neonatal rabbit renal cortical
sodium-inorganic phosphate messenger RNA and protein abundance. Pediatr Res 41: 20 –24, 1997.
PRATT RD AND PEDERSEN PL. Inhibition of Na-dependent phosphate
transport by group-specific covalent reagents in rat kidney brushborder membrane vesicles. Evidence for the involvement of ty-
323.
324.
325.
326.
327.
328.
329.
330.
331.
332.
333.
334.
335.
336.
337.
338.
339.
340.
341.
342.
343.
Volume 80
rosine and sulfhydryl groups on the interior of the membrane. Arch
Biochem Biophys 68: 9 –19, 1989.
PUSCHETT JB, AGUS ZS, SENESKY D, AND GOLDBERG M. Effects of
saline loading and aortic obstruction on proximal phosphate transport. Am J Physiol 223: 851– 857, 1972.
PUSCHETT JB, LIPUT J, AND GALYA C. Brush-border membrane phosphate transport: effects of volume expansion. Adv Exp Med Biol
208: 109 –113, 1986.
QUABIUS ES, MURER H, AND BIBER J. Expression of a renal Na/Pi
cotransporter (NaPi-1) in MDCK and LLC-PK1 cells. Pflügers Arch
430: 132–136, 1995.
QUABIUS ES, MURER H, AND BIBER J. Expression of proximal tubular
Na-Pi and Na-SO4 cotransporters in MDCK and LLC-PK1 cells by
transfection. Am J Physiol Renal Fluid Electrolyte Physiol 270:
F220 –F228, 1996.
QUAMME GA. Phosphate transport in intestinal brush-border membrane vesicles: effect of pH and dietary phosphate. Am J Physiol
Gastrointest Liver Physiol 249: G168 –G176, 1985.
QUAMME GA. Effect of pH on Na-dependent phosphate transport in
renal outer cortical and outer medullary BBMV. Am J Physiol
Renal Fluid Electrolyte Physiol 258: F1–F8, 1990.
QUAMME GA, BIBER JA, AND MURER H. Sodium-phosphate cotransport in OK cells: inhibition by PTH and “adaptation” to low phosphate. Am J Physiol Renal Fluid Electrolyte Physiol 257: F967–
F973, 1989.
QUAMME GA, PELECH S, BIBER J, AND MURER H. Abnormalities of
parathyroid hormone-mediated signal transduction mechanisms in
opossum kidney cells. Biochim Biophys Acta 1223: 107–116, 1994.
QUAMME GA, PFEILSCHIFTER J, AND MURER H. Parathyroid hormone
inhibition of Na⫹/phosphate cotransport in OK cells: generation of
second messengers in the regulatory cascade. Biochem Biophys
Res Commun 158: 951–957, 1989.
QUAMME GA, PFEILSCHIFTER J, AND MURER H. Parathyroid hormone
inhibition of Na⫹/phosphate cotransport in OK cells: intracellular
[Ca2⫹] as a second messenger. Biochim Biophys Acta 1013: 166 –
172, 1989.
QUAMME GS, PFEILSCHIFTER J, AND MURER H. Parathyroid hormone
inhibition of Na⫹/phosphate cotransport in OK cells: requirement
of protein kinase C-dependent pathway. Biochim Biophys Acta
1013: 159 –165, 1989.
QUAMME GA AND WONG NLM. Phosphate transport in the proximal
convoluted tubule: effect of intraluminal pH. Am J Physiol Renal
Fluid Electrolyte Physiol 246: F323–F333, 1994.
QUIGLEY R AND BAUM M. Effects of growth hormone and insulin-like
growth factor 1 on rabbit proximal convoluted tubule transport.
J Clin Invest 88: 368 –374, 1991.
QUIGLEY R AND BAUM M. Effects of epidermal growth factor and
transforming growth factor-␣ on rabbit proximal tubule solute
transport. Am J Physiol Renal Fluid Electrolyte Physiol 266: F459 –
F465, 1994.
QUIGLEY R, KENNERLY DA, SHEY JN, AND BAUM M. Stimulation of
proximal convoluted tubule phosphate transport by epidermal
growth factor: signal transduction. Am J Physiol Renal Fluid Electrolyte Physiol 269: F339 –F344, 1995.
RASMUSSEN H AND TENENHOUSE HS. Mendelian hypophosphatemias.
In: The Metabolic and Molecular Bases of Inherited Disease, edited
by Scriver CR, Beaudet AL, Sly WS, and Valle D. New York:
McGraw-Hill, 1995, p. 3717–3745.
RESHKIN SJ, FORGO J, BIBER J, AND MURER H. Functional asymmetry
of phosphate transport and its regulation in opossum kidney cells:
phosphate adaptation. Pflügers Arch 419: 256 –262, 1991.
RESHKIN SJ, FORGO J, AND MURER H. Functional asymmetry of phosphate transport and its regulation in OK cells: phosphate transport.
Pflügers Arch 416: 554 –560, 1990.
RESHKIN SJ, FORG J, AND MURER H. Functional asymmetry in phosphate transport and its regulation in OK cells: parathyroid hormone
inhibition. Pflügers Arch 416: 624 – 631, 1990.
RESHKIN SJ, FORGO J, AND MURER H. Apical and basolateral effects of
PTH in OK cells: transport inhibition, messenger production, effects of pertussis toxin and interaction with a PTH-analog. J Membr
Biol 124: 227–237, 1991.
RESHKIN SJ AND MURER H. Involvement of C3 exotoxin-sensitive G
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
307.
MURER, HERNANDO, FORSTER, AND BIBER
October 2000
344.
345.
346.
347.
348.
350.
351.
352.
353.
354.
355.
356.
357.
358.
359.
360.
361.
362.
363.
364.
365.
proteins (rho/rac) in PTH signal transduction in OK cells. Am J
Physiol Renal Fluid Electrolyte Physiol 262: F572–F577, 1992.
RESHKIN SJ AND MURER H. Parathyrod hormone regulation in OK
cells: in situ protein phosphorylation reactions involving PKA, PKC
and GTP-binding proteins. Cell Physiol Biochem 1: 143–159, 1991.
RESHKIN SJ, WUARIN F, BIBER J, AND MURER H. Parathyroid hormone
induced alterations of protein content and phosphorylation in enriched membranes of opossum kidney cells. J Biol Chem 265:
15261–15266, 1990.
RIBEIRO CP AND MANDEL LJ. Parathyroid hormone inhibits proximal
tubule Na-K-ATPase activity. Am J Physiol Renal Fluid Electrolyte
Physiol 262: F209 –F216, 1992.
RICCARDI D, HALL AE, CHATTOPADHYAY N, XU JZ, BROWN EM, AND
HEBERT SC. Localization of the extracellular Ca2⫹/polyvalent cation-sensing protein in rat kidney. Am J Physiol Renal Physiol 274:
F611–F622, 1998.
RITTHALER T, TRAEBERT M, LÖTSCHER M, BIBER J, MURER H, AND
KAISSLING B. Effects of phosphate intake on distribution of type II
Na⫹/Pi cotransporter mRNA in rat kidney. Kidney Int 55: 976 –983,
1999.
RIZZOLI R, RIZURKI L, AND BONJOUR JP. Tumoral parathyroid hormone-related protein: a new hormone affecting calcium and phosphate transport. News Physiol Sci 15: 195–198, 1989.
ROGERS SA AND HAMMERMAN MR. Growth hormone activates phospholipase C in proximal tubular basolateral membranes from canine kidney. Proc Natl Acad Sci USA 86: 6363– 6366, 1989.
ROUSE D AND SUKI WN. Modulation of phosphate absorption by
calcium in the rabbit proximal convoluted tubule. J Clin Invest 76:
630 – 636, 1985.
SACKTOR B AND CHENG L. Sodium gradient-dependent phosphate
transport in renal brush-border membrane vesicles: effect of an
intravesicular greater than extravesicular proton gradient. J Biol
Chem 256: 8080 – 8084, 1981.
SAXENA S AND ALLON M. The role of cytosolic calcium in chronic
adaptation to phosphate depletion in opossum kidney cells. J Biol
Chem 271: 3902–3906, 1996.
SAXENA S, DANSBY L, AND ALLON M. Adaptation to phosphate depletion in opossum kidney cells. Biochem Biophys Res Commun 216:
141–147, 1995.
SCHWAB SJ AND HAMMERMAN MR. Electrogenic Na-independent Pi
transport in canine renal basolateral membrane vesicles. Am J
Physiol Renal Fluid Electrolyte Physiol 250: F419 –F424, 1986.
SCHWAB SJ, KLAHR S, AND HAMMERMAN MR. Na-gradient dependent Pi
uptake in basolateral membrane vesicles from dog kidney. Am J
Physiol Renal Fluid Electrolyte Physiol 246: F663–F669, 1984.
SEGAL JH AND POLLOCK AS. Transfection-mediated expression of a
dominant cAMP-resistant phenotype in the opossum kidney (OK)
cell line prevents parathyroid hormone-induced inhibition of Naphosphate cotransport. J Clin Invest 86: 1442–1450, 1990.
SEIFERT SA, HSIAO SC, MURER H, BIBER J, AND KEMPSON SA. Renal
endosomal phosphate (Pi) transport in normal and diabetic rats
and response to chronic Pi deprivation. Cell Biochem Funct 15:
9 –14, 1997.
SHACHAF C, SKORECKI KL, AND TZUKERMAN M. The role of AP2 consensus sites in the regulation of the rat Npt2 (sodium-phosphate
cotransporter) promoter. Am J Physiol Renal Physiol 280: F406 –
F416, 2000.
SHAH SV, KEMPSON SA, NORTHRUP TE, AND DOUSA TP. Renal adaptation to a low phosphate diet in rats. Blockade by actinomycin D.
J Clin Invest 64: 955–966, 1979.
SIEGFRIED G, VRTOVSNIK F, PRIÉ D, AMIEL C, AND FRIEDLANDER G.
Parathyroid hormone stimulates ecto-5⬘-nucleotidase activity in
renal epithelial cells: role of protein kinase C. Endocrinology 136:
1267–1275, 1995.
SILVERSTEIN DM. Expression of the PiT transporter in the kidney
(Abstract). J Am Soc Nephrol 8: A2645, 1997.
SILVERSTEIN DM, BARAC-NIETO M, MURER H, AND SPITZER A. A putative
growth-related Na-Pi cotransporter. Am J Physiol Regulatory Integrative Comp Physiol 273: R928 –R933, 1997.
SILVERSTEIN DM, BARAC-NIETO M, AND SPITZER A. Mechanism of renal
phosphate retention during growth. Kidney Int 49: 1023–1026,
1996.
SORRIBAS V, LÖTSCHER M, LOFFING J, BIBER J, KAISLLING B, MURER H,
366.
367.
368.
369.
370.
371.
372.
373.
374.
375.
376.
377.
378.
379.
380.
381.
382.
383.
1407
AND LEVI M. Cellular mechanisms of the age-related decrease in
renal phosphate reabsorption. Kidney Int 50: 855– 863, 1996.
SORRIBAS V, MARKOVICH D, HAYES G, STANGE G, FORGO J, BIBER J, AND
MURER H. Cloning of a Na/Pi cotransporter from opossum kidney
cells. J Biol Chem 269: 6615– 6621, 1994.
SORRIBAS V, MARKOVICH D, VERRI T, BIBER J, AND MURER H. Thyroid
hormone stimulation of Na/Pi cotransport in opossum kidney cells.
Pflügers Arch 431: 266 –271, 1995.
STAUB O, GAUTSCHI I, ISHIKAWA T, BREITSCHOPF K, CIECHANOVER A,
SCHILD L, AND ROTIN D. Regulation of stability and function of the
epithelial Na⫹ channel (EnaC) by ubiquitination. EMBO J 16: 6325–
6336, 1997.
STAUB O AND ROTIN D. Regulation of ion transport by protein-protein
interaction domains. Curr Opin Nephrol Hypertens 6: 447– 454,
1997.
STOLL R, KINNE R, AND MURER H. Effect of dietary phosphate intake
on phosphate transport by isolated rat renal brush-border vesicles.
Biochem J 180: 465– 470, 1979.
STOLL R, KINNE R, MURER H, FLEISCH H, AND BONJOUR J-P. Phosphate
transport by rat renal brush-border membrane vesicles: influence
of dietary phosphate, thyro-parathyroidectomy, and 1,25-dihydroxyvitamin D3. Pflügers Arch 380: 47–52, 1979.
STOLL R, MURER H, FLEISCH H, AND BONJOUR J-P. Effect of diphosphonate treatment on phosphate transport by renal brush border
vesicles. Am J Physiol Renal Fluid Electrolyte Physiol 239: F13–
F16, 1980.
STROM TM, FRANCIS F, LORENZ B, BOEDDRICH A, ECONS M, LEHRACH H,
AND MEITINGER T. Pex gene deletions in Gy and Hyp mice provide
mouse models for X-linked hypophosphatemia. Hum Mol Genet 6:
165–171, 1997.
SUKI WN AND ROUSE D. Renal transport of calcium, magnesium, and
phosphate. In: Brenner and Rector’s The Kidney (5th ed.), edited
by Brenner BM. Philadelphia, PA: Saunders, 1996, p. 472–515.
SZCZEPANSKA-KONKEL M, YUSUFI AN, VANSCOY M, WEBSTER SK, AND
DOUSA TP. Phosphonocarboxylic acids as specific inhibitors of
Na⫹-dependent transport of phosphate across renal brush-border
membrane. J Biol Chem 261: 6375– 6383, 1986.
TAKAHASHI F, MORITA K, KATAI K, SEGAWA H, FUJIOKA A, KOUDA T,
TATSUMI S, NII T, TAKETANI Y, HAGA H, HISANO S, FUKUI Y, MIYAMOTO
K, AND TAKEDA E. Effects of dietary inorganic phosphate on the
renal Na⫹-dependent inorganic-phosphate transporter NaPi-2 in
thyroparathyroidectomized rats. Biochem J 333: 175–181, 1998.
TAKEDA E, TAKETANI Y, MORITA K, AND MIYAMOTO K. Sodium-dependent phosphate cotransporters. Int J Biochem Cell Biol 31: 377–
381, 1999.
TAKETANI Y, MIYAMOTO K, CHIKAMORI M, TANAKA K, YAMAMOTO H,
TATSUME S, MORITA K, AND TAKEDA E. Characterization of the 5⬘flanking region of the human NPT-1 Na⫹/phosphate cotransporter
gene. Biochim Biophys Acta 1396: 267–272, 1998.
TAKETANI Y, MIYAMOTO KI, KATAI K, CHIKAMORI M, TATSUMI S, SEGAWA
H, YAMAMOTO H, MORITA K, AND TAKEDA E. Gene structure and
functional analysis of the human Na/phosphate cotransporter. Biochem J 324: 927–934, 1997.
TAKETANI Y, SEGAWA H, CHIKAMORI M, MORITA K, TANAKA K, KIDO S,
YAMAMOTO H, IEMORI Y, TATSUMI S, TSUGAWA N, OKANO T, KOBAYASHI
T, MIYAMOTO K, AND TAKEDA E. Regulation of type II renal Na⫹dependent inorganic phosphate transporters by 1,25-dihydroxyvitamin D-3: identification of a vitamin D-responsive element in the
human NAPI-3 gene. J Biol Chem 273: 14575–14581, 1998.
TATSUMI S, MIYAMOTO K-I, KOUDA T, MOTONAGA K, KATAI K, OHKIDO I,
MORITA K, SEGAWA H, TANI Y, YAMAMOTO H, TAKETANI Y, AND TAKEDA
E. Identification of three isoforms for the Na⫹-dependent phosphate cotransporter (NaPi-2) in rat kidney. J Biol Chem 273:
28568 –28575, 1998.
TATSUMI S, SEGAWA H, MORITA K, HAGA H, KOUDA T, YAMAMOTO H,
INOUE Y, NII T, KATAI K, TAKETANI Y, MIYAMOTO KI, AND TAKEDA E.
Molecular cloning and hormonal regulation of PiT-1, a sodiumdependent phosphate cotransporter from rat parathyroid glands.
Endocrinology 139: 1692–1699, 1998.
TAUFIQ S, COLLINS JF, AND GISHAN FK. Posttranscriptional mechanisms regulate ontogenic changes in rat renal sodium-phosphate
transporter. Am J Physiol Regulatory Integrative Comp Physiol
272: R134 –R141, 1997.
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
349.
PROXIMAL TUBULAR PHOSPHATE REABSORPTION
1408
MURER, HERNANDO, FORSTER, AND BIBER
elicited by administration of phosphonoformate in vivo. Am J
Physiol Renal Fluid Electrolyte Physiol 255: F984 –F994, 1988.
405. VERRI T, MARKOVICH D, PEREGO C, NORBIS F, STANGE G, SORRIBAS V,
BIBER J, AND MURER H. Cloning of a rabbit renal Na/Pi cotransporter
which is regulated by dietary phosphate. Am J Physiol Renal Fluid
Electrolyte Physiol 268: F626 –F633, 1995.
406. VRTOVSNIK F, EL YANDOUZI EH, LE GRIMELLEC C, AND FRIEDLANDER G.
Sphingomyelin and cholesterol modulate sodium coupled uptakes
in proximal tubular cells. Kidney Int 41: 983–991, 1992.
407. WAGNER CA, RABER G, WALDEGGER S, OSSWALD H, BIBER J, MURER H,
BUSCH AE, AND LANG F. Regulation of the human brush border
Na⫹/phosphate cotransporter (NaPi-3) expressed in Xenopus oocytes by intracellular calcium and protein kinase C. Cell Physiol
Biochem 6: 105–111, 1996.
408. WAGNER CA, WALDEGGER S, OSSWALD H, BIBER J, MURER H, BUSCH AE,
AND LANG F. Heavy metals inhibit Pi-induced currents through
human brush border NaPi-3 cotransporter in Xenopus oocytes.
Am J Physiol Renal Fluid Electrolyte Physiol 271: F926 –F930,
1996.
409. WAGNER GF, VOZZOLO BL, JAWORSKI E, HADDAD M, KLINE RL, OLSEN
HS, ROSEN CA, DAVIDSON MB, AND RENFRO JL. Human stanniocalcin
inhibits renal phosphate exretion in the rat. J Bone Miner Res 12:
165–171, 1997.
410. WALKER JJ, YAN TS, AND QUAMME GA. Presence of multiple sodiumdependent phosphate transport processes in proximal brush-border membranes. Am J Physiol Renal Fluid Electrolyte Physiol 252:
F226 –F231, 1987.
411. WEBSTER SK, HARAMATI A, AND KNOX FG. Effect of dexamethasone
on segmental phosphate reabsorption in phosphate deprived rats.
Am J Physiol Renal Fluid Electrolyte Physiol 251: F576 –F580,
1986.
412. WEINMANN EJ, STEPLOCK D, TATE K, HALL RA, SPURNEY RF, AND
SHENOLIKAR S. Structure-function of recombinant Na/H-exchanger
regulatory factor (NHE-RF). J Clin Invest 101: 2199 –2206, 1998.
413. WEINMAN EJ, STEPLOCK D, WANG Y, AND SHENOLIKAR S. Characterization of a protein cofactor that mediates protein kinase A regulation
of the renal brush-border membrane Na-H exchanger. J Clin Invest
95: 2143–2149, 1995.
414. WERNER A, DEHMELT L, AND NALBANT P. Na-dependent phosphate
cotransporters: the NaPi protein families. J Exp Biol 201: 3135–
3142, 1998.
415. WERNER A, KEMPSON SA, BIBER J, AND MURER H. Increase of Na/Pi
cotransport encoding mRNA in response to low Pi diet in rat kidney
cortex. J Biol Chem 269: 6637– 6639, 1994.
416. WERNER A, MOORE ML, MANTEI N, BIBER J, SEMENZA G, AND MURER H.
Cloning and expression of cDNA for a Na/Pi cotransport system of
kidney cortex. Proc Natl Acad Sci USA 88: 9608 –9612, 1991.
417. WERNER A, MURER H, AND KINNE RK. Cloning and expression of a
renal Na/Pi cotransport system from flounder. Am J Physiol Renal
Fluid Electrolyte Physiol 267: F311–F317, 1994.
418. WHITE KE, BIBER J, MURER H, AND ECONS MJ. A PDZ domaincontaining protein with homology to Diphor-1 maps to human
chromosome 1q21. Ann Hum Genet 62: 287–290, 1998.
418a.WHITE KE, BIBER J, MURER H, AND ECONS MJ. Chromosomal localization of two human genes involved in phosphate homeostasis: the
type IIb sodium-phosphate cotransporter and stanniocalcin. Som
Cell Mol Gen. In press.
419. WINAVER J, BURNETT JC, TYCE GM, AND DOUSA TP. ANF inhibits
Na⫹-H⫹ antiport in proximal tubular BBM: role of dopamine. Kidney Int 38: 1133–1140, 1991.
420. WONG CK, HO MA, AND WAGNER GF. The co-localization of stanniocalcin protein, mRNA and kidney cell markers in the rat kidney. J
Endocrinol 158: 183–189, 1998.
421. WONG NLM, QUAMME GA, DIRKS JH, AND SUTTON RAL. Effects of
phosphate and calcium infusion on renal phosphate transport in
the dog. Renal Physiol 8: 30 –37, 1985.
422. WOODCOCK EA AND JOHNSTON CI. Selective inhibition by epinephrine
of parathyroid hormone-stimulated adenylate cyclase in rat renal
cortex. Am J Physiol Renal Fluid Electrolyte Physiol 242: F721–
F726, 1982.
423. WOODCOCK EA AND JOHNSTON CI. Renal proximal tubular ␣-adrenergic receptors oppose urinary 3⬘,5⬘-cyclic adenosine monophos-
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
384. TENENHOUSE HS. X-linked hypophosphatemia-A homologous disorder in humans and mice. Nephrol Dialysis Transplant 14: 333–341,
1999.
385. TENENHOUSE HS AND BECK L. Renal Na-phosphate cotransporter
gene expression in X-linked Hyp and Gy mice. Kidney Int 49:
1027–1032, 1996.
386. TENENHOUSE HS, GAUTHIER C, MARTEL J, GESEK FA, COUTERMARSH BA,
⫹
AND FRIEDMAN PA. Na -phosphate cotransport in mouse distal convoluted tubule cells: evidence for Glvr-1 and Ram-1 gene expression. J Bone Miner Res 13: 590 –597, 1998.
387. TENENHOUSE HS, MARTEL J, BIBER J, AND MURER H. Effect of Pi
restriction on renal Na⫹ -Pi cotransporter mRNA and immunoreactive protein in X-linked Hyp mice. Am J Physiol Renal Fluid
Electrolyte Physiol 268: F1062–F1069, 1995.
388. TENENHOUSE HS, ROY S, MARTEL J, AND GAUTHIER C. Differential
expression, abundance and regulation of Na-phosphate cotransporter genes in murine kidney. Am J Physiol Renal Physiol 275:
F527–F534, 1998.
389. TENENHOUSE HS, WERNER A, BIBER J, MA S, MARTEL J, ROY S, AND
MURER H. Renal Na phosphate cotransport in murine X-linked
hypophosphatemic rickets, molecular characterization. J Clin Invest 93: 671– 676, 1994.
390. THAKKER RV. Molecular genetics of mineral metabolic disorders.
J Inherit Metab Dis 15: 592– 609, 1992.
391. THAKKER RV. The role of renal chloride channel mutations in kidney
stone disease and nephrocalcinosis. Curr Opin Nephrol Hypertens
7: 385–388, 1998.
392. THIERRY J, POUJEOL P, AND RIPOCHE P. Interactions between Na⫹dependent uptake of D-glucose, phosphate and L-alanine in rat renal
brush-border membrane vesicles. Biochim Biophys Acta 647: 203–
210, 1981.
393. THORNTON LR, MEYER MH, AND MEYER RA. Isoproterenol increases
renal tubular reabsorption of phosphate in X-linked hypophosphatemic (Hyp) mice. Miner Electrolyte Metab 25: 204 –209, 1999.
394. TIEDER M, MODAI D, SAMUEL R, ARIE R, HALABE A, BAB I, GABIZON D,
AND LIBERMAN UA. Hereditary hypophosphatemic rickets with hypercalciuria. N Engl J Med 312: 611– 617, 1985.
395. TIMMER RT AND GUNN RB. Phosphate transport by the human renal
cotransporter NaPi-3 expressed in HEK-293 cells. Am J Physiol
Cell Physiol 274: C757–C769, 1998.
396. TRAEBERT M, HATTENHAUER O, MURER H, KAISSLING B, AND BIBER J.
Expression and localization of a type II sodium-phosphate cotransporter in murine type II alveolar epithelial cells. Am J Physiol Lung
Cell Mol Physiol 277: L868 –L873, 1999.
397. TRAEBERT M, LÖTSCHER M, ASCHWANDEN R, RITTHALER TH, BIBER J,
MURER H, AND KAISSLING B. Distribution of the sodium-phosphate
transporter (NaPi-2) during the postnatal ontogeny of the rat kidney. J Am Soc Nephrol 10: 1407–1415, 1999.
398. TRAEBERT M, ROTH J, BIBER J, MURER H, AND KAISSLING B. Internalization of proximal tubular type II Na/Pi cotransporter by parathyroid hormone: an immunogold electronmicroscopy study. Am J
Physiol Renal Physiol 280: F148 –F154, 2000.
399. TRAEBERT M, VÖLKL H, BIBER J, MURER H, AND KAISSLING B. 1–34 and
3–34 parathyroid hormone peptides downregulate proximal tubular
type IIa Na/Pi cotransporters but have different luminal vs. contraluminal actions. Am J Physiol Renal Physiol 280: F792–F798,
2000.
400. TURNER ST AND DOUSA TP. Phosphate transport by brush-border
membranes from superficial and juxtamedullary cortex. Kidney Int
27: 879 – 885, 1985.
401. TURNER ST, KIEBZAK GM, AND DOUSA TP. Mechanism of glucocorticoid effect on renal transport of phosphate. Am J Physiol Cell
Physiol 243: C227–C236, 1982.
402. ULLRICH KJ, RUMRICH G, AND KLOESS S. Phosphate transport in the
proximal convolution of the rat kidney. III. Effect of extracellular
and intracellular pH. Pflügers Arch 77: 33– 42, 1978.
403. UMEMURA S, MARVER D, SMYTH DD, AND JEFFRIES WB. ␣2-Adrenoceptors and cellular cAMP levels in single nephron segments from the
rat. Am J Physiol Renal Fluid Electrolyte Physiol 249: F28 –F33,
1985.
404. VANSCOY M, LOGHMAN-ADHAM M, ONSGARD M, SZCZEPANSKA-KONKEL M,
HOMMA S, KNOX FG, AND DOUSA TP. Mechanism of phosphaturia
Volume 80
October 2000
424.
425.
426.
427.
428.
430.
phate response to parathyroid hormone in vivo. Endocrinology
116: 1085–1089, 1985.
WUARIN F, WU K, MURER H, AND BIBER J. The Na/Pi cotransporter of
OK cells: reaction and tentative identification with N-acetylimidazole. Biochim Biophys Acta 981: 185–192, 1989.
XIAO YS, BOYER CJC, VINCENT E, DUGRE A, VACHON V, POTIER M, AND
BELIVEAU R. Involvement of disulphide bonds in the renal sodium/
phosphate cotransporter NaPi-2. Biochem J 323: 401– 408, 1997.
YABUUCHI H, TAMAI I, MORITA K, KOUDA T, MIYAMOTO K, TAKEDA E, AND
TSUJI A. Hepatic sinusoidal membrane transport of anionic drugs
mediated by anion transporter Npt 1. J Pharmacol Exp Ther 286:
1391–1396, 1998.
YANAGAWA N, NAGAMI GT, JO O, UEMASU J, AND KUROKAWA K. Dissociation of gluoconeogenesis from fluid and phosphate reabsorption
in isolated rabbit proximal tubules. Kidney Int 25: 869 – 873, 1984.
YUN CH, OH S, ZIZAK M, STEPLOCK D, TSAO S, TSE CM, WEINMAN EJ,
AND DONOWITZ M. cAMP-mediated inhibition of the epithelial brush
border Na/H exchanger, NHE3, requires an associated regulatory
protein. Proc Natl Acad Sci USA 94: 3010 –3015, 1997.
YUSUFI AN, BERNDT TJ, MOLTAJI H, DONOVAN B, DOUSA TP, AND KNOX
FG. Rat atrial natriuretic factor inhibits phosphate transport in
brush-border membrane from superficial and juxtamedullary cortex. Proc Soc Exp Biol Med 190: 87–90, 1989.
YUSUFI AN, BERNDT TJ, MURAYAMA N, KNOX FG, AND DOUSA TP.
Calcitonin inhibits Na⫹ gradient-dependent phosphate uptake
across renal brush-border membrane. Am J Physiol Renal Fluid
Electrolyte Physiol 252: F598 –F604, 1987.
1409
431. YUSUFI AN, MOLTAJI H, AND DOUSA TP. Dexamethasone blocks adaptive increase of Na⫹-Pi cotransport in renal brush-border membrane elicited by thyroid hormone. Biochem Biophys Res Commun
161: 1160 –1165, 1989.
432. YUSUFI AN, MURAYAMA N, GAPSTUR SM, SZCZEPANSKA-KONKEL M, AND
DOUSA TP. Differential properties of brush-border membrane vesicles from early and late proximal tubules of rat kidney. Biochim
Biophys Acta 1191: 117–132, 1994.
433. YUSUFI AN, MURAYAMA N, KELLER MJ, AND DOUSA TP. Modulatory
effect of thyroid hormones on uptake of phosphate and other
solutes across luminal brush-border membrane of kidney cortex.
Endocrinology 116: 2438 –2449, 1985.
434. YUSUFI AN, SZCZEPANSKA-KONKEL M, HOPPE A, AND DOUSA TP. Different mechanisms of adaptive increase in Na⫹/Pi cotransport across
the renal brush-border membrane. Am J Physiol Renal Fluid Electrolyte Physiol 256: F852–F861, 1989.
435. ZAJICEK H, WANG H, KUMAR V, WILSON P, AND LEVI M. Role of
sphingolipids in the regulation of renal phosphate transport. Kidney Int 52 Suppl: S32–S35, 1997.
436. ZALUPS RK AND KNOX FG. Calcitonin decreases the renal tubular
capacity for phosphate reabsorption. Am J Physiol Renal Fluid
Electrolyte Physiol 245: F345–F348, 1983.
437. ZAMPIGHI GA, DREMAN M, BOORER KJ, LOO DD, BEZANILLA F, CHANDY
G, HALL JE, ZHANG XX, TENENHOUSE HS, HEWSON AS, MURER H, AND
EYDOUX P. Assignment of renal-specific Na⫹-phosphate cotransporter gene SLC17A2 to mouse chromosome band 13B by in situ
hybridization. Cytogenet Cell Genet 77: 304 –305, 1997.
Downloaded from http://physrev.physiology.org/ by 10.220.32.246 on July 4, 2017
429.
PROXIMAL TUBULAR PHOSPHATE REABSORPTION